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The testicular toxicity of several chemicals was investigated using 
laboratory rats and Beagle dogs. Testicular measurements, assays of 
circulating pituitary-testicular hormones, semen examinations and 
quantitative histometric studies of spermatogenesis were used, when 
appropriate, to complement the results of organ weight analyses and 
conventional histological examinations.
Variations in testicular function may be encountered as a result of 
differences due to species, strain, age, diurnal and seasonal 
rhythms, methods of sampling and spontaneous pathological changes in 
the male reproductive organs. These factors should be considered 
when assessing the importance of testicular changes found after 
administering large doses of chemicals to experimental animals.
Compounds were administered to rats and dogs which affected LH and 
prolactin concentrations as a result of pharmacological overdosage. 
Similar hormonal changes were detected for both species, but differ­
ing degrees of morphological change were encountered in the testes 
and secondary sex organs. The dog appeared to be more susceptible 
to effects on the hormonal control of spermatogenesis than was the 
rat. Hormonally mediated suppression of spermatogenesis was shown 
to be reversible within two spermatogenic cycles following with­
drawal of the test compounds.
Toxicological assessment of some chemical actions on the seminiferous 
epithelium of rats and dogs was attempted. It was possible to 
obtain useful information for compounds having a primary antisperm- 
atogenic action, and the Beagle dog seems to be a suitable non­
rodent species for the toxicological study of these compounds. The 
methods employed for these investigations were less useful for 
assessing the safety of domestic or agricultural chemicals, which 
affected the seminiferous epithelium when administered at excessive 
dosages only.
(i)
Almost 2000 years ago Pliny (77) observed that the toxic potential 
of identical chemicals varied for different animal species. In 
spite of this early observation,toxicologists have tended for 
centuries almost exclusively to study the noxious effects of 
xenobiotic substances. During the last few decades a change in 
emphasis has begun and the modern toxicologist should aim to assess 
the safety of chemicals in normal use. The demonstration of 
toxicity following massive overdosage is probably of secondary 
importance (Noel, 1970). Increasing awareness of the need for 
consumer protection has prompted many governments to introduce 
legislation intended to prevent hazardous exposure to chemicals.
A number of empirical animal toxicity studies must be performed, 
normally in rodents and dogs or other suitable non-rodent species 
(Noel, 1974). The experimental design and choice of animal species 
for these studies is theoretically influenced by metabolic, 
pharmacokinetic and pharmacological considerations (Burns, 1968; 
Noel, 1970; Plaa, 1976). In practice these constraints are seldom 
realised and, correspondingly, the predictive value of animal 
toxicity data may be limited (Fletcher, 1978; Heywood, 1978). 
Species difference in toxicology is not surprising when one 
considers the diverse physical, behavioural, anatomical, physiolo­
gical, biochemical and genetic variations that occur in the animal 
kingdom (Clarke, 1976). Although the need for consumer protection 
is accepted, welfare groups also express concern about animal 
experimentation. In an attempt to reconcile these points of view, 
toxicologists should critically assess the scientific basis and 
predictive limitations of their experiments before subjecting 
animals to prolonged chemical overdosage.
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The toxic effects of chemicals are often selective and tend to 
affect particular target organs or tissues, including the gonads.
It is expected that 15% of married couples will be childless 
and that 30% of these cases__.a%@_attributable to male 
reproductive failure (Walsh, 1979). The diagnosis, therapy and 
prognosis in cases of male infertility pose difficult problems for 
both human and veterinary clinicians (Yeates, 1978). Although the 
clinical manifestations of male reproductive disturbance are readily 
defined, it is possible to implicate a wide variety of aetiological 
factors. The role of chemicals in the pathogenesis of male gonadal 
disorders is largely undetermined. Conventional animal toxicity 
studies identify effects on male reproduction either as reduced 
pregnancy rates or increased intra-uterine losses during fertility 
or multigeneration studies (Jackson et al., 1961; Wright, 1978). 
Changes in the weight and histological appearance of the testes and 
secondary sex organs may become apparent during chronic toxicity 
tests (Heywood and James, 1978). Observations of this type merely 
draw attention to a response in the species tested and provide no 
information about the underlying disruption of physiological 
processes. Even if the mechanisms of toxic action are common to all 
species, extrapolation of toxicity data between species is possible 
only if the inter-species ability to adapt and respond to these 
common mechanisms is understood. Eliasson (197 6) and also a recent 
editorial in the British Industrial Biological Research Association 
Bulletin (1977) have drawn attention to the fundamental lack of 
knowledge concerning chemically mediated testicular toxicity.
Before considering how testicular function may be appropriately 
assessed during animal toxicity studies it,is pertinent to review 
existing knowledge of the ways in which chemicals may modify male 
gonadal activity. Most available data have been discovered during 
attempts to identify compounds suitable for use as male anti­
fertility substances (Gomes, 1970; Jackson, 1969, 1972; de Kretser, 
1976; Patanelli, 1975). More limited information concerning
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compounds with a non-andrological use is available from published 
animal toxicity studies and retrospective epidemiological human 
surveys (Lee and Dixon, 1978; Newburgh, 1975; Ribelin, 1963). The 
most convenient classification is based on the primary disturbance 
induced by the compound, but overlap does occur, and the categories 
listed below are by no means mutually exclusive.
A. Effects on hypothalamic-pituitary-testicular relationships
The hormonal control of mammalian spermatogenesis depends on complex 
interactions between hypothalamic releasing factors, pituitary 
gonadotrophins and testicular androgens (Davidson and Bloch, 1969: 
Creep, 1976; Kovacic, 1970; Steinberger, 1971). Prolactin also 
appears to be important, although its precise actions have yet to be 
defined (Bartke, 1976; Horrobin, 1977). The majority of investi­
gations have been performed with rodent species; more limited 
information is available concerning man and domestic animals.
While a working hypothesis is available,it cannot be assumed that 
species differences do not exist. A number of substances are known 
to impair spermatogenesis by modifying the production or action of 
male reproductive hormones. Table I lists some of the more well- 
known examples.
i) Androgen antagonism
Anti-androgens prevent the uptake of androgens in target tissues 
but do not affect androgen production. Androgens influence bone, 
liver, kidney and skin physiology, as well as the gonads and second­
ary sex organs. Prolonged administration of anti-androgens may 
therefore result in changes similar to those which occur following 
castration (Neumann and Eiger, 1966). Cyproterone acetate has been 
extensively studied as a possible male fertility control agent 
(Morse et al., 1973; Ott et al., 1972; Prasad et al., 1970).
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TABLE I
Chemicals modifying hypothalamic-pituitary-testicular hormones
























Neumann & Eiger (1966) 
Cummins & Orgebin- 
Crist (1974)
Cicero et al. (1975a) 
Saksena et al. (1975) 
Thomas & Dombrosky 
(1975)
Cicero et al. (1977a,b) 
Muraki et al. (1978)
Sherrins et al. (1971) 
Briggs & Briggs (1974) 
Heller et al. (1950)









Van Thiel et al. (1979)
Hemsworth et al. (1968) 
Call & Barker (1967)
Keogh et al. (1976) 
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McGinty & Djerassi (1958) 
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Heller et al. (1959)
Frick et al. (1976) 
Coutinho & Melo (1973)
















Francis et al. (1976) 
Meltzer et al. (1975) 
Rubin et al. (1976) 
Falaschi et al. (1978) 
Bohnet et al. (1976) 
Bartke (1976)
Debeljuk et al. (1975)
Wong et al. (1972) 
Takatori & Yamaoka 
(1979)









Hexachlorocyclohexane Nigam et al. (1979)
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Thomas et al. (1978)
Inhibition of spermatogenesis is achieved only at high dosages 
which also affect libido and other androgen-dependent functions.
ii) Gonadotrophin suppression
Chemicals in this category affect the secretion and release of 
hypothalamic or pituitary hormones. Many investigators have 
attempted to utilise this action as a means of male fertility 
control; compounds developed for non-andrological purposes have 
also exerted similar effects.
Androgens suppress gonadotrophin secretion, but most preparations 
are inactive by the oral route (Jackson, 197 2). Methyltestosterone 
is effective when given orally but induces hepatotoxic changes in 
Beagle dogs (Heywood et al., 1977a) and irreversible testicular 
atrophy in rats (Heywood et al., 1977b) at comparatively low 
dosages.
Oestrogens are potent inhibitors of spermatogenesis. However, 
prolonged administration of these compounds to dogs induced bone 
marrow disorders, together with prostatic hypertrophy and metaplasia 
(Wadsworth, 1979). Administration to rodents for their entire life 
span may induce testicular tumours in mice and hepatic neoplasia 
in rats (Bonser and Robson, 1940; Hooker et al., 1940). In man, 
thrombo-embolic disorders are associated with oestrogen administra­
tion (Vessey and Doll, 1969).
Both the 19-norprogestogens and the 17d-acetoxyprogestogens can 
suppress spermatogenesis, but they are not as active as the 
oestrogens, and the 17^-acetoxyprogestogens are inactive when given 
orally. Published toxicity studies with progestogens in male
6:
laboratory animals are limited. However, the extragonadal 
effects induced in female dogs included obesity, decreased values 
relating to red blood cells, increased liver function enzyme 
activity, hyperglycaemia and mucinous hyperplasia of the gall 
bladder (Capel-Edwards et al., 1973; Rivett et al., 1977).
Hydrazine derivatives (e.g. methallibure) selectively suppress 
gonadotrophin production in rats and dogs. These compounds, 
together with the oestrogens and progestogens, also affect libido 
and potency. Other reported adverse reactions following oestrogen 
or progestogen usage by men include gynaecomastia, breast develop­
ment and tenderness, headaches and nausea (de Kretser, 1976) .
Animal testicular extracts can exert anti-FSH properties (Keogh et 
al., 1976; Reichert and Abou-Issa, 1977). While this may be a new 
approach to the selective suppression of spermatogenesis, the 
toxicological evaluation of these materials must include careful 
assessment of the immune responses which will follow administration 
of 'foreign' protein.
The hypothalamic releasing factors are polypeptide molecules, sec, Teaie-uü 
(Crighton, 1973). Analogues of LH - RH have been synthesised (Coy 
et al., 1974). However, both FSH and LH secretion are affected. 
Depression of LH release produces undesirable loss of libido and 
potency.
Compounds able to modify pituitary gonadotrophin output, but studied 
for non-andrological reasons, include narcotic and peripheral 
analgesics, cannabinoids and histamine receptor antagonists. A 
significant proportion of the population takes narcotic and hall­
ucinogenic drugs indiscriminately and it is important to realise the 
potential gonadal toxicity of these compounds. There is widespread
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non-prescription usage of peripheral analgesics and Boyd (1970) 
noted that many men admitted to hospital following analgesic abuse 
had failed to father children.
The practice of repeatedly administering massive daily dosages to 
animals can be expected to cause exaggerated pharmacological 
reponses. Failure to explain and demonstrate the reversibility of 
effects on reproductive hormones, such as those which occur following 
high dosages of non-addictive narcotic analgesics to animals, means 
that potentially useful drugs may fail to satisfy pre-clinical 
toxicity regulations.
iii) Prolactin stimulation
A large number of tranquillisers, neuroleptic and psychotropic 
drugs exert their pharmacological activity by inhibiting dopamine 
synthesis or release. Bang and Gautvik (1977) have shown that 
dopamine can inhibit prolactin release from pituitary cells. Over­
dosage with a dopamine blocking agent may therefore produce a state 
of hyperprolactinaemia. In the human male, hyperprolactinaemia is 
associated with decreased libido and testosterone levels and 
testicular atrophy (Horrobin, 1977). Dopamine inhibitors often 
have major clinical indications such as schizophrenia, alcoholism, 
dyskinesias and depression syndromes. Assessment of hyperprolactin- 
aemic potency may be an important factor in the animal safety 
evaluation of such drugs.
iv) Testosterone synthesis inhibition
The Leydig cells are the major site of androgen synthesis. Drugs 
which interfere with Leydig cell metabolism or block steroid 
synthesis may decrease synthesis of testosterone and other related 
androgens. The clinical manifestations of decreased androgen
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synthesis would be similar to those seen after administration of 
anti-androgens. Drugs with pharmacological actions on lipid and 
steroid metabolism, e.g. anorectics, hypocholesterolaemic agents 
and antihistamines, may induce phospholipidosis. Histologically, 
phospholipidosis is characterised by the presence of foamy 
macrophages and myeloid inclusion bodies at sites of steroid 
synthesis; the testes and epididymides are common sites for these 
lesions (Heywood and James, 1978).
Certain organochlorine insecticides are widely used for agri­
cultural and horticultural purposes. The biodégradation of these 
compounds is slow, and appreciable quantities may accumulate in the 
environment. It has been shown that DDT and several other insecti­
cides have induced fertility disorders in rodents and other wild 
life. The bulk of experimental evidence suggests that impaired 
testosterone metabolism occurs because these insecticides inhibit 
the binding of dihydrotestosterone to cytoplasmic receptors during 
testosterone synthesis, C TViomaS «-t ojl. j .
B. Effects on the seminiferous epithelium
The seminiferous epithelium comprises the germinal cells and Sertoli 
cells. Cell renewal and division occurs continuously throughout 
adult male life. Characteristic associations between successive 
generations of germ cells (Clermont, 1962) and clockwork precision 
in the timing of cell divisions (Roosen-Runge, 1962) have been 
demonstrated for several mammalian species. The entry of substances 
into the germinal compartment of the testes is selectively regulated 
by a physiological 'blood-testis' barrier (Setchell and Waites, 1975). 
In addition to selective permeability, the presence of testicular 
detoxicating enzymes and efficient DNA. repair mechanisms in pre- 
meiotic spermatogenic cells (Lee and Dixon, 1978) also influences
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the toxic and mutagenic potential of chemicals. Table II lists some 
chemicals known to exert cytotoxic actions on the seminiferous 
epithelium. Selective chemical actions on the seminiferous epithel­
ium include alteration of blood flow and actions on mitotic and 
meiotic stages of spermatogenesis. Ionising radiation attacks 
dividing spermatogonia (Johnson and Newmany 1976) , but resting 
spermatogonia are unaffected; consequently transient infertility 
occurs. Drugs such as aziridine derivatives, sulphonic acid esters, 
nitrogen mustards, cyclophosphamide and trimethylphosphate also exert 
this 'radiomimetic' effect. Many other substances, including anti­
biotics, anthelmintics, cyclamates, phthalate esters, organic 
insecticides and metals also exert cytotoxic effects. The cell types 
affected and the severity of damage often reflect the dose administe­
red. Cadmium has been shown to affect spermatogenesis by altering 
testicular blood flow (Gunn et al., 1963).
The radiomimetic drugs have been studied extensively for their anti­
fertility effects. However, selective action cannot be obtained and 
the toxic effects in other tissues, notably the bone marrow, preclude 
long-term usage of these compounds. The diamines, nitrofurans, 
thiopenes and nitro-aromatic compounds have all produced unacceptable 
toxic reactions or side effects and cannot be considered to be suit­
able as male contraceptive agents. The indazole-carboxylic acids are 
currently being investigated and extensive toxicity data are not yet 
available. The data from animal studies concerning the testicular 
damage due to cyclamates, other food additives and industrial chemi­
cals cause considerable debate. The changes are usually seen after 
prolonged massive administration and,in most cases,the underlying 
mechanisms of toxicity have yet to be defined. Human epidemiological 
data show that 1,2-dibromo-3-chloro-propane is associated with 
abnormal male fertility at production plants (Biava et al.,
1978; Sandifer et al., 1979; Whorton et al., 1977).
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TABLE II










Hendry et al. (1951) 
Brittinger (1966) 











Texter & Coffey (1969) 
Trentini et al. (1974) 
Prior & Ferguson (1950)
Sieber et al. (1978)
Anthelmintics Carbon tetrachloride 
Hexachlorophene
de Toranzo et al. (1978) 
Thorpe (1967)
Diamines Dichloroacetyldiamines Coulston et al. (1960)
Food additives Cyclohexylamine 
Metanil yellow
Mason & Thompson (1977) 
Singh & Khanna (1974)
Indazoles 5-Aminoindazole Lobl & Porteus (1977)
Indazole-carboxylic acids Catanese et al. (1977)






Eyden et al. (1978)
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TABLE II (continued)















King et al. (1963) 
Jackson (1969)
Jones et al. (1976)
Biava et al. (1978) 
Sandifer et al. (1979) 
Whorton et al. (1977) 
Steinberger & Sud (1970)







Friedman et al. (1979)
Bustos-Obregon & Feito 
(1974)
Cooke et al. (1978)
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Torkelson et al. (1961) reported testicular damage as one of the 
toxic effects of this compound in several species of laboratory 
animal, and it was suggested that the maximum tolerated atmospheric 
concentration should be 1 ppm. This is a rare example of absolute 
correlation between empirical animal toxicity data and subsequent 
human experience.
C . Effects on extratesticular spermatozoa
After completion of testicular spermatogenesis, the formed 
spermatozoa are also vulnerable to chemical action during passage 
through the excurrent duct systems. Spermicidal and spermiostatic 
effects or interference with fertilising capacity have been 
demonstrated for a number of compounds (Table III). Mann (1964) , 
although mainly using ^  vitro experiments, has demonstrated that 
spermicidal or spermiostatic actions follow disruption of sperm- 
atozoal carbohydrate metabolism and respiration, enzyme inhibition, 
sulphydryl binding and surface effects on sperm membranes. Many 
chemicals acting in this way have been used for local contraception 
in the form of creams and lotions, but most are unsuitable for 
parenteral administration. A number of synthetic proteinase 
inhibitors have been shown to inhibit sperm acrosin vitro 
(Bhattacharyya et al., 197 6). These substances cannot be tested 
in vivo until their effects on proteinases from other tissues, pan­
creatic trypsin for example, are known. Chlorohydrin and its 
analogues have been studied extensively for their selective glyco­
lytic effect on epididymal spermatozoa when administered at low 
dosages (Mohri et al., 1975). The first analogues were found to be 
myelotoxic in primates and to produce- severe testicular atrophy in 
rats at a small multiple of the clinically effective dosage* The 
most recent analogue, l-amino-3-chloro-2-propanol hydrochloride, 
induced lesions in the medulla oblongata of rhesus monkeys (Heywood 
et al., 1978) and testicular atrophy and epididymal sperm granulomata in
;13:
TABLE III
Chemicals affecting extratesticular spermatozoa
Generic class Cited examples Author(s)
Acrosin inhibitors p-Nitrophenyl-p'- Bhattacharyya et al
Chlorohydrins
guanadino benzonate (1976)
Diisopropyl fluorophos- Gilboa et al. (1973)
phate
Tosylamide phenylethyl Fritz et al. (197 2) 
chloromethyl ketone
Tosyl-lysine chloro- Zaneveld et al. (197 2) 
methyl ketone
3-Chloro-l,2-propane- Ericsson & Youngdale 
diol (1970)
l-Amino-3-chloro-2 Coppola & Saldarini
propanol hydrochloride (1974)
Chlorinated sugars 6 Chloro-6-deoxyglucose )
/Ford & Waites (1978) 
6 Chloro-6-deoxyfructose)
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rats at doses Qf 50 mg/kg/day and above (James et aL , 1978). Ford and 
Waites (1978) have investigated the reversible contraceptive action 
of some chlorinated sugars in rats. The results of studies on the 
extragonadal toxicity of this group have not yet been published.
D. Effects of chemically induced nutritional disturbance
Present regulations for the safety assessment of food additives, 
crop sprays, herbicides, insecticides, etc. require dietary 
administration to dogs and rodents for up to two years. Addition 
of large quantities of chemicals to the diet may restrict the 
availability of some essential nutrients, or, alternatively, may 
reduce palatability. The effects of restricted food intake on the 
fertility of domestic animals were discussed by Reid (1949) . Oishi 
et al. (1979) studied the effects of food restriction on some common 
toxicity characteristics in rats and noted tha,t severer malnutrit­
ion prevented testicular growth. Much earlier, Mulinos and 
Pomerantz (1941) showed that inanition atrophy of the rat testes 
and secondary sex organs could be reversed by administration of 
chorionic gonadotrophin. Dietary deficiency of the amino acid 
valine resulted in decreased serum concentrations of FSH and LH in 
female rats (Glass and Swerdloff, 1977). Leathern (1975) reviewed 
the relevant literature and stated that essential fatty acid 
deficiency, avitaminosis A and E, lack of biotin, pyridoxine and 
thiamine and reduced availability of phosphorus, zinc, manganese and 
calcium,can each produce adverse effects on spermatogenesis. The 
same author concluded that the changes could be attributed to 
effects either on testicular metabolism or on the production of 
hypothalamic pituitary hormones. Immature animals are more prone to 
nutritional disturbance of reproductive function than are adults.
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This is important when one realises that most regulatory 
authorities require long-term studies to incorporate the period 
of active growth within the dosage schedule. Toxicological 
investigations may also require overdosage with naturally occurring 
substances. The observation that dietary excess of ethionine, for 
example,(Goldberg et al., 1961) causes degenerative testicular 
lesions,emphasises the need to consider the toxicological effects 
of dietary excesses as well as those of deficiencies.
Within the existing framework of chronic and reproductive toxicity 
testing it is sometimes difficult to assess the relevance of 
adverse effects on the testes of laboratory animals, particularly 
when the responses occur only after administration of abnormally 
high dosages or as a result of impaired food intake. Understanding 
of the pharmacological and physiological basis for the observed 
changes may contribute significantly to the assessment of risk 
attributable to the test chemicals. From the toxicological view­
point, the mechanisms of action, functional disturbances and 
duration of the effect are important factors. Two major functional 
disturbances are likely to arise: either infertility, or mutagenic
damage to spermatozoa. Bateman and Jackson (1974) have discussed 
screening procedures for mutagenic hazards of chemicals exerting 
antifertility effects and this aspect will not form a major theme 
of this dissertation. The principal aim of the experiments 
reported in the first section of this thesis was to assess the 
feasibility of incorporating some clinical testicular function 
tests and quantitative histological examinations within the frame­
work of existing chronic toxicity protocols. In the second and 
third sections the value of these techniques in the toxicological 
assessment of chemical effects on the hypothalamic-pituitary- 
testicular axis and on the seminiferous epithelium is examined.
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1. The assessment of testicular function
In clinical practice the diagnostic techniques available for the 
investigation of abnormal testicular function include detailed 
history, chromosomal analyses, endocrine assays, semen evaluation 
and histological examination of testicular biopsies (Adamopoulos et 
al., 1978; Chapman et al., 1979; Holdsworth et al., 1977; Nieschlag, 
197 9). Anamnesis includes in-depth surveys of previous fertility, 
contraceptive habits, intercurrent health or injury, libido and 
sexual behaviour. Genetically induced reproductive failure may be 
recognised by chromosomal examination. The functional integrity of 
the hypothalamic-pituitary-testicular axis can be assessed on the 
basis of circulating FSH, LH, prolactin and testosterone activities. 
Hormonal responsiveness in various stimulation or suppression tests 
is practicable. Such tests include the LH-RH stimulation test (de 
Kretser et al., 1975), the pituitary LH suppression and human 
chorionic gonadotrophin (HCG) stimulation tests (Holdsworth et a l . ,
1977) and the metabolic clearance rate of LH (Pepperell et a l . , 1975)* 
Aiman et al. (1979) have demonstrated the value of measuring the 
affinity of cytosolic receptor protein for dihydrotestosterone in 
genital skin fibroblast cultures as an index of androgen sensitivity. 
The potential of semen evaluation in the management of male infertil­
ity and the assessment of testicular hazards following occupational 
exposure to chemicals has been discussed by Eliasson (1978). The 
standard semen examinations include measurements of volume, 
viscosity and liquefaction together with spermatozoal motility, 
concentration and morphology. Biochemical investigations of semen 
can include estimation of acid phosphatase, citric acid, fructose, 
prostaglandins, zinc and magnesium. Crabbe (1977) considers that 
fumarase and diamine oxidase are the most reliable enzyme indices of 
fertility in human semen. Histological assessment of the seminifer­
ous epithelium is normally limited to the examination of testicular
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biopsies for the infertile human male (Hendricks et al., 1969;
Rowley and Heller, 1966; Wong et al., 197 3a, b)..-Qunatitative assess­
ment of spermatogenesis (Holdsworth et al., 1977; de Kretser et al., 
1974) and seminiferous tubule curvature (Averback and Wight, 1979) 
are useful adjuncts to subjective assessment of testicular biopsies. 
Application of some or all of the systematic testicular function 
tests already described enables andrologists to define lesions, to 
speculate on aetiological mechanisms and to prognosticate and 
institute appropriate therapeutic measures,.
In the field of experimental animal pathology the range of available 
investigations can be extended (Neumann and Schenck, 197 9) and 
includes testicular enzyme histochemistry (Blackshaw and Elkington, 
1970; Cohen et al., 1976), blood-testis-barrier pharmacokinetics 
(Setchell and Main, 1978) and induction of testicular metabolising 
enzymes (Lee and Dixon, 1978). With regard to conventional labor­
atory animal safety evaluation studies, the inclusion of testicular 
function tests is subject to the constraint that investigations 
performed in the living animal should not exert any influence which 
might prejudice the overall objectives of the investigation. In 
practice, toxicological protocols are frequently limited to clinical 
observation, examination of body fluids and tissue biopsies, which 
complement a more extensive range of post-mortem studies.
The aim of the studies described in this chapter was to define 
characteristics of testicular function which can usefully be inclu­
ded in chronic animal toxicity protocols to clarify mechanisms of 
testicular toxicity and enhance the risk-benefit assessment of the 
data obtained.
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1.1. Choice of animal models and parameters
The ultimate test of male fertility is the induction of pregnancy 
in receptive females. In the context of predictive animal safety 
evaluation the absence of effects in rodent breeding studies, and 
failure to induce gonadal changes following long-term administration 
to both rodent and non-rodent species, are normally considered to be 
satisfactory negative data for the assessment of potential human 
reproductive hazards. When positive findings occur, particularly 
after prolonged overdosage, it is desirable to determine the 
biological significance and potential reversibility of the observed 
effects. Serial mating procedures (Jackson et al., 1961; Wright,
1978) may clarify the situation. The availability, convenient size 
and reproductive physiology of the common laboratory rodent species 
facilitates the conduct of test-mating procedures. The non-rodent 
species,such as the Beagle dog and sub-human primates, take longer to 
attain sexual maturity, exhibit seasonal breeding rhythms, do not 
always breed successfully under laboratory conditions and have 
lengthy gestation periods. For these reasons, and the numbers of 
successful matings required for meaningful statistical appraisal, 
the assessment of testicular toxicity in non-rodent species presents 
serious practical difficulties. Assessment of male fertility based 
on testicular measurements, hormonal assays, and semen evaluation 
followed by detailed pathological examination,appears to offer 
attractive alternative possibilities (Heywood and James, 1978). 
Extension of these techniques to chronic toxicological evaluations 
in rodent species may provide explanations for apparent species 
differences in the severity and manifestations of testicular 
toxicity.
:19;
It should be stated at the outset that although all, or most, of 
these alternative techniques can be successfully applied to male 
rodents and dogs, the suitability of male laboratory macaques and 
baboons to these investigations is limited (Heywood and James, 1980). 
Male animals of these species do not attain sexual maturity before 
five years of age; the physical size and aggressive behaviour'of 
mature male macaques and baboons presents problems with regard to 
housing, restraint, dosing and examination. The male rhesus 
(Macaca mulatta) is a seasonal breeder and despite maintenance of 
a constant laboratory environment, circulating reproductive hormone 
concentrations (Beck and Wuttke, 1979; Michael and Bonsall, 1977;
Slob et al., 1979) and the histological appearance of the seminifer­
ous epithelium (Richter et al., 1978) vary according to the time of 
year. Mahone and Dukelow (1979) were unable to demonstrate seasonal 
changes in body weight or the semen characteristics of cynomologous 
monkeys (Macaca fasicularis); however, seasonal variation in test­
icular volume was apparent. The importance of the latter observation 
with regard to the overall reproductive efficiency of laboratory- 
housed male cynomologous monkeys has yet to be determined. Rectal 
probe electro-ejaculation is the most feasible method of collecting 
semen from monkeys (Roussel and Austin, 1968). There are con­
siderable variations in the quality of the semen collected by 
electro-ejaculation (van Pelt and Keyser, 1970) and, unless 
elaborate precautions are taken, the ejaculate rapidly coagulates 
(Fordney Settlage and Hendrickx, 1974). For these reasons the 
present studies were confined to rats and Beagle dogs.
: 20:
1.2. Clinical Assessment
The procedures selected for study were testicular measurements, 
assay of pituitary-testicular hormones, semen evaluation and 
testicular biopsy. The principal aims were to establish ranges of 
expected values for the various characteristics with particular 
attention to methodology and age-related variations. A review of the 
relevant literature indicated that, although considerable published 
data were available for the laboratory rat, studies of the Beagle 
dog were almost non-existent. Eight pure-bred male Beagles, 
aged ten weeks, were selected from the colony maintained at 
Huntingdon Research Centre. The animal management and housing was as 
described in Appendices I (i) - (iii) . These dogs were used to 
monitor the onset of sexual maturity and to establish valid 
testicular function criteria for young adult male Beagles. The 
potential of testicular biopsy as an investigative toxicological 
technique was assessed. Analysis of variance was performed on the 
results from biopsied and non-biopsied dogs. Because no statistic­
ally significant differences (p>0.05) were apparent, the pooled 
data are presented in the following sub-sections. The results of 
the canine investigations have been complemented by inclusion of 
comparable data for rats abstracted from the literature available.
1.2.1. Testicular measurements
Although the embryology, gross anatomy and histology of the testes is 
essentially similar for all mammals, marked species differences occur, 
particularly in the position of the testes within the scrotum 
(McKeever, 1970). The testes of the dog are well descended into a 
thin-walled scrotum and the epididymides are easily located by 
palpation; however, the scrotum of the rat is thickened and well 
defined, the testes being carried high up and difficult to
:21:
distinguish from the epididymides by palpation. The measurement of 
testicular dimensions is probably of value for the dog only.
The testes of eight growing Beagle dogs were measured and the cross-
2
sectional area (mm )in a sa^gital plane calculated, see Appendix 
I (iv), at 13, 17 and 21 weeks of age and then at fortnightly 
intervals until 49 weeks and additionally at 53 and 60 weeks. The 
area of each testis, on each occasion, was averaged and mean values 
calculated. The body weight (kg) of each dog was also noted at the 
time of testicular measurement. Regression analyses were performed 
and linear correlations between body weight and testicular area were 
assessed.
The relationships found between testicular area and body weight are 
presented diagrammatically in Fig. 1.2.1.1. Statistically signifi­
cant linear correlations (p<0.05) were apparent between 19-31 weeks 
of age only. At all other times examined, testicular area appeared 
to vary independently of body weight. After 37 weeks there were no 
marked fluctuations in testicular area or body weight. The overall
mean testicular area of the dogs between 37 and 60 weeks of age was
+ 2 2 
547 - 27 (SEM) mm per testis with a range of 456 - 746 mm . The
results are in agreement with the findings of Lutzen et al. (1976)
who recorded positive allometric growth of the Beagle testes between
7 and 180 days of age only.
1.2.2. Pituitary testicular hormones
Radioimmunoassay procedures for the determination of prolactin, 
follicle-stimulating hormone (FSH), luteinising hormone (LH) and 
testosterone are well established for the rat. Although prolactin, 
LH and testosterone assays are available for the dog, a validated 
canine FSH assay does not appear to have been described.
; 22:
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Fig. 1.2.1.1. Relationship between testicular area 
and body weight for growing male Beagles. Data are 
mean values obtained from 8 dogs on each occasion.
23:
Plasma was obtained. Appendix I (v), from eight growing male 
Beagles at monthly intervals from 13 to 45 weeks of age. The 
samples were obtained between 10.00 and 12.00h on each occasion.
The plasma concentrations (ng/ml) of prolactin, LH and testosterone 
were determined by appropriate radioimmunoassay techniques. Appendix 
I (vi).
1.2.2.1. Prolactin
Only recently has prolactin been considered to be involved in male 
reproduction. Under physiological conditions, prolactin synergises 
with LH in the regulation of testosterone synthesis, secretion and 
inhibition (Horrobin, 1977). Paradoxically, increased circulating 
prolactin concentrations are associated with decreased androgen 
synthesis and testicular atrophy.
For young adult male rats, aged 50-90 days, serum prolactin 
concentrations between 20 - 40 ng/ml are expected (Table 1.2.2.1.). 
Prolactin concentrations in sera from rats under 30 days old normally 
measure less than 10 ng/ml (Negro-Vilar et al., 1973; Piacsek and 
Goodspeed, 1978). Mattheij and Swarts (1978) confirmed the 
existence of circadian variations in the plasma prolactin concen­
trations of adult male rats, aged 6 - 9  months. These authors 
concluded that prolactin levels were most constant between 07.00 
and 15.00h. Circulating prolactin concentrations of male rats, aged 
22-30 months, show at least a three-fold increase in comparison with 
rats aged 4-6 months (Riègle and Meites, 1976).
Euker et al. (1975) provided evidence that prolactin levels were 
lower in serum from non-stressed decapitated rats than in serum 
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Canine prolactin cannot be satisfactorily measured using 
heterologous radioimmunoassay techniques. Homologous radioimmuno­
assays for canine prolactin have been described (Graf et al., 1977; 
Knight et al., 1977). Published values for serum prolactin 
concentrations of normal male dogs vary from 1-2 ng/ml (Graf et al., 
1977) to 8.8 - 0.8 ng/ml (Knight et al., 1977). No previously 
published studies of prolactin concentration in growing or aged 
dogs, or of the effects of stress, were found in the literature.
Measurements of plasma prolactin concentrations in samples obtained 
at monthly intervals from eight Beagle dogs between the ages of 
13 - 45 weeks (Fig. 1.2.2.1.) gave the highest values at 13 weeks 
(2.4 - 5.8 ng/ml). Lower values were apparent at 17 and 21 weeks; 
subsequently only minor variations in plasma prolactin concentrat­
ions occurred. From the pooled data obtained between 29 and 45 
weeks of age,the results of this study suggest that prolactin 
concentrations of the order of 1-2 ng/ml are to be expected in the 
plasma of normal adult male Beagles.
1.2.2.2. Follicle-stimulating hormone (FSH)
The aJtimuKTfa for FSH secretion is thought to involve 'inhibin', 
an inhibitory hormone produced in the seminiferous tubules 
(Setchell et al., 1977). Although the precise role of FSH in 
spermatogenesis remains controversial, rises in serum FSH follow 
selective or massive depletion of the seminiferous epithelium 













13 17 21 25 29 33 37 41 45 Age (weeks)
Fig. 1.2.2.1. Plasma hormone concentrations of growing male 
Beagles. Prolactin expressed as ng/ml of canine pituitary 
preparation CPA3/F4. LH expressed as ng/ml canine pituitary 
preparation LER-1685-1. Vertical lines represent 1 
standard deviation of the mean.
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In the male rat# FSH levels are high (660 - 58 ng/ml) during the
first five days of post-natal life (Lee et al., 1975), but
subsequently fall to between 200-300 ng/ml. Elevated concentrations 
exceeding 300 ng/ml are apparent between 30 and 45 days of age,
coinciding with the appearance of mature spermatozoa in the
seminiferous tubules (de Jong and Sharpe, 1977; Lee et al., 1975; 
Negro-Vilar et al., 1973; Piacsek and Goodspeed, 1978). For young 
adult male rats,the published values for serum FSH concentration 
(Table 1.2.2.1.) appear to vary according to strain. For Sprague- 
Dawley rats, values between 200-600 ng/ml are expected.
As stated earlier, there appear to be no—reports of a validated 
radioimmunoassay for canine FSH and, consequently, no data can be 
provided for FSH in the Beagle dog.
1.2.2.3. Luteinising hormone (LH)
The consensus of current scientific opinion is that LH regulates 
androgen synthesis and may be involved in spermatid maturation. 
Depletion of the seminiferous epithelium does not provoke 
increased LH secretion in the rat (Collins et al., 1978; Debeljuk et 
al., 1973), a J Ü U t w ^  Houma. •
During immediate post-natal life the serum concentration of LH of 
male rats is high ( >3 ng/ml) corresponding to the period of the 
regression of foetal Leydig cells (Lee et al., 1975). Lower 
circulating LH concentrations occur in male rats aged 10-3 5 days ; 
peak concentrations occur from 35 days onwards, associated with the 
establishment of adult Leydig cell function (de Jong and Sharpe, 
1977; Lee et al., 1975; Negro-Vilar et al., 1973; Piacsek and 
Goodspeed, 1978). There is considerable disagreement in the publi­
shed values for the serum LH concentrations of young adult male rats
:28
(Table 1.2.2.1.). Mock et al. (1975) studied seasonal variations 
in serum LH concentrations of laboratory maintained SprSgue-Dawley 
rats and concluded that, although testicular function remained 
constant throughout the year, seasonal effects on hormonal status 
were apparent. Gray (1978) provided experimental evidence that the 
concentration of LH in the circulation of male Long-Evans rats 
declines with advancing of age. Reduced LH concentrations at 13,
17, 19 and 21 months of age differed significantly (p <0.05) from 
those in rats aged 3 - 4  months.
The use of anti-ovine LH has been validated for the heterologous 
radioimmunoassy of canine LH (Smith and McDonald, 1974). DePalatis 
et al. (1978) measured the serum LH concentrations of healthy adult 
male mongrel dogs at 20-minute intervals for 24 consecutive hours 
and recorded^values of 0.2-12.0 ng/ml. Measurement of plasma LH 
concentrations in eight young Beagle dogs at monthly intervals 
between 13 - 45 weeks of age (Fig. 1.2.2.1.) indicated a wide 
variation in LH concentration and, apart from lower values (<0.5 ng/ 
ml) at 13 weeks, no obvious trends were apparent. For young adult 
male Beagles aged 29-45 weeks, plasma LH values varied between <0.5 
- 11.6 ng/ml (Table 1.2.2,2.).
1.2.2.4. Testosterone
In man it is known that significant cross-reaction between 
circulating androgens other than testosterone e.g. dihydrotestos­
terone and androstendione, requires elaborate extractive chromato - 
graphic treatment of samples before radioimmunoassay. Tremblay 
et al. (1972) studied the dynamics of plasma androgens in dogs, and 
concluded that the major peripheral androgen is, in fact, testosterone
;29
Hormone Concentration ( ng/ml )
Mean SEM Range
Prolactin 1.76 - 0.16 1.1 - 3.3
Luteinising hormone 
(LH)
3.81 - 0.78 <0.5 - 11.6
Testosterone 1.55 - 0.38 0.2 - 4.1
Table 1.2.2.2. Circulating pituitary-testicular hormone 
concentrations of young adult male Beagles.
Pooled data based on 40 assays per hormone using plasma obtained 
from eight Beagles at monthly intervals from 29 until 45 weeks of 
age. Prolactin expressed as ng/ml of canine pituitary preparation 
CPA3/F4. LH expressed as ng/ml of canine pituitary preparation LER- 
1685-1.
: 30:
Frankel and co-workers (197 5) undertook extensive characterisation 
and physiological validation of a radioimmunoassay for plasma 
testosterone in the male rat. These workers developed an 
extraction procedure, excluding a chromatographic phase, which 
reduced cross-reaction with dihydrotestosterone to less than four 
per cent. This particular radioimmunoassay procedure has 
previously been used for the measurement of circulating canine 
testosterone (DePalatis et al., 1978).
For male rats, circulating testosterone concentration is consistently 
less than 0.5 ng/ml before the 25th day of post-partum existence 
(Gupta et al., 1975; de Jong and Sharpe, 1977; Lee et aL, 1975; 
Moger, 1977). Subsequently, values tend to increase until about 70 d a y s , 
when adult values are established, the expected range being shown 
in Table 1.2.2.1. Circadian variations in testosterone secretion 
are found in both immature and mature male rats (Bartke et al.,
1973; Moger and Murphy, 1977), and seasonal variations in testos­
terone concentrations are also apparent (Mock et al., 197 5). Aged 
Long-Evans rats developed a statistically significant reduction of 
circulating testosterone after 15 months of age; by 21 months the 
values obtained showed a three-fold diminution in comparison with 
contemporary male rats aged 3 - 4  months (Gray, 1978).
Previously recorded peripheral testosterone concentrations for 
normal adult mongrel dogs were 1.15 - 0.46 ng/ml (Tremblay et al., 
1972) and 0.4 - 6.0 ng/ml (DePalatis et al., 1978). Serial 
examinations of plama testosterone values in growing Beagle dogs 
(Fig. 1.2.2.1.) revealed marked age-related changes. At 13 weeks 
of age, values varied between 0.2 and 0.4 ng/ml, and successive 
increases were recorded between 13 and 29 weeks of age. After 29 
weeks there were no major differences in the range of results 
obtained at each examination. The findings of this study agreed
:31:
with previously published data and established a range of expected 
plasma testosterone values of 0.2 - 4.1 ng/ml for young adult 
male Beagle dogs.
1.2.3. Semen examination
Semen collection using a 'teaser' bitch, artificial vagina or 
digital manipulation is feasible for dogs. The most convenient 
method is to use an artificial vagina (Harrop, 1954). There are 
comparatively few reports of systematic semen evaluations performed 
with rats. Electro-ejaculation of male rats is recorded, but the 
applied voltage and frequency of stimulation are critical factors 
(Birnbaum and Hall, 1961; Blandau and Jordan, 1941; Moore and 
Gallagher, 1934; Scott and Dzuick, 1959). Long-term adverse 
effects on subsequent growth and performance were apparent, follow­
ing electro-ejaculation of rats (Scott and Dzuick, 1959) . Surgical 
cannulation of the rat rete testis efferent ductules (Cooper and 
Waites, 1974; Tuck et al., 1970) is not entirely satisfactory 
because the spermatozoa are not exposed to the secondary sex 
secretions produced in the epididymis, prostate and seminal 
vesicles. Mason and Thompson (1977) described a procedure for the 
collection and examination of epididymal spermatozoa during post­
mortem examination. In life, male rats, housed away from females 
ejaculate spontaneously (Orbach, 1961) . Vandenbergh (1971) suggests 
that regular examination of penile smears may provide limited 
information concerning testicular function. In the absence of a 
satisfactory technique for collecting semen from rats, semen 
examination was therefore restricted to Beagle dogs. Physical and 
biochemical investigations are pertinent to the examination of dog 
semen.
:32
1.2.3.1. Physical examination of canine semen
The physical examination of semen includes assessment of ejaculate 
volume, motility and density together with determinations of sperm 
concentration and morphology. Normal values, including expected 
ranges of variation for these semen characteristics, are reported 
for healthy adult dogs of various breeds, including Beagles (Boucher 
et al., 1958; Harrop, 1955; Heywood and Sortwell, 1971).
Eight young Beagles were introduced to the use of an artificial 
vagina at 25 weeks of age. Once the dogs had produced ejaculates 
regular semen collections were made at fortnightly intervals until 
45 weeks of age, also at 49 and 53 weeks with weekly collections 
between 61 and 66 weeks. The volume, density, motility, sperm 
concentration and morphology of the samples were assessed, see 
Appendix I (vii).
Although some of the dogs responded to stimulation with the 
artificial vagina at 29 weeks, no ejaculates were obtained before 33 
weeks of age. The changes in the mean values for the selected 
characteristics at all the examinations made between 33 and 66 weeks 
are presented graphically in Fig. 1.2.3.1. The first ejaculates 
tended to be of low volume (1.6 - 0.8 ml) and contained large numbers 
of dead (41.2 - 17.8%) and morphologically abnormal (41.8 - 8.2%) 
spermatozoa. The principal structural abnormalities observed were 
loose or split heads, cytoplasmic beads and coiled or short tails. 
Between 35 - 41 weeks of age,semen volume increased and the incidence 
of dead or abnormal spermatozoa decreased. The data obtained bet­
ween 41 and 66 weeks were used to calculate expected values and 






























Fig. 1.2.3.1. Changes in the semen characteristics of Beagle 
dogs between 33 and 66 weeks of age.
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Inspection of the results shows that considerable variations 
occurred for all the parameters measured but most notably for the 
ejaculate density, motility and sperm concentration.
1.2.3.2. Biochemical examination of canine semen
The accepted methods of assessing sperm concentration, morphology 
and motility, although essentially quantitative, may be prone to 
observer bias. The sperm concentration of canine ejaculates is 
very variable and, because of the length of time elapsing from 
start to completion of ejaculation, the often low values recorded 
for sperm motility may not be a reliable index of semen quality. 
Crabbe (1977) has suggested that determinations of enzyme 
concentrations in human semen could form the basis of a rigorous 
quantitative assay of semen quality. Parallelism between semen 
characteristics and aminotransferase concentrations has been 
investigated in the bull by Roussel and Stallcup (19 61). The same 
authors (1966) published data for the phosphatase activities of 
bovine semen. Bartlett (1962b) reviewed the results of biochemical 
studies of canine semen published before 1962; data concerning pH, 
electrolyte and trace element composition, protein, carbohydrate 
and amino-acid content were also described. The large volume of 
the canine ejaculate is largely attributable to the third fraction 
secreted by the prostate gland (Bartlett, 1962a; Harrop, 1955) .
The presence of both alkaline and acid phosphatase was first 
recorded by Huggins (194 5). The presence of acid phosphatase in 
canine prostatic secretion has been confirmed by Rosenkrantz and 
Kirdani (1961). Boria et al. - (1963) compared the phosphatase 
activities of canine prostatic fluid obtained by pharmacological 
and mechanical stimulation and found some evidence that these 
enzymes may be useful indices of canine prostatic function.
; 36 :
Tenniswood et al. - (1978) concluded, on the basis of histochemical 
studies, that acid phosphatase is an accurate biochemical marker 
of prostate activity in the rat.
Semen was collected from eight Beagle dogs at weekly intervals from 
61 to 66 weeks of age. The same dogs had been used for the 
studies previously described, and were considered to be a 
population of dogs with normal testicular function. The volume, 
density, motility, sperm concentration and morphology of each 
ejaculate was assessed, see Appendix I (vi). The ejaculates were 
kept at room temperature for approximately 30 minutes and then 
centrifuged at 2000 g for 10 minutes. The supernatant seminal 
plasma (free from spermatozoa) was decanted. The remaining sperm 
fractions were resuspended in Fison's phosphate buffer solution 
(pH 7, sodium 53 mEq/litre, potassium 20.1 mEq/litre). Seminal 
plasma and sperm fractions were stored deep-frozen (-20°C) until 
biochemical examinations were made. Sodium and potassium ions, 
alanine and aspartate aminotransferase and alkaline and acid 
phosphatase concentrations were measured, see Appendix I (vi).
Mean values for each physical (Table 1.2.3.1.) and biochemical 
(Table 1.2.3.2.) parameter were calculated. Statistical compari­
sons (Anovar) between the mean values for individual dogs and 
pooled weekly data did not reveal any significant differences 
(p >0.05). The following results are therefore based on the 
pooled weekly data.
Each dog produced satisfactory ejaculates at every collection and 
the physical characteristics of the ejaculates were all within 
previously published ranges (Boucher et al., 1958; Harrop, 1955; 
Heywood and Sortwell, 1971) . The concentrations of all the bio­
chemical parameters examined in seminal plasma differed from those 
found in sperm fractions. Soidum ion and acid and alkaline phos­
phatase concentrations were higher in seminal plasma but amino­
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The amount of alanine aminotransferase in seminal plasma was less 
than one-tenth of that found in sperm fractions. Seminal plasma 
was approximately one hundred times richer in phosphatases than 
were sperm fractions. The sodium ion concentrations in seminal 
plasma were similar to the values reported by Bartlett (1962b).
The values found for potassium ion concentration were higher than 
those reported by Bartlett (1962b).
Regression analyses were performed to assess linear correlations 
between the physical and biochemical characteristics of the
ajrbcjÇacSr
ejaculates (Table 1.2.3.3.). In order to reduce statistical Ja^àrtrSf 
the mean weekly values were analysed in preference to individual 
results from the same dogs. In consequence, the number of degrees 
of freedom in the analysis were correspondingly reduced and 
correlation coefficients less than 0.8 did not attain statistical 
significance (p>0.05).
Statistically significant (p<iQ.Q5) linear correlations were found 
between sperm concentration with alkaline phosphatase in sperm 
fractions and potassium ions in seminal plasma. The percentage of 
morphologically abnormal spermatozoa correlated with acid and 
alkaline phosphatase in sperm fractions and aspartate amino­
transferase concentration in seminal plasma. Sperm motility was 
correlated with potassium ion and aspartate aminotransferase 
concentrations in seminal plasma. The visual density of ejaculates 
showed correlations between potassium ion concentration in seminal 
plasma and alanine aminotransferase in sperm fractions. Although 
not attaining statistical significance, good correlations (r^O.5) 
were apparent for seminal plasma acid phosphatase and the volume, 
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These observations provide some evidence that the concentrations of 
aspartate aminotransferase and acid phosphatase in seminal plasma 
may serve as biochemical indices of canine semen quality, particul­
arly in respect of sperm morphology and motility and the quality of 
the prostatic secretion.
1.2.4. Testicular Biopsy
The idea of defining the onset and progress of histological changes 
in any tissue is attractive to all experimental pathologists. The 
surgical removal of small samples of tissue by means of appropriate 
biopsy techniques is both convenient and practical. For the 
purposes of toxicological investigation the inclusion of serial 
testicular biopsies in experimental protocols is acceptable only 
if representative samples of tissue can be obtained,and provided 
that the procedure does not itself induce any detrimental effects on 
testicular function.
The problems associated with testicular biopsy in the dog have been 
discussed in detail by several authors (Evans and Renton, 197 3; 
Finco, 1974; Hadley, 1972; Harrop, 1966; Hunt et al., 1965; Larsen, 
1977; Renton and Aughey, 1971). A variety of techniques are 
available (Larsen, 1977), including open excision and percutaneous 
needle-punch or aspiration biopsy. The risk of post-operative 
infection, haemorrhage or adhesions is possible with all methods.
The significance and duration of slight post-operative changes is 
relatively unknown. Hunt et al. . (19 65) monitored semen production 
in Beagle dogs following excisional testicular biopsy; Galina 
(1971) has evaluated the effects of needle-punch biopsy in some farm 
animals. Both investigators reported initial adverse effects on 
semen characteristics but persistent effects were not apparent.
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Martin and Richmond (1972) have described a procedure for the 
repeated biopsy of rodent testes, but follow-up studies do not 
appear to have been reported. Because it is easy to study 
sufficiently large groups of rats to obtain whole testes at intervals 
during the dosing period, testicular biopsy in the rat will not be 
considered further.
The histopathological changes at 72h and 14 days after single 
percutaneous testicular biopsy (Hendricks et al., 1969), were 
assessed in a young male Beagle aged 28 weeks. Tissue was removed 
under general anaesthesia ('Brietal', Elanco Ltd., administered 
intravenously at a dose of 10 mg/kg using a 2.5% w/v solution^ The 
scrotal skin was cleaned with chlorhexidine gluconate solution 
('Hibitane', ICI), followed by application of surgical spirit. An 
incision (0.5 cm long) was made in the scrotal wall over the poster­
ior pole of the testis, taking care to avoid the epididymis, and 
extended through the underlying dartos and tunica vaginalis. A 
sterile Menghini biopsy needle (1.0 mm diameter x 40 mm length) 
attached to a 5 ml syringe was inserted through the scrotal incision 
and directed anteriorly into the body of the testis. A portion of 
testicular tissue was removed by withdrawing the plunger of the 
syringe to provide negative pressure. The wound was not sutured and 
capillary haemorrhage was controlled by digital swab pressure. The 
tissue obtained was preserved in Helly's fluid, see Appendix I (viii). 
The procedure was repeated immediately for the contralateral testis. 
HemieHTohidootomiee were performed at 72h and 14 days after biopsy: 
each testis was fixed in buffered neutral formalin and paraffin wax 
sections were examined after staining with haematoxylin and eosin, 
see Appendix I (viii).
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At 7 2h, post-biopsy haemorrhage, cellular degeneration and necrosis 
were obvious at the sampling site (Fig. 1.2.4.1.). The changes 
were confined to a small focal area and the majority of semini­
ferous tubules were considered to have a n o m a l  appearance.
Sections from the testis obtained 14 days after biopsy (Fig. 1.2.
4.1.) contained a single focus of atrophic seminiferous tubules 
with associated interstitial tissue fibrosis. In all other 
respects the sections appeared to be histologically normal.
In order to assess the value of serial percutaneous testicular 
biopsy and to identify possible adverse effects, four Beagle dogs 
were subjected to seven successive monthly testicular biopsies 
taken alternately from the right and left gonad between 29 and 53 
weeks of age. Each biopsy specimen was processed through graded 
ethanol, and paraffin wax sections were stained with PAS,
Appendix I (viii). The biopsies were examined to monitor changes 
in the seminiferous epithelium and to determine the number of 
tubules present in circular cross-section, suitable for quantit­
ative analysis of spermatogenesis, see Appendix I (ix). The 
effects of repeated testicular biopsy were assessed by comparing 
testicular area, see Appendix I (vi), semen characteristics, see 
Appendix I (vii), plasma prolactin, LH and testosterone concentra­
tions, see Appendix I (vi), with comparable data from four 
unoperated dogs maintained as contemporary controls^. These 
observations were performed at monthly intervals starting when 
the dogs were 17 weeks old, although it was not possible to collect 
semen until the dogs were 33 weeks old. Semen collections and 
testicular measurements continued at monthly intervals until 53 
weeks, with additional examinations 7 and 13 weeks after the last 
biopsy. Plasma hormone assays were not performed after 45 weeks.
: 44 :
Haemorrhage and necrosis present 72h after testicular 
biopsy, H & E, X 125
'.i
; . ' \ ' " j r
■ - r e '  _ , '
Interstitial fibrosis and tubular atrophy 14 days after
testicular biopsy, H & E, x 125.
Fig. 1.2.4.1. Histological appearance of the testes from a 
Beagle dog 72h and 14 days after single bilateral testicular 
biopsy.
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The technique proved satisfactory in that portions of tissue were 
obtainable at each biopsy. Haemorrhage rarely occurred and was 
readily controlled by gentle digital swab pressure. Minimal scrotal 
swelling and erythema were sometimes seen up to 72h after biopsy. 
After the first biopsy one dog developed clinical atrophy of the 
biopsied gonad; however, the semen characteristics and hormonal 
values relating to this dog remained within normal limits through­
out the investigation.
Although a large number of tubular sections were present in the 
biopsy material it was difficult to find tubules in circular cross- 
section (Table 1.2.4.1.). The earliest biopsies at 29 and 33 weeks 
showed poor organisation of the seminiferous epithelium, and cells 
were rarely apparent beyond the spermatocyte stage (Fig. 1.2.4.2.). 
At 37 weeks the germinal epithelium was organised and all stages of 
spermatogenesis, see Appendix I (ix), could be defined, although it 
was rare to observe all eight stages in circular cross-sections from 
an individual dog. It was not possible to undertake meaningful 
assessment of differential germ cell counts at each stage of 
spermatogenesis with increasing age. As a compromise,the number of 
type B spermatogonia, primary spermatocytes, spermatids and Sertoli 
cells were counted in all tubules found in circular cross-section, 
regardless of the stage of spermatogenesis. Tubular diameters and 
the mean diameter of ten nuclei of each cell type were measured. 
Appendix I (ix). The crude cell counts were then mathematically 
adjusted for differences in tubular and nuclear diameter 
(Abercrombie, 1946; Swierstra and Foote, 1963). The ratio of the 
total number of germ cells to Sertoli cells per tubule, designated 
the Sertoli cell index, was then calculated. Quantitative differ­
ences in germ cell populations were apparent (Table 1.2.4.1.).
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Age 29 weeks. Poor organisation 
of germinal epithelium; few 
spermatids present.
Age 33 weeks. Germinal epithe­
lium becoming organised; round 
and elongated spermatids present.
Age 37 weeks. Germinal epithe­
lium well differentiated and 
organised, with mature spermat­
ids present.
Fig. 1.2.4.2. Examples of testicular biopsies obtained from 
Beagle dogs ; PAS, x 500.
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At 29 weeks of age the numbers of primary spermatocytes and 
spermatids were much less than recorded subsequently. The number 
of primary spermatocytes was comparable at all examinations between 
33 and 53 weeks. Spermatid numbers gradually increased at succes­
sive examinations until 41 weeks of age; subsequently the spermatid 
counts remained reasonably constant. The number of Sertoli cells 
found in tubules between 29 and 37 weeks decreased slightly but 
remained fairly constant thereafter. The proportion of germ cells 
to Sertoli cells increased between 29 and 41 weeks,but remained 
fairly constant in the later specimens.
The mean changes in testicular area are plotted in Fig. 1.2.4.3.
The marginal reduction in group mean testicular area for biopsied 
dogs between 29 and 41 weeks is possibly accentuated by the onset 
of unilateral testicular atrophy for one dog. After the fifth 
biopsy (45 weeks) the group mean testicular areas were essentially 
comparable for biopsied and control dogs.
Differences between control and biopsied dogs in respect of plasma 
prolactin, LH and testosterone are shown in Fig. 1.2.4.4. The data 
were statistically analysed (Anovar) and no statistically signifi­
cant differences were apparent (p>0.05). The maturational 
patterns for plasma prolactin and testosterone were similar for both 
groups of dogs. Although minor differences in LH and testosterone 
concentrations were sometimes apparent, all the values obtained were 
within published ranges for normal dogs (DePalatis et al., 1978; 
Tremblay et al., 1972).
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Q  Control 1^ Biopsy
Fig. 1.2.4.4. Comparisons of plasma prolactin, LH and testosterone
concentrations in 4 Beagles subjected to repeated testicular biopsy
with data from 4 Beagles maintained as contemporary controls.
Prolactin expressed as ng/ml canine pituitary preparation CPA3/F4;
LH expressed as ng/ml canine pituitary preparation LER-1685-1.
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Table 1.2.4.2. summarises the semen examination data. No marked 
differences were found in the semen characteristics of either group 
of dogs. It was not possible to collect semen until after the 
second biopsy; on this occasion the numbers of spermatozoa per ml 
and the percentage of live forms was decreased in the biopsied 
dogs. Although reduced sperm counts were recorded for biopsied 
dogs at 37, 41 and 45 weeks the values still fell within accepted 
ranges (Boucher et al., 1958; Harrop, 1955; Heywood and Sortwell, 
1971). There were no obvious persistent effects on any 
characteristic, and routine analysis of variance did not indicate 
any experimentally induced effects (p>0.05).
Monitoring testicular measurements, circulating prolactin, LH and 
testosterone and semen characteristics failed to demonstrate any 
statistically significant differences caused by testicular biopsy. 
However, it should be remembered that severe clinical unilateral 
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The pathological assessment of toxic effects in animals is usually 
based on organ weight analysis and descriptions of the macroscopic 
and microscopical appearance of tissues. Although emphasis is 
placed largely on comparison of data from test and concurrent 
control animals, knowledge of the spontaneous and age-related 
variations in the weight and structure of organs is necessary.
This is especially true if small numbers of animals are studied.
In the case of non-rodent studies, the group sizes rarely exceed 
five animals of each sex per group. A fortuitous distribution of 
normal variants among small numbers of subjects could lead to 
erroneous conclusions. In the following sections the findings of 
surveys undertaken to investigate the range of spontaneous variat­
ions in the weight and histological appearance of testes obtained 
from Sprague-Dawley rats and Beagle dogs maintained as untreated 
control animals for toxicity studies conducted at the Huntingdon 
Research Centre are described.
Although quantitative assessment of spermatogenesis is described in 
the literature, this approach has not been critically examined as an 
adjunct to the appraisal of testicular toxicity. The concept of 
quantitative testicular histomorphometry is introduced, with empha­
sis on the role this technique may have in defining sites or 
mechanisms of toxic actions on the testis.
1.3.1. Testicular Weights
Several investigators have published ranges for the organ weights 
of rats of various strains and ages (Scharer, 1977; Stevens, 197 5; 
Trieb et al., 1976) . Insufficient information was available to 
determine whether significant age-related changes in testicular
: 54 ;
weight occurred for Sprague-Dawley rats. Data were abstracted 
from studies undertaken with CD strain Sprague-Dawley rats between 
197 2 and 1975. During this period 165 male rats were used as 
untreated controls for studies of 13, 26, 52 or 104 weeks' duration. 
The housing, feeding and management of the rats were as described 
in Appendices I (i) - (iii). At completion of the experimental 
periods the rats had been killed by carbon dioxide asphyxiation.
The post-mortem procedures included weighing of the testes, free of 
fat. The data were classified according to the length of the 
experimental periods. Within each period the initial body weight, 
together with the arithmetic mean, standard deviation and ranges for 
final body weight and testicular weight were obtained.
The initial body weights of all the rats were in the range 90-180 g . 
The terminal body weight and testicular weight data are given in 
Table 1.3.1.1. Body weights increased according to the duration of 
the studies: rats maintained for 104 weeks were almost twice as 
heavy as rats maintained for 13 weeks. The mean testicular weights 
did not show appreciable age-related differences. Expression of the 
standard deviation as a percentage of the mean value gave higher 
values for studies of 52 or 104 weeks' duration (12% and 16% 
respectively) than after 13 or 26 weeks (8% and 4% respectively).
The range of individual values increased with age, and after 52 or 
104 weeks, at least 13% of the rats were found with testicular 
weights below the lowest values recorded in the 13- or 26-week 
groups. Thus, the variation in testicular weights appeared to 
increase with age, and this was principally due to some old rats, 
kept for more than 52 weeks, having smaller testes than rats main­
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Ranges of normal Beagle dogs' organ weights have been described by 
Jackson and Cappiello (1964) and Lutzen et al. (1976). The first- 
named authors studied biological variation in terms of relative 
organ weight only. Lutzen and his co-workers consider this appro­
ach to be unsatisfactory and studied organ weights allometrically. 
The testes of Beagle dogs show positive allometric growth between 
7 and 180 days of age only. This observation suggests that, if 
studies are started with dogs less than 180 days old, the dosing 
period not only includes the period of testicular growth, but, for 
13-week studies, the dogs may be killed before the testes have 
reached adult size. In order to assess the impact of variations in 
testicular weight on shorter-term studies and also to determine 
whether testicular weight varies with age in adult dogs, a compar­
able survey to that already described in rats was instituted for 
Beagle dogs. Sufficient data were available for control dogs kept 
for 13-, 26-, 52-and 104-week experiments. Heywood et al. (1979) 
evaluated the carcinogenicity of toothpaste, containing chloroform, 
when given to Beagle dogs. No treatment-induced effects were 
apparent in male reproductive organs: data from the 48 male dogs 
used for this experiment were therefore included in the survey.
The population sample comprised 198 male Beagles aged from 37 weeks 
to 7.7 5 years at the time of examination. The data were classified 
according to the length of the experimental periods. Within each 
period the arithmetic mean, standard deviation and ranges were 
obtained for initial age and body weight together with terminal 
body weight and testicular weights. The percentage of dogs with 
testicular weights in various ranges was also determined for each 
category.
:57:
The findings of this survey are presented in Table 1.3.1.2. The 
dogs used for 13-week studies were slightly older and heavier at 
the start of experimentation. Judged on the basis of differences 
in mean final body weight for studies of increasing duration it 
was apparent that, after 13-week studies, a proportion of dogs were 
killed before attaining full adult body weight. There were no 
marked differences in mean testicular weight for dogs kept for 26-, 
5 2 - or 104-week observation periods. In comparison with these three 
groups, dogs kept for 13-week periods had lower mean testicular 
weight and, conversely, dogs kept for 377 weeks developed increased 
mean testicular weight. Of the dogs kept for 13 weeks, 40% had 
testes weighing less than 10 g. Over 50% of the dogs observed for 
377 weeks had testes weighing more than 30 g . The majority of the 
dogs in the 26-,52- and 104-week categories had testes weighing 
between 20 and 30 g .
These results suggested that a significant proportion of Beagle 
dogs kept for 13-week studies (mean age 37 weeks when killed) can 
be expected to have small testes weighing less than 10 g. Such a 
finding is probably attributable to sexual immaturity and may pre­
clude meaningful assessment of toxic effects on the testes.
It is also apparent that a large number of dogs kept for long-term 
(7-year) experiments can be expected to have higher testicular 
weights than young adult Beagles.
1.3.2. Histopathological examination
The descriptive histopathology of the male reproductive tract of 
laboratory rats and dogs has been reviewed by King (1978). More 
detailed information with regard to the dog is available from 
the works of Bloom (1954) and Jubb and Kennedy (1970).
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Hottendorf and Hirth (1974) reported the findings of a histological 
survey of the major organs of 1000 Beagle dogs aged 8 - 2 0  months. 
The findings in the testes included atrophic changes, giant-cell 
formation and epididymitis. In order to provide specific informa­
tion concerning the spontaneous age-related variations in the 
histological characteristics of the rat and Beagle testes, a retro­
spective survey on populations of 165 Sprague-Dawley rats (CD strair) 
and 198 Beagle dogs was instituted. All the animals had been main­
tained at the Huntingdon Research Centre as previously described 
(1.3.1.). Paraffin wax sections (56°C) were cut at 5 pm and 
stained with haematoxylin and eosin for examination by light 
microscopy. The histological observations were collated according 
to the length of study and further classified according to the site 
and nature of the change. The classification of testicular tumours 
was based on the criteria of Nielsen and Lein (1974) .
The findings of this survey are presented in Tables 1.3.2.1. and
1.3.2. 2. Apart from a very low incidence of minor epididymal 
inflammatory cell infiltration, no changes were seen in the testes 
of rats maintained for periods of less than 52 weeks. The major 
changes seen in the testes of rats maintained for longer periods 
were varying degrees of lack of spermatogenesis. In up to 7% of 
rats maintained for 52 weeks, spermatogenesis did not proceed beyond 
the spermatocyte stages. A further 7% of rats in this group and 
almost 20% of those maintained for 104 weeks developed atrophy of 
the seminiferous epithelium, characterised by the absence of germinal 
cells in seminiferous tubules containing Sertoli cells only (Fig.
1.3.2.1.). Unilateral or bilateral cases occurred at similar 
frequency although the atrophic changes were almost invariably 
diffuse rather than focal. These findings were not surprising, 
because Gray (1978) has reported reduced circulating LH and testos­
terone concentrations in aged male rats. Ribelin (1963) has 
previously suggested that atrophy of the rat testis is a useful 
index of chemical toxicity. However, age-related spontaneous
testicular atrophy must be considered.
: b O  ;
Incidence of lesions (%) Study duration (weeks)
13 26 52 104
Interstitial cell adenoma 
















Table 1.3.2.1. Incidence of testicular lesions observed in 165 
Sprague-Dawley rats (CD strain) maintained as controls for toxicity 
studies.
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Fig. 1.3.2.1. Rat testes showing 
atrophy of seminiferous tubules 
with periarteritic inflammatory 
cell infiltration. H & E, x 125.
Fig. 1.3.2.2. Rat testes with 
normal seminiferous epithelium but 
marked inflammatory cell infiltra­
tion in and around blood vessels.
H & E, X 125
Fig. 1.3.2.3. Spermatocoele 
granuloma in rat epididymis, 
with extensive inflammatory cell 
infiltration of stromal zones.
H & E, X 125.
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A high incidence (over 17%) of inflammatory cell infiltrations into 
and around testicular blood vessels was found among rats maintained 
for 104 weeks (Fig. 1.3.2.2.). This result agrees with the find­
ings of Yang (1965) who recorded a 14.6% incidence of polyarteritis 
in various organs of male and female rats aged 541 - 797 days. 
Lesions were observed in mesentery, pancreas, kidneys, stomach, 
intestine and testes. Although muscular arteries were most 
frequently involved, lesions were occasionally present in arterio­
les. The aetiological factors remain obscure. Yang (1965) observed 
similar lesions in both control and experimental animals, and drew 
attention to the resemblance to the human condition polyarteritis 
nodosa. The latter condition is considered to be based on auto­
immune reactions.
Spontaneous testicular tumours occur at a low incidence among 
Sprague-Dawley rats (Gillmann et al., 1953; Russfield, 1967; 
Thompson et al., 1961) . In the present survey, a very low incidence 
of less than 2% was recorded for neoplastic or hyperplastic changes 
in interstitial (Leydig) cells. It should be noted that this 
finding is in marked contrast to that in rats of the Rochester and 
Fischer strains, which develop a high incidence (60 - 70%) of 
interstitial cell tumours (Crain, 1958; Jacobs and Huseby, 1967). 
During the last 50 years there appears to have been only one report 
of a possible seminoma in a single rat of unspecified strain 
(Bullock and Curtis, 1930).
Spermatocoele granulomata (Fig. 1.3.2.3.) occurred at an incidence 
of approximately 3% among rats of varying ages. The development of 
these lesions probably represents a 'foreign body' reaction to 
'non-self' protein following extravasation of spermatozoa into 
epididymal stroma (Glassy and Mostofi, 1956).
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Although a low frequency of spermatocoele granulomata can be 
expected, James et al. (1978) have reported the dose-dependent 
induction of similar epididymal lesions in rats given high doses 
of the male antifertility compound l-amino-3-chloro-2-propanol 
hydrochloride (CL 88263) .
A variety of histological changes occurred in the Beagle dog testes 
(Table 1.2.3.2.). Cryptorchid or retained testes were found at an 
incidence of 3.82 - 4.36% irrespective of age. Most cases were 
unilateral and inguinal, usually involving the right testis. The 
histological appearance (Fig. 1.2.3.4.) was that of seminiferous 
tubules lined by Sertoli and spermatogonial cells only. Retention 
of the testes is considered to be a single autosomal recessive 
trait which may not manifest itself before puberty (King, 1978) .
A number of markedly age-specific changes were encountered in the 
testes. Incomplete spermatogenesis, characterised by absence of 
spermatids (Fig. 1.2.3.5.\ was seen in 7% of dogs retained for 13- 
week study periods. No cases of abnormal spermatogenesis, 
excluding obvious cryptorchidism, were seen in dogs kept for 26 or 
52 weeks. For studies of longer duration, a low but increasing 
incidence of dogs showing regressive changes in the seminiferous 
epithelium (Fig. 1.2.3.6.) was apparent. Inflammatory lesions 
involving testicular blood vessels were not found in dogs kept for 
52 weeks or less. Arteritic changes (Fig. 1.2.3.7.) were described 
in dogs kept for 104 weeks or 377 weeks; the incidence (8.3%) was 
highest for the oldest dogs. Arteritic lesions are found in a wide 
range of tissues taken from domestic animals (Jubb and Kennedy, 
1970). In the dog, testicular arteritis has been reported in dogs 
infected with Brucella canis (Carmichael and Kenney, 1968) .
: 65 :
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Fig. 1.2.3.4. Cryptorchid Beagle 
testis. Seminiferous tubules 
contain Sertoli cells and sperm­
atogonia only. H & E, x 125.
Fig. 1. 2.3.5. ImiTiature Beagle 
testes; note absence of elongated 
spermatids. H & E, x 125.
Fig. 1.2.3.6. Regression of 
spermatogenesis seen in the testes 





Fig. 1.2.3.7. Chronic inflaminatory cell infiltration 
(arteritis) with disruption of spermatogenesis in an 
ageing Beagle. H &  E, x 125.
r
Fig. 1.2.3.8. Interstitial (Leydig) cell adenoma in 
testis of an ageing Beagle. Note atrophic seminiferous 
tubule adjacent to neoplasm. H & E, x 125.
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Harcourt (1978) considers that autoimmune mechanisms are important 
in the pathogenesis of this disease. Testicular neoplasia or 
hyperplasia was found only among dogs kept for 377 weeks, but over 
20% of these dogs were affected. Testicular neoplasms occurred in 
5/48 dogs, comprising one case of unilateral seminoma, one case of
bilateral interstitial cell adenoma (Fig. 1.2.3.8.) and three cases
'\
of unilateral Sertoli cell tumours, two of which developed contra­
lateral interstitial cell adenomata. Two of the Sertoli cell 
tumours occurred in cryptorchid testes. Only two of the eight 
tumours were apparent at macroscopic post-mortem examination. 
Microscopical evidence of moderate to marked interstitial cell hyper­
plasia was seen in 8.3% of the oldest dogs. Although non-rodent 
species are rarely used for carcinogenic evaluation of chemicals, 
the high spontaneous incidence of testicular neoplasms in Beagle 
dogs could complicate the assessment of chemical carcinogenesis 
involving the testis. The aetiological factors and endocrine 
implications of canine testicular tumours are well documented 
(Cotchin, 1960; Dow, 1962; Jones and Friedman, 1950; Reif et al., 
1979; Scully and Coffin, 1952). Hooker et al. (1946) considered 
that the dog is an atypical mammal, in that the interstitial cells 
of the testes increase in size and vacuolation with advancing age, 
which probably represents a pre-neoplastic change.
Epithelial hyperplasia of the ductus epididymis was recorded for 76% 
of dogs maintained for 377 weeks and 6.8% kept for 104 weeks; 
younger age groups were not affected. The lesion (Fig. 1.2.3.9.) 
is characterised by the presence of epithelial bridges containing 
closely packed nuclei. The condition was first described by 
Mawdesley-Thomas and Urwin (1967), who included nutritional, hormonal 
and genetic factors among the possible causes.
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Fig. 1.2.3.9. Hyperplasia of 
epididymal epithelium of an ageing 
Beagle. H X E, x 125.
Fig. 1.2.3.10. Epididymal sperm- 
atocoele granuloma in a Beagle.
H & E, X 125.
Fig. 1.2.3.11. Focal chronic inflam­
matory cell infiltration in the 
epididymis of a Beagle dog. H & E, 
X 125.
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Occasional epididymal spermatocoele granulomata were found for dogs 
of variable age (Fig. 1.2.3.10.). The lesions are essentially 
similar to those seen in the rat and probably occur as a result of 
slight injury (Cronqvist, 194 9; Friedman and Garske, 1949; Glassy 
and Mostofi, 1956). Minor epididymal, focal chronic inflammatory 
cell infiltrations (Fig. 1.2.3.11.) were found at a low incidence 
in dogs of all ages,but occurred most frequently among the oldest 
dogs.
1.3.3. Quantitative testicular histomorphometry
A number of well-defined spermatogenic cells can be identified in 
histological sections of the testis. The status of spermatogenic 
activity is normally assessed in a subjective manner, being 
described as normal, reduced or suppressed. Counting of spermato­
gonia, spermatocytes and spermatids may be useful in determining 
which particular cell types are affected when a selective toxic 
effect on spermatogenesis is suspected (Heywood and James, 1978).
In order to undertake realistic quantitative assessment of spermato­
genic cell populations, the kinetics of the seminiferous epithelium
must be considered. Cell division proceeds in waves along the 
I vbui&ünaf
horiaon^ al axis of the seminiferous tubules. Clockwork precision 
and synchronisation of the cell divisions results in constant and 
predictable cellular associations. The time of appearance and 
duration for each cell type is constant for each species. The 
simplest available classification (Roosen-Runge, 1962) is based on 
recognition of eight stages of spermatogenesis according to the 
morphology and position of spermatids specifically associated with 
earlier spermatogenic cells (Fig. 1.3.3.1.). Because 
spermatogenesis is a continuous and dynamic process, not all cell 
types are present in every tubular cross-section.
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Detailed morphological descriptions of the cellular associations 
found in the seminiferous tubules of both the rat and dog have been 
published (Clermont and Perey, 1957a^b;Foote et al., 1972; Leblond 
and Clermont, 1952a, b ) . The mechanism of stem cell (sperm- 
atogonial) renewal is critical. Clermont (1962) undertook elaborate 
mapping of spermatogonial populations in rat testes and subsequently 
proposed a mathematical model of stem cell renewal for this species. 
These investigations indicated that type A spermatogonia are 
arranged in pairs which undergo three successive synchronous 
mitoses. Of the 16 resulting cells, two become dormant for a time 
and subsequently divide to form the next generation of type A 
spermatogonia. The remaining 14 cells divide mitotically to form 
intermediate type spermatogonia which undergo a further mitosis to 
form type B spermatogonia. Mitotic division of type B spermatogonia 
results in the formation of primary spermatocytes which undergo 
meiotic division to produce spermatids. In the normal adult rat 
the actual yields of spermatocytes and spermatids are lower than 
expected, because of constant degeneration of some type A 
spermatogonia and spermatocytes during cell division. Foote et al. 
(197 2) were unable to discriminate adequately between the various 
kinds of canine spermatogonia to establish an accurate model of 
stem cell renewal for the dog. While the spontaneous degeneration 
of canine spermatogonia remains speculative, degeneration of sperm­
atocytes does not seem to occur in the d o g . Counts of type B 
spermatogonia, primary spermatocytes and spermatids in tubules 
identified at appropriate stages of spermatogenesis may provide a 
basis for quantitative assessment of spermatogenesis in both the 
rat and dog. The appropriate stage of spermatogenesis for 
counting a particular cell type should be selected on the basis 
that a complete generation of these cells is present.
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The expected frequency of tubules at each of the eight stages for 
normal adult rats and dogs is given in Table 1.3.3.1. Inspection 
of these data shows that the various stages occur at differing 
frequencies,and species differences are also apparent. Fortunately, 
the cellular associations at each stage remain reasonably constant 
for all animal species studied so far (Fig. 1.3.3.1.). Type B 
spermatogonia are present in greatest numbers at stage 7, divide 
ing to form preleptotene primary spermatocytes by stage 8. The 
primary spermatocyte phase is of long duration and, in fact, a 
second generation of primary spermatocytes is formed before the end 
of the prolonged pachytene phase which extends from stage 5 until 
stage 2. During stages 5 - 8, only pachytene primary spermato­
cytes are present. After the prolonged pachytene phase the primary 
spermatocytes enter a short diakenesis (stage 3); the secondary 
spermatocytes appear in stage 4^ and undergo the second reduction 
division becoming round (early spermatids) by stage 5. During 
stages 5 to 1, round spermatids undergo changes in the acrosomal 
and Golgi systems,and the process of elongation begins at stage 2 . 
Only round spermatids are seen in the lumina of tubules at stage 1, 
Mature (elongated) spermatids become spermatozoa at stage 8 when 
they are found detached from Sertoli cells, lying free in the tubular 
lumen.
Table 1.3.3.2. shows some published mean counts for type B 
spermatogonia, pachytene primary spermatocytes, round (early) 
spermatids and mature (elongated) spermatids found in tubules at 
stages 7, 5 and 8 of the spermatogenic cycle of normal adult 
rats and dogs (Clermont, 1962; Foote et al., 1972). Photomicro­
graphs of tubules found at stages 1, 5, 7 and 8 in the testes 
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Table 1.3.3.1. Frequency of tubules at stages 1 to 8 of 
spermatogenesis per 100 circular tubular cross-sections 
of rat and dog testes.
1. Identification of stages based on Roosen-Runge (19 62)
2. Data obtained from Leblond and Clermont (1952b)
3. Data obtained from Foote et al. (1972)
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Table 1.3.3.2. Numbers of spermatogenic cells counted in
circular cross-sections at specific stages of spermatogenesis 
for rats and dogs.
1. Identification of stages based on Roosen-Runge (1962)
2. Data obtained from Hemsworth et al. (1968)





Stage 1. Early spermatids (E); 
pachytene primary spermatocytes 
(P); leptotene primary 
spermatocytes (L).
I
Stage 5 , Late spermatids (S); 
early spermatids (E); pachytene 
primary spermatocytes (P).
P
&  '■ 
cB
Stage 7. Late spermatids (S) ; 
early spermatids (E); pachytene 




Stage 8. Late spermatids 
(S) ; early spermatids (E); 
pachytene primary spermatocytes 
(P); preleptotene primary 
spermatocytes (pi).
Fig. 1.3.3.2. Photomicrographs of rat seminiferous tubules at 




Stage 1. Early spermatids (E); 
pachytene primary spermatocytes 





Stage 5. Late spermatids (S); 
early spermatids (E); pachytene 
primary spermatocytes (P).
P' , S  V. '
P.
pi
Stage 7. Late spermatids (S); 
early spermatids (E); pachytene 
primary spermatocytes (P); type 
B spermatogonia (B).
Stage 8. Late spermatids 
(S); early spermatids (E); 
pachytene primary spermatocytes 
(P); preleptotene primary sperm­
atocytes (pi) .
Fig. 1.2.3.3. Photomicrographs of canine seminiferous tubules at 
stages 1, 5, 7 and 8. PAS, x 512.
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Although a large number of substances have been found which induce 
changes in spermatogenesis,there are only a few reports of 
experimental studies utilising quantitative histomorphometric 
assessment of spermatogenesis. Hemsworth et al. (1968) made 
quantitative assessments of spermatogenesis in the testes of rats 
exposed to the pituitary inhibitor methallibure. Similar studies 
have also been undertaken for rats given triethylenemelamine and 
rabbits receiving amphotericin B (Steinberger, 1962; Swierstra 
et al., 1964). All these investigators were able to identify the 
target cell types affected and could at least infer the possible 
mechanisms of toxic action.
:78
1.4. Discussion
The choice of animal model and characteristics selected for the 
predictive safety evaluation of chemicals exerting testicular 
toxicity is a challenging problem. The ideal criteria include 
demonstration of successful reproduction in animal species chosen 
on the basis of pharmacokinetic and metabolic similarity to man 
or the target species. The ultimate index of male fertility is 
the induction of successful pregnancy in receptive females.
Although breeding studies are easily undertaken with rodent species» 
practical difficulties arise in the case of the larger non-rodent 
species. The problems to be overcome include seasonal breeding 
cycles, poor spontaneous conception rates, prolonged gestation 
periods and the large number of successful matings necessary for 
statistical analysis. The findings of the present studies offer 
possible alternative techniques to establish and elucidate 
mechanisms of testicular toxicity. Although these approaches are 
most useful for non-rodent studies, similar studies in rodent 
species may complement breeding performance data or provide a 
rational basis for evaluating differences in species response to 
the same chemical.
The measurement of testicular size, circulating pituitary- 
testicular hormones and semen examinations in the living animal 
can be undertaken without resorting to administration of diagnostic 
chemicals which may prejudice the overall toxicological objectives. 
Furthermore, the information obtained may usefully contribute to 
the assessment of histopathological observations in the dead 
animal. In practice, it seems that not all tests can be applied 
to all species of laboratory animal. The seasonal breeding 
rhythms and physical size of the common laboratory macaques and
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baboons prevents serious consideration of these species except in 
the most specialised laboratories. It is also important to note 
that the present embargo on the export of rhesus macaques from their 
country of origin severely restricts the number of animals 
available to experimental scientists. It seems likely that» in the 
foreseeable future,the majority of studies will be restricted to 
laboratory rats and dogs. Consequently, the theoretical criteria 
of selecting animal species on the basis of physiological and 
metabolic suitability are set at nought. All the characteristics 
suggested are easily studied with dogs; however, the only useful 
observations applicable to the living rat are probably hormonal 
assays.
In order to interpret experimental data satisfactorily, background 
information concerning spontaneous and age-related variations of 
the measured parameters is vital. Considerable information of this 
type,concerning testicular function in the rat and dog, has become 
available as a result of the present work.
The measurement of testicular dimensions is a simple but reliable 
index of the rate of testicular growth in young dogs. Some 
variation in testicular dimensions is apparent for adult dogs, and 
the size of these organs does not appear to be related to current 
body weight. In order to assess the effect of chemical overdosage 
on testicular size, it seems necessary to establish predosing base­
line data for individual dogs. Marked spontaneous fluctuations 
in testicular measurements are not expected to occur if young adult 
dogs are studied. The profile of circulating FSH, LH, testosterone 
and prolactin provides valuable information on hypothalamic- 
pituitary-testicular relationships. The pattern of chronological 
response may be expected to differ according to the site of chemical
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action. The effects of chemicals which suppress pituitary 
gonadotrophin secretion, inhibit hypothalamic control of prolactin 
release or alter testosterone synthesis will be apparent at an early 
stage and should precede any observable changes in the testicular 
functions dependent on these hormones. Conversely, if the primary 
sites of chemical action are the target tissues for these hormones, 
delayed and progressive changes in circulating hormone concentrations 
will follow as a result of the sensitive feed-back control mechanisms. 
If the cells of the seminiferous epithelium are depleted,the 
principal response is a compensatory rise in FSH (Collins et al.,
1978; Debeljuk et al., 1973). The lack of availability of a canine 
FSH assay is a drawback in this respect.
When considering the results of hormonal investigations it is 
important to consider any extraneous influences which may affect the 
values obtained. Time of day, season of the year, age, species and, 
strain, or the stress of the sampling procedure,can all exert 
measureable effects. The results of the plasma prolactin, LH and 
testosterone determinations in growing male Beagles indicate that 
the hormonal events coinciding with the onset of sexual maturation 
in this species are,at least qualitatively, similar to the changes 
observed in male rats (de Jong and Sharpe, 1977: Piacsek and 
Goodspeed, 1978). Maturational changes in the concentration of male 
reproductive hormones must be considered if rats aged less than 70 
days or dogs under 29 weeks old are examined. There is sufficient 
available evidence to show that the circulating hormonal profile 
of male rats changes with age, particularly in respect of prolactin 
(Reigle and Meites, 1976) and LH and testosterone (Gray, 1978).
There do not appear to be any published observations on the hormonal 
status of aged male dogs.
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Male Beagles appear to respond readily to the use of the 
artificial vagina and no difficulties should be experienced in 
obtaining semen from young naive dogs which have not previously 
been used as breeding animals. The available evidence implies 
that adult semen characteristics are not fully established in 
Beagles less than 41 weeks old. The examination of semen quality 
for dogs aged between 41 and 66 weeks of age showed considerable 
variation in respect of ejaculate density, motility and sperm 
concentration. This is in agreement with the findings of other 
authors (Bartlett, 1962a; Boucher et al., 1958; Harrop, 1955;
Heywood and Sortwell, 1971). This emphasises the need carefully to 
screen dogs selected for testicular function studies, during the 
predosing phase, in order to exclude dogs which consistently 
produce semen of poor quality. The assessment of sperm motility 
in canine ejaculates may be misleading, because zero scores are 
frequently recorded which may be attributable to cooling of the 
samples during the protracted collection time of up to 20 minutes. 
Changes in semen characteristics may reflect the mode of chemical 
action. The timing and appearance of changes in sperm concentrat­
ion and morphology will differ if toxic action affects the cells 
of the seminiferous, epithelium, the hormonal control of spermatid 
maturation or the production of epididymal secretions necessary for 
sperm capacitation. It is important to consider that, from the 
time of spermatogonial division until the appearance of spermatozoa 
in the ejaculate, four cycles of the seminiferous epithelium occur 
(Roosen-Runge, 1962). Consequently^ there will be delays in the 
appearance of spermatozoal abnormalities following chemical insult to 
the seminiferous epithelium. ..The earlier the stage of spermatogen­
esis affected, the longer the latent period to the recognition of 
semen abnormalities. Rapid loss of libido, or marked changes in the 
volume of ejaculate, will be indicative of primary effects on 
androgenic hormones.
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The limited data available for the biochemical examination of semen 
are insufficient to substantiate definite conclusions. There are 
some indications that useful information may be obtained from the 
determination of acid phosphatase and aspartate aminotransferase 
concentrations in seminal plasma. Further studies are needed to 
define the relationships between aspartate aminotransferase and 
sperm morphology and motility. There is evidence that acid 
phosphatase can serve as an index of prostate function, and this 
estimation can usefully be included where effects on the secretory 
activity of the prostate are suspected.
Testicular biopsy is not recommended for inclusion in routine 
toxicological studies. There is a low, but significant, risk of 
inducing testicular atrophy, which is unacceptable. While suff­
icient tissue can be obtained to allow subjective histological 
assessment, insufficient tubules in circular cross-section are 
obtained to perform detailed quantitative analysis. The serial 
testicular biopsies obtained from Beagles between 27 and 45 weeks of 
age have provided some useful information. Before 29 weeks, 
spermatogenesis did not proceed beyond the spermatocyte stage. The 
numbers of primary spermatocytes and spermatids increased between 29 
and 37 weeks of age. The characteristic organisation of the 
seminiferous epithelium was not apparent before 37 weeks. It 
therefore seems that organised divisions of the canine seminiferous 
epithelium probably are not established earlier than 37 weeks post 
partum. This would appear to be the first reported investigation 
of the physiological onset and maintenance of canine spermatogenesis.
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Interpretation of testicular weights should be based, not only on 
comparison with concurrent control animals, but also with regard to 
the age of the animals. The testicular weights of rats maintained 
for 13-week or 26-week studies showed remarkably little variation. 
The weight of the testes seems to decrease in ageing rats. Canine 
testicular weights showed considerably more variation than that 
found for rats. Testicular growth may not be complete in dogs of 
the age conventionally used for 13-week studies. Low testicular 
weights found for dogs of this age should be only cautiously 
attributed to chemical administration, particularly when small 
groups of dogs are studied. In marked contrast to the rat, the 
weight of the canine testes appears to increase in old age.
The principal spontaneous histological variation observed in rat 
testes was the development of inflammatory cell infiltrations, 
involving testicular blood vessels and atrophic changes in the 
seminiferous epithelium of aged rats. Approximately 20% of 
Sprague-Dawley rats maintained for 104 weeks' observation can be 
expected to develop these lesions. A much higher incidence of 
these changes would be necessary to recognise chemically induced 
lesions with certainty. The Sprague-Dawley rat appears to be 
unusual in that it shows a low incidence of spontaneous testicular 
neoplasms. No difficulty should be experienced, therefore, in 
recognising the carcinogenic effects of chemicals on the testes of 
rats of this strain. Incomplete testicular spermatogenesis was a 
feature of 7% of the dogs maintained for 13-week studies. This is 
a sufficiently high incidence to complicate the assessment of 
testicular effects in dogs studied before the attainment of sexual 
maturity. Arteritis and degeneration of the seminiferous epithelium 
occur in ageing dogs, but at a considerably lower incidence than 
among rats. Again in marked contrast to the Sprague-Dawley rat, 
spontaneous testicular neoplasia is a major feature of the older
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dog. Although carcinogenicity studies are rarely undertaken with 
dogs, it is important to record the high rate of spontaneous 
testicular tumours in this species. Hyperplasia of the epithelium 
of the ductus epididymis was found in the majority of dogs 
exceeding seven years of age; however, no explanation can be 
offered for this phenomenon.
1.5. Abstract
Techniques, other than serial mating, for the assessment of 
testicular toxicity in the laboratory rat and Beagle are described. 
Function tests performed in live animals can complement post­
mortem studies. Testicular measurements, pituitary-testicular 
hormone assays and semen examinations, together with testicular 
weights, histology and quantitative histometric analysis of sperm­
atogenesis, provide useful information to identify sites of chemical 
action and so elucidate mechanisms of toxicity. The impact of 
spontaneous variations due to sexual maturation, ageing, circadian 
or seasonal rhythms and experimental techniques is discussed.
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2. Studies of chemical action on the hypothalamic-pituitary-
testicular axis
The testicular changes arising from chemical modulation of 
hypothalamic-pituitary hormones have been examined by many 
investigators as a possible method of male contraception. Natural 
and synthetic androgens, oestrogens and progestogens, hypothalamic 
releasing factors and compounds which compete for receptor sites 
mediating the neurohumoral feedback control and peripheral actions 
of male hormones, have been extensively studied. Toxicological 
appraisal of these compounds includes demonstration that the 
intended pharmacological action is readily reversible, assessment 
of potential teratogenic or genetic hazards, modifications in 
sexual activity and undesirable effects on extragonadal tissues. 
These aspects of testicular toxicity are also applicable to the 
safety evaluation of a wide variety of agents which, although 
developed for non-andrological indications, may modulate hypothala­
mic-pituitary hormones when repeatedly administered to experimental 
animals at excessive dosages. The roles of centrally active neuro­
transmitters and prostaglandins in the secretion of anterior 
pituitary hormones are becoming increasingly clear (Krulich, 1979; 
Sato et al., 1975). Modification of neurotransmitter substances 
forms the pharmacological basis for the therapeutic actions of many 
narcotics, sedatives, tranquillisers, mood-modifying drugs, 
bronchodilators and some cardiovascular agents. Inhibition, of 
prostaglandin synthesis is an important property of non-steroidal 
anti-inflammatory drugs used in the treatment of arthritis.
Although it is rare for these compounds to disrupt spermatogenesis 
when administered to animals at low multiples of the recommended 
therapeutic dosages, the effects of chronic overdosage must also be
: 8 6
studied. The currently accepted practice is to study the effects of 
overdosage on the mating performance of rodents and to examine 
changes in the weights and morphology of male reproductive organs 
of rodents and non-rodents following prolonged exposure. Recent 
experience at Huntingdon Research Centre has suggested that some 
compounds,although not affecting the fertility of male rodents, 
suppress spermatogenesis in Beagle dogs.
In view of these apparent differences in species sensitivity, some 
experiments were undertaken to study the hypothalamic-pituitary- 
testicular responses of rats and Beagle dogs, following overdosage 
with compounds known to act on central neurotransmitters or to 
inhibit prostaglandin synthesis.
:87:
2.1. Administration of morphine sulphate to rats for 9 weeks
Narcotic analgesic compounds are widely used in the symptomatic 
relief of severe pain. Many compounds such as morphine, heroin, 
methadone, levorphanol and pentazocine, which possess this 
pharmacological property, are based on the T-phenyl-N-methyl 
piperidine configuration (Gero, 1954). The pharmacological 
mechanisms whereby these drugs induce analgesia are not clear, but 
inhibition of neuronal firing at opiate receptor sites occurs both 
in the central and peripheral nervous systems (Bradley et al., 1978; 
North and Williams, 1977). Social abuse of these drugs results in 
well-documented side effects in humans who become physically 
dependent on these drugs (Takemori, 1974). Modifications of male 
and female reproductive physiology in narcotic addicts have been 
described (Thomas et al., 1977). Decreased plasma testosterone 
concentrations, loss of libido, impotence, reduced ejaculate volume, 
and sperm motility defects have been correlated with heroin and 
methadone use in men (Cicero et al., 1975a; Mendelson et al., 1975). 
A number of investigators have attempted to define the effects of 
narcotic analgesic overdosage on the hypothalamic-pituitary- 
testicular axis and secondary sex organs of male rodents (Cicero et 
al., 1974, 1975b, 1976a; Thomas and Dombrosky, 1975).
Changes in the weight of the testes, prostate and seminal vesicles, 
and increased prostatic cyclic adenosine monophosphate (cAMP) 
activity, have been described. More recently, attention has been 
given to the effects of overdosage on hypothalamic luteinising 
hormone-releasing hormone (LH-RH) and pituitary secretion of LH 
(Cicero, 1977; Cicero et al., 1976b, 1977a, 1977b; Muraki et al., 
1978). Morphine overdosage apparently inhibits release of LH-RH, 
so that LH is not released from the pituitary gland, and circulating 
concentrations of LH therefore decrease. This last effect is
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correlated with the half-life of the drug and, following clearance 
of morphine, the circulating LH concentration reverts to normal 
levels but total 24-hour production is decreased. Follicle- 
stimulating hormone (FSH) production is not affected, but the 
decreased LH concentrations precede reductions in testosterone 
concentrations. The effects of narcotic analgesic overdosage on 
pituitary-testicular morphology have not, apparently, been assessed. 
An experiment was therefore performed with Sprague-Dawley rats in 
an attempt to correlate changes in pituitary-testicular morphology 
with the known effects of morphine overdosage on gonadotrophin and 
androgen secretion.
2.1.1. Experimental design
Thirty specific pathogen-free male rats (CD strain) aged 35 days 
were obtained, and maintained under standard conditions as 
described in Appendices I (i) and (ii). Morphine sulphate 
crystals B.P. were obtained (Boots Wholesale Chemists, Ltd., UK). 
The acute subcutaneous LDg^ of morphine sulphate to rats is 229 - 
46 mg/kg (Chen, 1948). Fifty mg/kg/day was selected as a suitable 
dose to assess the chronic effects of morphine overdosage.
Morphine sulphate was dissolved in sterile water for injection (5% 
w/v) and administered by subcutaneous injection at a volume of 0.1 
ml/100 g to 15 rats for up to nine weeks so that each rat received 
50 mg morphine sulphate/kg/day. The remaining 15 rats acted as 
controls and received daily injections of sterile water at 0.1 
ml/100 g. Five rats from each group were killed after four or nine 
weeks' treatment; the remaining rats were allowed 13 weeks' 
recovery after receiving treatment for nine weeks.
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The rats were examined several times daily for assessment of 
clinical and behavioural abnormalities. Body weight changes and 
food and water intake were monitored, see Appendix I (iii) . Rats 
which died prematurely were given complete post-mortem examinations 
to establish factors contributing to death.
Serum was obtained, see Appendix I (v), from five rats per group,
4 h after dosing on day 1, during weeks 4 and 9, and after 13 
weeks' recovery. Testosterone, FSH and LH concentrations were 
measured in each serum sample, see Appendix I (vi). Terminal 
examination of rats killed at the scheduled intervals included 
weighing of the testes, seminal vesicles, prostate and pituitary 
glands. Portions of these tissues were preserved and prepared for 
histological examination, see Appendix I (viii). Measurements of 
seminiferous tubule diameter, and counts of type B spermatogonia, 
pachytene primary spermatocytes, early and late spermatids, and 
Sertoli cells were made, see Appendix I (ix).
2.1.2. Results
There were three premature deaths: one control rat during week 7
of the recovery period and two rats which were given morphine, one 
during the ninth week of dosing and one during the fourth week of 
the recovery period. These deaths were attributable to chronic 
respiratory disease.
Injection of morphine at 50 mg/kg/day induced marked sedation during 
the first and second days of the dosing period; subsequent tolerance 
developed rapidly. During the last two weeks of the dosing period.
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the morphine-treated rats became irritable and aggressive during 
the later afternoon, presumably as a result of increasing 
physical dependence liability. Morphine-treated rats showed an 
overall 30% reduction of body weight gain in comparison with 
control rats over the nine-week treatment period (Fig. 2.1.2.1.). 
During the period following morphine withdrawal, the rate of 
change of body weight was essentially comparable for both groups 
of rats. Rats given morphine ate less than control rats during 
the first three weeks of dosing; this trend subsequently regressed 
(Fig. 2.1.2.1.). Reduction of food intake was also seen during 
the first week following withdrawal of morphine; there were no 
subsequent significant differences in food consumption among rats 
retained for 13 weeks' recovery. No differences were found between 
control and treated rats in respect of serum FSH concentration. 
Treatment with morphine sulphate at 50 mg/kg/day resulted in 
persistent reductions in the concentrations of LH and testosterone 
detectable in sera obtained 4 h after dosing (Table 2.1.2.1.).
There was no evidence of a progressive reduction in hormone concen­
tration as the period continued. This effect was completely 
reversed for rats examined 13 weeks after the final dose of 
morphine.
The effects of repeated morphine treatment on pituitary, testicular 
and secondary sex-organ weights are presented in Table 2.1.2.2. 
Because of the marked effects on body weight, analysis of covar­
iance was undertaken with initial and final body weights as 
covariates. When significant interaction between body weight and 
treatment was apparent, organ weights were adjusted for differences 
in body weight before analysis of variance. No statistically 
significant effects (p >0.05) were found with regard to pituitary 
or testicular weights. Prostatic weights were reduced after four 
and nine weeks' treatment, but seminal vesicle weights were reduced 


















"Dosing" ■Recovery- 13 (weeks)
Fig. 2.1.2.1. Effects of morphine sulphate (50 mg/kg/day) on body 
weight and food intake when administered to male rats for nine 
weeks, followed by a 13-week recovery period. Controls ( O ); 
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Differences in pituitary gonadotrophic cell morphology were 
detected after four and nine weeks' morphine treatment (Fig.
2.1.2.2.). Cellular atrophy, nuclear pyknosis and condensation 
of granules were thought to indicate a reduction in secretory 
activity. Pituitary morphology was comparable for control and 
previously dosed rats examined 13 weeks after experimental 
treatment had stopped. No changes in cellular morphology of 
prostates or seminal vesicles were detected, although decreased 
eosinophilia of the secretions of these glands was apparent. All 
stages of spermatogenesis were recognisable on histological 
examination, but mature spermatids, detached in the lumina of 
seminiferous tubules, were less obvious in testes obtained after 
four and nine weeks' treatment with morphine sulphate (Fig. 2.1.
2.3.) than in the testes of control rats.
Quantitative histometric analysis of spermatogenesis gave further 
evidence that administration of morphine sulphate affected 
spermatid development (Table 2.1.2.3.). Statistically significant 
(p<0.05) decreases in crude and corrected counts of early (stage 
1) spermatids and late (stage 8) spermatids were recorded 
after four and nine weeks' treatment. After nine weeks' treatment 
significant decreases were also found for Sertoli cell counts, 
pachytene primary spermatocytes and type B spermatogonia. These 








Fig. 2.1.2.2. Sections of anterior pituitary glands from a control
rat and a rat given morphine sulphate (50 mg/kg/day) for four weeks
PAS-Alcian blue-Orange G: x 512.








Fig. 2.1.2.3. Seminiferous tubules at stage 8 of spermatogen­
esis of a control rat and a rat given morphine sulphate (50 mg/kg/ 
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Decreases in circulating LH concentrations can be induced in rats, 
following overdosage with a variety of narcotic analgesic 
agents (Cicero, 1977). This effect can be correlated with 
pharmacological potency in a variety of dm vitro test systems, 
including displacement of radiolabelled opiates from brain 
receptor homogenates, inhibition of guinea-pig ileum contractions, 
naloxone blockade and stereospecificity (Kosterlitz and 
Waterfield, 1975). Tolerance and physical dependence are impor­
tant features of morphine abuse, but the available literature 
indicated that the hormonal modifications do not differ substan­
tially between tolerant and non-tolerant rats. A constant dosage 
schedule was selected for this investigation because it was 
intended to assess the toxicological significance of simple 
narcotic overdosage rather than to mimic narcotic addiction. The 
dose of 50 mg/kg/day represents a 35- to 50-fold multiple of the 
recommended therapeutic dose (1-1.5 mg/kg). Although a degree of 
physical tolerance developed after repeated administration of 50 
mg/kg/day, the hormonal effects after nine weeks' treatment were 
similar to those detected after one day's administration.
Macroscopic post-mortem examination, organ weight analysis and 
subjective histological examination are key features of 
conventional safety evaluation studies. Based on these criteria, 
the only conclusive evidence of treatment-related effects on male 
reproductive physiology were the differences detected in weight, 
without major morphological changes for the prostate glands and 
seminal vesicles. Specialised staining of pituitary gland sections 
provided some evidence of reversible modifications in the secretory 
activity of gonadotrophic cells. Although subjective assessment 
of testicular histology suggested a reduction in the numbers of 
mature spermatids among morphine-treated rats, all stages of 
spermatogenesis were present in the sections examined.
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Quantitative assessment of testicular spermatogenesis revealed 
a degree of impairment in germ-cell differentiation. The 
earlier work of Clermont and Morgentaler (1955) demonstrated that 
spermatogenesis is not completely abolished in rats, following 
hypophysectomy^ Although initial disruption occurs, a degree of 
residual spermatogenesis is restored within 25 days. Chowdhury 
(1979) provided evidence that, apart from stem-cell renewal and 
spermatid maturation, other phases of spermatogenesis in the rat 
are not entirely hormone-dependent. Administration of anti-LH 
serum for 14 days to 20-day-old rats reduced secondary sex-organ 
weights and the counts of pachytene spermatocytes and round 
spermatids (Madhwa Raj and Dym, 197 6) . It is possible to 
conclude that the reversible modifications of pituitary-testicular 
morphology detected in this investigation were consequences of 
reduced LH concentrations following morphine overdosage. Further 
experiments are necessary to determine whether these effects 
result in impaired breeding performance of male rats.
2.1.4. Abstract
Morphine sulphate was administered, by subcutaneous injection, to 
male rats at a dose of 50 mg/kg/day for up to nine weeks. Control 
rats were given injections of sterilised water (BP).. Serum LH and 
testosterone concentrations and the weight and morphology of 
testes, pituitary glands and secondary sex organs were examined 
after four and nine weeks' morphine treatment and also 13 weeks 
after dosing stopped. Treatment with morphine decreased serum LH 
and testosterone concentrations and reduced secondary sex-organ 
weights. Differential staining techniques revealed modified 
secretory activity of pituitary gonadotrophic cells. All stages 
of spermatogenesis were found in testicular sections, but
:100;
quantitative reductions in spermatogenic cell populations were 
found among morphine-treated rats. All the observed effects 
were reversed within 13 weeks of drug withdrawal. These findings 
are discussed in relation to existing knowledge of the hormonal 
control of spermatogenesis in rats.
:101;
2.2. Administration of cogazocine lactate to Beagle dogs for 9 
weeks
The effects of morphine overdosage in rats were studied in the 
previous experiment. A review of the literature did not provide 
any recorded evidence that the hypothalamic-pituitary-testicular 
effects of narcotic analgesic overdosage had been examined in 
dogs. Erratic responses to administration of therapeutic doses of 
morphine are common in dogs: consequently, prolonged morphine 
overdosage was considered to be impracticable for this species.
In recent years, attention has been given to the development of 
morphine analogues which retain analgesic potency but have a 
reduced physical dependence liability. The benzmorphan derivatives 
which contain narcotic antagonist chains on the T-phenyl- 
piperidine configuration show only minimal addictive properties. 
Karras and North (1979) consider that the beneficial pharmacological 
effects of narcotic analgesics are probably due to inhibition of 
neuronal firing or neurotransmitter release, whereas the develop­
ment of physical dependence is likely to be associated with an 
effect on intracellular cyclic nucleotide metabolism. Because the 
effects of morphine on LH are probably due to inhibition of central 
neuronal pathways, overdosage with non-addictive narcotic analgesics 
may exert similar effects. Cogazocine lactate, 2-cyclobutyl methy1- 
5-ethyl-2'-hydroxy-9, 9-dimethy1-6,7-benzmorphan lactate, is a 
novel benzmorphan analgesic which is 80 times more potent in the 
rhesus monkey dental pulp stimulation test and 30 times more potent 
in the rat writhing test than morphine sulphate (unpublished data, 
Huntingdon Research Centre). Preliminary investigations showed 
that repeated overdosage of dogs with cogazocine lactate did not 
provoke the emesis, defaecation and hyperaesthesia sometimes 
induced with morphine in this species. This compound was
102:
selected to study the testicular responses of dogs following 
overdosage with a narcotic analgesic. At the same time it was 
possible to determine whether suppression of circulating LH 
concentration is a common property of both addictive and non- 
addictive narcotic agents.
2.2.1. Experimental design
a) Four adolescent male Beagles were obtained? the husbandry 
and management were as described in Appendices I (i) and (ii). 
Cogazocine lactate, supplied by ACF Chemiefarma, Maarsen, The 
Netherlands, was prepared as a 0.667% (v/v) solution in 5% dextrose 
so that 0.15 ml of solution contained 1 mg cogazocine lactate.
Each dog was weighed before receiving a single intramuscular 
injection of cogazocine lactate at a dose of 1 mg/kg. Serum was 
obtained from each dog, see Appendix I (v), immediately before 
dosing and 0.5, 1, 2, 4, 6 and 24 h after administration of the 
drug. The concentrations of LH and testosterone, see Appendix I 
(vi), were measured in each serum sample.
b) Six sexually mature male Beagles were also obtained and 
maintained under standard conditions of husbandry and management, 
see Appendices I (i) and (ii). These dogs were given daily 
intramuscular injections of cogazocine lactate (1 mg/kg/day) for 
nine weeks. Two dogs were killed for terminal studies after nine 
weeks' treatment. Two dogs were killed nine weeks after receiving 
the last dose of cogazocine lactate and the remaining two dogs were 
killed 18 weeks after the last dose. Body weight changes, food and 
water consumption were recorded, see Appendix I (iii). The
:103:
testes of each dog were measured, see Appendix I (iv), before 
treatment started, after 2, 4 and 9 weeks' dosing and during 
weeks 4, 9, 13 and 18 of the recovery period. Semen samples were 
collected, see Appendix I (vii) before treatment, after 1, 2, 4 and 
8 weeks' dosing and at approximately monthly intervals during the 
withdrawal phase.
LH and testosterone concentrations, see Appendix I (vi), were 
measured in serum samples obtained 24 h after the preceding dose 
of cogazocine lactate on days 2, 8, 15, 29 and 57 of the dosing 
period and during weeks 8 and 17 of the withdrawal period. Terminal 
examinations comprised complete post-mortem examinations, and weigh­
ing of testes,pituitaries and prostate glands, with_^re^ervation of 
these organs for histological examination, see Appendix I (viii). 
Counts of type B spermatogonia, pachytene spermatocytes, early 
(round) spermatids, late (elongated) spermatids, Sertoli cells and 
measurements of seminiferous tubule diameters were made, as 
described in Appendix I (ix).
2.2.2. Results
The administration of a single dose of cogazocine lactate (1 mg/kg) 
induced narcosis lasting approximately 4 h. However, the clinical 
appearance of the dogs was normal 24 h later. Repeated daily 
administration of 1 mg/kg produced the same effect during the 
first five days. Subsequently, the severity decreased and, after 
the second week, the only central effects were transient drowsiness 
lasting about 30 minutes. During the first week of dosing, food 
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Fig. 2.2.2.1. Effects of cogazocine lactate on body weight 
and food residue when administered to Beagle dogs at 1 mg/kg/ 
day for nine weeks.
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Food intake subsequently improved but the body weight effect 
persisted. Following withdrawal of treatment, further weight loss 
occurred and body weight gains were not apparent until the tenth 
week after cessation of dosing. Eighteen weeks after withdrawal 
the body weights of the remaining two dogs were similar to those 
before treatment.
The acute effect of a single dose of cogazocine lactate (1 mg/kg) 
on serum LH and testosterone is shown in Fig. 2.2.2.2. The 
values obtained at 0 h were within the expected range of values 
for these hormones in young adult Beagles. After 0.5 h, LH values 
were decreased, although expected values for testosterone were 
still apparent. Serum concentrations of both hormones were 
depressed at 1, 2 , 4  and 6 h after dosing. The serum of the same 
dogs showed normal LH and testosterone concentrations 24 h after 
administration of cogazocine lactate.
The mean changes in testicular area relative to the start of 
treatment are shown in Fig. 2.2.2.3. During the dosing period 
there was a progressive reduction in these areas, as shown by 
testicular measurement. Four weeks after cessation of dosing, 
recovery was apparent and the subsequent measurements did not 
differ appreciably from the pre-dose values. The results of 
hormonal assays, performed 24 h after the dose had been given, are 
shown in Table 2.2.2.1. Apart from reduced testosterone 
concentration 24 h after the first dose, the results were similar 
to, or slightly higher than, the baseline values. Before the 
start of treatment, all dogs produced satisfactory ejaculates.
106:







• ---- # Luteinising hormone (LH)
Testosterone
Fig. 2.2.2.2. The effects of a single dose of cogazocine 
lactate (1 mg/kg) on serum LH and testosterone concentrations 
of Beagle dogs. LH expressed as ng/ml canine pituitary 
standard LER-1685-1. Lowest levels of detectability; LH <0.5 




































Fig. 2.2.2.3. Mean changes in testicular area, relative to the 
start of dosing, for Beagle dogs given cogazocine lactate (1 mg/kg/ 
day) for nine weeks, followed by an 18-week recovery period. 
Vertical lines represent - standard deviation.
: 108 :
rH in in r - CD CN CN o
m O cn CD CN
Q) 1 1 1 1 1 1 1 1
c fS CN Tf in m CN CN
1-4 Id





u CO r 4 m CN rH CN 1-4 CN
0 )
+J rH o rH rH CN CN 1-4 O
U] G






p (d <y\ m 00 CD cn CTi
o cu
w s rH O rH n CN CN rH CD
o\ Tf rH CN
rH cn CN r~
O m CJ\ m
i-H CN rH CTi rH CN CD
(U 1 1 1 1 I 1 1 1
S'c in in m ro 00 in in O
(d
05 O O O rH o O O TT
1-4 (N CN r» rH cn r-' C7C
G
\ CN 00 r - cn O rH
cn Q




p fd VÛ CO O CD CD CD CN
(U C)





CD 0 P I C
c 1 •H O 5
0 a P Cu
•H (U r~
•p a in cri r- >1 00 rH
(0 0) CN 00 rH CN m  p
c CO 0)
•H 0 c >1 ÎP >1 >1 >1 > <D (U
g 'O ■H (d (d (d fd fd  0 (Ü
(d m in Q Q Q Q D  Ü 5
X p 0 (U












































































































During the dosing period all dogs continued to show normal libido, 
although after seven days* dosing, only two dogs actually 
ejaculated. Most dogs subsequently produced ejaculates, but there 
was a marked reduction in its volume, density, motility and sperm 
concentration. A large number of dead and morphologically abnormal 
spermatozoa were present, the principal abnormalities being loose 
heads and coiled tails. Fig. 2.2.2.4. illustrates the progressive 
changes seen in volume of ejaculate and sperm characteristics.
After withdrawal of the treatment, all the dogs readily produced 
ejaculates. One week after withdrawal, the percentage of dead or 
abnormal spermatozoa was less than that during the dosing period, 
but the lowest sperm counts were recorded at this time. Four weeks 
after withdrawal, and at all subsequent examinations, the semen 
characteristics assessed were all satisfactory. The selected organ 
weights of the dogs examined at the chosen intervals are given in 
Table 2.2.2.2. Apart from reduced prostatic weight following nine 
weeks' treatment and also nine weeks' withdrawal of the drug, the 
other organ weights were considered to be within the normal range of 
variation. Light-microscopic examination of the testes after nine 
weeks' treatment (Fig. 2.2.2.5.) revealed an obvious reduction in 
the number of elongated (late) spermatids in the lumina of the 
seminiferous tubules. Subjective assessment of testicular sections 
examined after nine and 18 weeks' withdrawal indicated normal 
morphology with mature spermatids present. Quantitative histo­
metric analysis (Table 2.2.2.3.) revealed a statistically signifi­
cant (p <0.01) reduction in the number of pachytene spermatocytes 
after nine weeks' treatment. The major effect was, however, a 
marked reduction in both early (round) and late (elongated) sperma­
tids after nine weeks' treatment, but only in late spermatids after 
nine weeks' withdrawal. Sertoli cells appeared to be unaffected and 
the values for the germinal cell counts obtained after 18 weeks' 
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Fig. 2.2.2.4. Changes induced in ejaculate volume, sperm count 
and spermatozoal morphology by administering cogazocine lactate 
(1 mg/kg/day) to Beagle dogs for nine weeks. Numbers of dogs 
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Fig. 2.2.2.5. Section of a testis obtained from a Beagle dog 
given cogazocine lactate (1 mg/kg/day) for nine weeks, showing 















CQ CJ Of 00 oiH <V




















TP Tp en CO





U1 CO Of CO





f 1 + I + 1 H
p
m 00 m Id
rH CM cn p








at Ü Ü en
0 01 0)





<u 01 01 01
> > > rH
P



























































After nine weeks' treatment, the prostate glands (Fig. 2.2.2.6.) 
showed predominance of interstitial stroma, and inactive acini 
lined by flattened epithelium with no evidence of secretory 
activity. Nine weeks after withdrawal the prostatic acini, 
although reduced, showed some evidence of secretory activity. 
Prostate morphology was considered to be normal after 18 weeks' 
withdrawal. Differential staining of the pituitary glands 
(Fig. 2.2.2.7.) revealed cellular atrophy, pyknosis and conden­
sation of granules in gonadotrophic cells after nine weeks' 
treatment, but not after nine or 18 weeks' recovery.
2.2.3. Discussion
The effects of a single dose of cogazocine lactate (1 mg/kg) on 
serum LH and testosterone in the Beagle dog are similar to the 
effects observed following morphine administration to rats.
Repeated administration of cogazocine lactate to dogs, at 
approximately 20 times the likely clinical dosage (0.05 mg/kg/day), 
induced reversible effects on semen characteristics, spermatid 
maturation and in the androgen-dependent prostate gland. The 
principal abnormalities found in semen were dead sperm, coiled 
tails and loose heads. Swanson and Boyd (1962) studied the 
factors associated with coiled-tail spermatozoa in the bull and 
found that variation of this type developed after migration to 
the cauda epididymis, and susceptibility increased towards the vas 
deferens. It was suggested that variations in the composition of 
the secondary sexual fluids governed the presence or absence of 
this abnormality. Although the evidence is circumstantial, the 
appearance of coiled-tail spermatozoa in ejaculates from dogs 
given cogazocine lactate could be due to the reduction of the 
prostate secretion (Harrop, 1955) as a result of testosterone 
depletion.
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Fig. 2.2.2.6. Section of prostate gland obtained from a Beagle 
dog after nine weeks' administration of cogazocine lactate (1 mg/ 
kg/day). Note atrophy of prostate acini and predominance of 
interstitial stroma. H & E, x 50.
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Appearance of pituitary gonadotrophs (blue cells) after nine 
weeks' treatment.
\
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Appearance of pituitary gonadotrophs (blue cells) after 18 weeks 
recovery.
Fig. 2.2.2.7. Histological sections of pituitary glands obtained 
from Beagle dogs after nine weeks' treatment with cogazocine 
lactate (1 mg/kg/day) and after 18 weeks' recovery. PAS-Alcian 
blue-Orange G; x 512.
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In the dog, ablation of the posterior median eminence of the 
hypothalamus induces severe testicular and prostatic atrophy. 
Ablation of the anterior or median eminence results in reduced 
sperm concentration and motility, together with partial suppression 
of spermatogenesis (Davidson and Ganong, 1960). These observations, 
and the occurrence of altered staining properties of pituitary 
gonadotrophic cells after administering cogazocine lactate for 
nine weeks, support the hypothesis that the effects on the late 
stages of spermiogenesis, prostatic function and circulating 
testosterone concentrations are secondary to inhibition of LH 
release. The reversibility of the changes and the underlying 
biological mechanism do not suggest an unpredictable toxic hazard, 
but merely an exaggerated pharmacological response to repeated 
overdosage.
The similarity of the results obtained with morphine in rats and 
with cogazocine lactate in dogs suggests that similar effects may 
be induced in either species following overdosage with a variety of 
addictive or minimally addictive narcotic analgesic drugs.
2.2.4. Abstract
Acute single overdosage (1 mg/kg, i.m.) with the novel benzmorphan 
narcotic analgesic agent,cogazocine lactate,lowered serum LH and 
testosterone concentrations of Beagle dogs. The effect was rapidly 
reversible and persisted for less than 24 h after drug administrat­
ion. Repeated administration (1 mg/kg, i.m.) induced reversible 
suppression of spermatid maturation with subsequent effects on semen 
characteristics. Examination of circulating LH and testosterone 
concentrations, together with pituitary and prostate morphology, 
suggested that the changes were due to^nhibition of LH release.
;118:
It is probable that the underlying mechanism is an exaggerated 
pharmacological response to repeated overdosage, common to many 
potent narcotic analgesic agents.
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2.3. Administration of Compound A to Beagle dogs for 9 weeks
Body (1970) drew attention to the association between male 
infertility and analgesic abuse. This author also described 
experimentally induced testicular atrophy in rats and guinea-pigs 
as a result of prolonged overdosage with aspirin, phenacetin or 
paracetamol. Inhibition of prostaglandin synthesis is an important 
property of aspirin-like drugs (Vane, 1971). Abbatiello et al.,
(1975) reported that administration of prostaglandin-inhibiting 
agents could modify the seminiferous epithelium of laboratory 
animals. Prostaglandins are thought to be mediators in the release 
of anterior pituitary hormones (Batta et al., 1974; Carlson et al., 
1977; Ojeda et al., 1974; Sato et al., 1975). Prostaglandin 
synthesis occurs in mammalian testicular tissue (Ellis et al.,
197s A  Prostaglandin concentrations are low in seminiferous 
tubules and interstitial tissue, but greater amounts are found in 
the epididymides and vas deferens (Johnson and Ellis, 1977).
Seminal plasma is also rich in prostaglandin activity (Badr et al., 
1975; Poulos et al., 1975; Sorgen and Glass, 1972; Voglmayr, 1973). 
Bartke et al. (1976) have demonstrated the role of prostaglandins 
in testicular synthesis of androgenic hormones. While the precise 
role of prostaglandins in male reproductive physiology remains 
debatable, it is apparent that continuous administration of high 
doses of prostaglandin inhibitors to experimental animals may be 
expected to modify testicular function.
Indomethacin and structurally similar compounds are important non­
steroidal anti-inflammatory drugs, all of which are recognised 
inhibitors of prostaglandin synthesis. The preclinical safety 
evaluation of these agents in laboratory animals presents practical
:120:
difficulties. Rats and dogs tend to concentrate non-steroidal 
anti-inflammatory drugs in the enterohepatic circulation to a 
greater extent than humans (Duggan et al., 1975). The development 
of gastrointestinal, hepatic or renal disturbances often limits 
the magnitude and extent of exposure which can be achieved in 
laboratory species. Compound A, a structural analogue of 
indomethacin, is well tolerated by Beagle dogs. This provided an 
opportunity to assess the testicular responses following exaggera­
ted prostaglandin inhibition in the Beagle dog.
2.3.1. Experimental design
Fifteen sexually mature Beagle dogs were obtained and were 
maintained under standard conditions, see Appendices I (i) and (ii). 
compound A tablets were made available on condition that the source 
and structure of the active principle remained confidential. Three 
dogs were given compound A at a dose rate of 150 mg/kg/day and six 
dogs received 600 mg/kg/day. The doses are expressed in-terms of 
active ingredient and correspond to 10 and 40 times the proposed 
therapeutic dosages. Six dogs were dosed with placebo tablets 
containing the same amount of excipient as the compound A formula­
tion. Dosing continued on a daily basis for nine conaecutive weeks.
Body weight changes, food and water consumption were recorded, see 
Appendix I (iii). The dogs were examined several times daily for 
clinical evidence of malreaction to the experimental treatment.
The dogs given 150 mg/kg/day, three dogs given 600 mg/kg/day and 
three control dogs, were killed on completion of nine weeks' dosing.
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All remaining dogs were killed 13 weeks after receiving the final 
dose of compound A or placebo tablets. The testes of each dog 
were measured, see Appendix I (iv), before treatment started, after 
two, four and eight weeks' treatment and also four, eight and 12 
weeks after dosing stopped. LH and testosterone concentrations 
were measured, see Appendix I (vi), in serum samples obtained 4 h 
after dosing on day 3, during weeks 4 and 9 of the dosing period 
and also after 12 weeks' withdrawal of treatment. Semen samples 
were collected and evaluated, see Appendix I (vii), for each dog 
at the same intervals as the testes were measured. Acid phospha­
tase concentrations, see Appendix I (vii), were measured in seminal 
plasma obtained after centrifugation of each semen sample.
During the terminal studies each dog was given a complete post­
mortem examination which included weighing and preservation of the 
testes, prostates and pituitary glands, see Appendix I (viii). 
Histological sections of the preserved organs were prepared for 
light-microscopical examination. Measurements of seminiferous 
tubule diameter and counts of type B spermatogonia, pachytene 
primary spermatocytes, early and late spermatids and Sertoli cells 
were made for each dog, see Appendix I (ix).
2.3.2. Results
Vomiting and salivation occurred among dogs given compound A at 
600 mg/kg/day. The signs appeared up to one hour after dose 
administration: the frequency diminished as the treatment period 
progressed, and neither sign was seen after week 5. Body weight 
changes and appetite were not adversely affected. Dogs given 600 
mg/kg/day drank significantly increased ( p < 0.001) quantities of 
water, but excessive thirst was not apparent. Modifications in
:122:
testicular area, serum hormone concentrations and semen 
characteristics were seen among dogs given 600 mg/kg/day. 
Progressive reductions in the mean testicular area of these dogs 
attained statistical significance (Table 2.3.2.1.) after eight 
weeks' treatment. This effect was, at least partly, reversible 
after 13 weeks' withdrawal of compound A. Consistent reduction of 
circulating LH and testosterone concentrations were induced in 
dogs receiving 600 mg/kg/day (Fig. 2.3.2.1.; Table 2.3.2.2.).
This trend had completely regressed by 12 weeks after the final 
dose of compound A. Treatment with 600 mg/kg/day was associated 
with decreased ejaculate volume and sperm concentration, thoughout 
the nine weeks of dosing (Fig. 2.3.2.2.; Table 2.3.2. 3.). These 
trends were reversed following withdrawal of compound A treatment, 
but statistically significant (p <0.01) increases in the number 
of dead and abnormal spermatozoa were apparent after eight and 
12 weeks' recovery in dogs previously given 600 mg/kg/day. The 
principal morphological abnormalities were coiled tails and loose 
or detached heads. Seminal plasma acid phosphatase concentrations 
were unaffected by the experimental procedure.
No difference in macroscopic appearance or weight were found at 
the terminal inspections of the pituitaries, testes and prostate 
glands. No treatment-related histological abnormality was found 
in the prostate gland of any dog. Differential staining of 
pituitary sections, confined to dogs given 600 mg/kg/day and 
concurrent controls examined after nine weeks' treatment, 
indicated an effect on gonadotrophic cells. Evidence of reduced 
secretory activity in these cells was characterised by cellular 
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Serum LH (ng/ml) 
10
Serum testosterone (ng/ml) 
4 r -
day 3 2 weeks 4 weeks 9 weeks 12 weeks'
recovery
4--------- Dosing period  »
Fig. 2.3.2.1. Effect of compound A on serum LH and testosterone 
concentrations of Beagle dogs. Controls; ( Q  ); Compound A:
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Fig. 2.3.2.2. Effect of compound A on semen characteristics of 
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Histological examination of the testes of dogs which had received 
600 mg/kg/day for nine weeks showed marked reduction in the number 
of mature spermatids present in the lumina of seminiferous tubules. 
Quantitative assessment of testicular spermatogenesis (Table 2.3.2.4) 
confirmed the subjective histological assessment. The numbers of 
all spermatogenic cells were conclusively reduced by nine weeks' 
treatment with compound A at a dose of 600 mg/kg/day. Following 13 
weeks' withdrawal of compound A,the germinal cell counts of 
previously treated dogs were essentially comparable with the control 
data. Apparent increases in the Sertoli cell counts of dogs treated 
with compound A may have been artefactual consequences of decreased 
seminiferous tubule diameter (Clermont and Morgentaler, 1955) , 
although after 13 weeks' withdrawal of clanobutin the seminiferous 
tubule diameters of dogs which had received the drug were compara­
ble with control values.
2.3.3. Discussion
Previous investigators (Saksena et al., 1975) have studied the 
effects of repeated indomethacin overdosage on serum LH and 
testosterone, testicular and secondary sex-organ weight and male 
fertility in rats. The maximum tolerated daily dose was 2.5 mg 
indomethacin. At this dosage, serum LH and testosterone, and 
seminal vesicle weights were decreased, but testicular and 
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In addition to reducing serum LH and testosterone, treatment of dogs 
with compound A at 600 mg/kg/day exerted anti-fertility effects as 
evinced by decreased testicular area, ejaculate volume and sperm 
concentration and also changes in testicular and pituitary morphol­
ogy. Two considerations are of merit in evaluating this apparent 
discrepancy in species response. First, compound A overdosage is 
well tolerated by dogs and it proved possible to administer a greater 
multiple of the likely therapeutic dosage than would be possible 
with indomethacin. S e c o n d l y s p e r m a t o g e n e s i s  can proceed, at a aCt«dbu« 
reduced rate, after hypophysectomy in the rat (Clermont and 
Morgentaler, 1955) whereas hypophysectomy or ablation of the post­
erior median eminence invariably results in testicular atrophy in the 
dog (Davidson and Ganong, 1960). The lack of effect of compound A 
on prostate and testicular weights and on seminal plasma acid 
phosphatase concentrations in Beagle dogs may appear to contradict 
the observed effects on testicular size and morphology and semen 
characteristics. Experimental data (Joseph and Siwela, 1976) exist 
to show that suppression of prostaglandin synthesis may enhance the 
sensitivity of the prostate to testosterone. It is possible, there­
fore, that adequate prostate function may be maintained in animals 
with reduced endogenous testosterone concentrations due to prolonged 
suppression of prostaglandin synthesis. A wide normal range is 
found for the weight of Beagle dog testes, and serial testicular 
measurements may be a more sensitive index of testicular toxicity 
than comparison of testicular weights at terminal examination.
Although modification of serum LH and testosterone concentration 
provides a basis for explaining primary biological mechanisms 
involved in the genesis of abnormal testicular function, the 
present data do not completely justify this conclusion. Although 
a reduction in the number of mature spermatids found in semini­
ferous tubules may be a consequence of LH depletion (Steinberger,
1971) this does not readily explain the decreased counts of earlier 
spermatogenic cells. Examination of the ratio between successive
:131
generations of cell types counted in the germinal epithelium 
(Hemsworth et al., 1968) shows that pachytene spermatocytes and 
early spermatids were found at similar daughter-cell ratios in 
treated and control dogs. It may be inferred that reduction in 
germinal cell numbers occurred as a result of a drug effect on 
spermatogonial divisions. Jackson (1972) considers that drug- 
induced modifications in spermatogonia result from local action on 
the seminiferous epithelium. The persistence of morphological 
abnormalities in spermatozoa from dogs kept for recovery studies 
after receiving 600 mg compound A/kg/day cannot be explained from 
the available data. The effects of compound A  overdosage on serum 
LH and testosterone were, however, reversed within 13 weeks of 
withdrawal of the drug.
This investigation supports the hypothesis that prolonged over­
dosage with compounds belonging to a pharmacological class widely 
accepted as inhibitors of prostaglandin synthesis (Sorrentino et 
al., 1972) may modify pituitary-testicular physiology. The 
finding that administration of ten times the likely therapeutic 
dosage did not adversely affect testicular size, LH or testosterone 
semen characteristics or testicular morphology, implies that 
testicular effects seen at higher dosages may be regarded as 
predictable responses to overdosage rather than indications of 
toxicity following normal use.
2.3.4. Abstract
Compound A, a prostaglandin inhibitor, was administered in tablet 
form to Beagle dogs at dosages of 150 or 600 mg/kg/day for nine 
weeks.. .Control dogs received placebo tablets containing the same 
amount of excipient as the compound A tablets. Treatment at 600 
mg/kg/day was associated with decreased serum LH and testosterone
:132:
concentrations, reduced testicular size, ejaculate volume and sperm 
concentration, lowered spermatogonial and mature spermatid counts in 
seminiferous tubules and evidence of reduced secretory activity in 
pituitary gonadotrophic cells. Recovery was assessed; although 
hormonally mediated changes regressed, spermatozoal morphology was 
persistently abnormal in dogs which had received 600 mg/kg/day.
The effects of exaggerated prostaglandin inhibition on pituitary- 
testicular physiology are discussed, together with the toxicological 
significance of these findings in relation to their clinical 
application.
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2.4. Administration of Compound B to Beagle dogs (13 weeks) and 
to rats (median life span)
The role of prolactin in male reproductive physiology is becoming 
increasingly recognised (Horrobin, 1977). Experimental studies 
in rodents suggest a synergic role for prolactin at physiological 
concentrations, in testicular spermiogenesis and steroidogenesis 
(Bartke and Dalterio, 1976; Hafiez et al., 1972; Moger and 
Geschwind, 1972). Hyperprolactinaemia has been associated with 
infertility and hypogonadism in human males (Horrobin. 1977). 
Decreased circulating luteinising hormone (LH) and follicle- 
stimulating homone (FSH) concentrations are apparent in hyper- 
prolactinaemic male rodents and humans (McNeilly et al., 1978; 
Thorner et al., 1974). Testicular atrophy has been induced in 
rats by injection of prolactin-secreting pituitary tumour cells 
(Fang et aL , 1974). Ectopic pituitary transplantation with male rats 
and mice was used as a model to study hyperprolactihaemic modifi­
cations of male reproductive behaviour (Svare et al., 1979). Rats 
appeared to be the more sensitive species, but both species 
exhibited longer latency in mounting females,intromission and 
ejaculation; however, fertility was not affected.
The release of prolactin from the pituitary gland is regulated by a 
negative neurohumoral hypothalamic feedback mechanism (Frantz,
197 8). Modification of the neurotransmitter substance involved in 
this mechanism forms the neuropharmacological basis for the actions 
of many psychotropic drugs (Fjalland and Boeck, 1978). Enhanced 
prolactin release is a well-documented feature of dopaminergic 
blocking agents (Bang and Gautvik, 1977; Levin and Voogt, 1978; 
Macleod and Lehmeyer, 1974). Well-known drugs possessing this 
activity include clomipramine (Francis et al., 1976; Groom and 
Evans, 1977), clozapine (Meltzer et al., 1975), haloperidol 
(Quadri et al., 1978) metoclopramide (Carlson et al., 1973;
;134:
Falaschi et al., 1978; Fang et al., 1977), some phenothiazine 
derivatives (Bohnet et al., 1976) and sulpiride (Debeljuk et al., 
1975; Mannisto et al., 1978). This biological activity may modify 
the pituitary-testicular axis of experimental animals subjected to 
prolonged overdosage with compounds belonging to this neuro­
pharmacological category.
In order to study the effects of prolonged hyperprolactinaemia. 
Compound B, a novel neuroleptic derivative in the orthopramide 
2-methoxybenzamide series of dopamine antagonists (Lanza et al., 
1975) , was administered to male rats and Beagle dogs.
2.4.1. Experimental design
Fifteen sexually mature male Beagles and 150 male Sprague-Dawley 
rats (CFY strain) weighing 80-120 g were obtained. The animals 
were maintained under standard conditions, see Appendix I (i) and 
(ii) .
Compound B, supplied on condition that the source and structure of 
the active principle remained confidential, was administered in 
gelatine capsules to dogs at oral dosages of 30 mg/kg/day to three 
dogs, at 120 mg/kg/day to six dogs, and six control dogs were given 
empty gelatine capsules for 13 weeks. Three dogs given 120 mg/kg/ 
day and three control dogs were maintained for a recovery period 
of 13 weeks. Seventy-five rats were given compound B by oral 
gavage at a dose of 300 mg/kg/day, dissolved in distilled water. 
Seventy-five rats acted as controls, receiving distilled water 
alone. Five rats per group were killed after 13 or 52 weeks' 
treatment. Fifteen rats per group acted as satellite animals and 
were used solely for the provision of serum samples. Dosing of the 
remaining rats continued until the 20% survival point for each 
group.
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Body weight changes, food and water consumption were recorded, see 
Appendix I (iii). The animals were observed several times daily 
for clinical evidence of malreaction to experimental treatment. 
Prolactin and testosterone concentrations were measured in serum 
samples, see Appendix I (iv), obtained from each dog before 
treatment started, 2 h after dosing during weeks 6 and 13, and 
after 13 weeks' recovery. Serum was also obtained from five rats 
per group, under ether anaesthesia, after 4, 13, 26, 52 and 78 
weeks' dosing, for measurement of prolactin concentration. The 
testes of each dog were measured, see Appendix I (iv), before 
treatment started and subsequently at monthly intervals. Canine 
semen samples were collected and evaluated, see Appendix I (vii), 
before dosing commenced, after six and 13 weeks' treatment, and 
after six and 13 weeks' recovery.
Rats which died prematurely were given thorough post-mortem 
examinations, followed by preservation of the testes and pituitary 
glands. Terminal examinations of dogs killed at the scheduled 
intervals included weighing and preservation of the testes, prost­
ate and pituitary glands. The testes and pituitary glands of rats 
killed after 13 and 52 weeks' treatment, or at the 20% survival 
point, were also weighed and preserved. All tissues were fixed in 
10% buffered neutral formalin. Routine haematoxylin and eosin 
sections of all preserved organs were examined by conventional 
light microscopy, see Appendix I (viii). Measurements of semi­
niferous tubule diameter and counts of type B spermatogonia, 
pachytene primary spermatocytes, early and late spermatids and 
Sertoli cells were made, see Appendix I (ix), for all dogs and rats 
which attained the 20% survival point, but excluding rats which 
developed atrophy of the seminiferous epithelium.
:136;
2.4.2. Results '
No detectable clinical signs or behavioural modifications were 
observed in rats given compound B. Pupillary constriction occurred 
in dogs receiving either dose level of compound B , but was apparent 
only during the first three weeks of the dosing period. Sedation, 
squinting, body tremors and occasional convulsions or vomiting 
were induced in dogs receiving 120 mg/kg/day. There were no 
persistent effects on body weight or food consumption. The water 
intake ol rats was not affected by compound B, but dogs dosed at 
120 mg/kg/day drank less water than control dogs during the 
treatment period. The 20% survival point was reached after 84 
weeks' treatment of rats with 300 mg/kg/day: however, 20% of the 
control rats survived until week 113 of the investigation.
Prolactin and testosterone concentrations were affected at both 
30 and 120 mg/kg/day in the canine study (Fig. 2.4.2.1.). Although 
the serum prolactin concentrations of dogs given compound B showed 
a five- to ten-fold increase in comparison with control data, a 
linear dose-response relationship was not apparent. A dose-related 
effect was not demonstrable with regard to the lower serum test­
osterone concentrations found in the groups given compound B. The 
variations recorded in control rat serum prolactin concentrations 
followed the age-related pattern described by Riegle and Meites
(1976). An overall three-fold increase in serum prolactin concen­
trations was apparent for rats given compound B (Fig. 2.4.2.2.): 
differences between control and treated rats became more obvious 
as the dosing period progressed.
No significant variations were found in the testicular area of 


















Predose -Dosing- ■> Recovery
Week 6 Week 13
Fig. 2.4.2.1. Effects of compound B on serum prolactin and 
testosterone of Beagle dogs. Controls: ( Q )  Treated: (EH))
30 mg/kg/day; (^ ) 120 mg/kg/day. Prolactin expressed as ng 
CPA3/F4/ml.
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13 26 52 78 (weeks)
Fig. 2.4.2.2. Effects of compound B on serum prolactin concentration 
of rats. Controls: ( Q ) ;  Treated: ( #  ) 300 mg/kg/day.
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An overall 10% reduction of testicular area occurred during 13 
weeks' treatment of dogs with 120 mg/kg/day, but this trend was 
completely reversed during the recovery period. Differences in 
ejaculate volume, sperm motility and morphology were found 
between treated and control dogs (Table 2.4.2.1.) after six and 
13 weeks' dosing. There was an increase in the percentage of 
spermatozoa with proximal cytoplasmic beads, and decreased sperm 
motility at 30 and 120 mg/kg/day. Ejaculate volume was decreased 
and the number of dead spermatozoa increased, in dogs given 120 
mg/kg/day. Although marked individual variations in sperm 
concentration occurred, there was no conclusive difference between 
control and treated dogs. After 13 weeks' withdrawal, the semen 
characteristics of dogs which had previously been given 120 mg/kg/ 
day were very similar to those of the concurrent control group.
Treatment of rats with 300 mg compound B/kg/day induced statistically 
significant increases in pituitary weights (Table 2.4.2.2.). The 
mean prostate weight of dogs given 120 mg/kg/day was significantly 
reduced after 13 weeks' treatment (Table 2.4.2.3.). No 
statistically significant differences were found in canine 
pituitary weights or in testicular weights for either species. Red­
uction of prostatic weight was not evident among dogs examined 
after the 13-week recovery period. There were no histologically 
detectable changes in the testes or pituitary glands of rats 
examined after 13 and 52 weeks' treatment. After 20% survival 
was attained, the cumulative incidences of pituitary chromophobe 
adenomata, chromophobe hyperplasia and cysts were 17%, 7% and 2% 
respectively among rats given compound B. The corresponding 
incidences among control rats were 24%, 7% and 7%. The incidence 
of testicular atrophy was 7% among rats given compound B and 24% 
among control rats. Arteritic lesions were present in the testes 
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The prostate glands of dogs examined after receiving 120 mg 
compound B/kg/day for 13 weeks, showed evidence of acinar 
epithelium and absence of secretion, with a relative increase in 
stromal tissue. Considerable variations were noted for prostate 
morphology among control and previously dosed dogs after the 
13-week recovery period, but evidence of secretory activity was 
seen in all the sections examined. All types of spermatogenic 
cells were present in the seminiferous tubules of dogs at all 
examinations. However, detached mature spermatozoa in the lumina 
of seminiferous tubules appeared to be scanty in some dogs 
examined after 13 weeks' treatment with compound B, at both dose 
levels tested.
The results of quantitative assessment of canine testicular 
spermatogenesis and a similar examination for rats attaining the 
20% survival point, but excluding rats which developed testicular 
atrophy, are presented in Tables 2.4.2.4. and 2.4.2.5. 
Statistically significant reductions (p<0.05) in the counts of 
late spermatids at both dosages, and also early spermatids in 
dogs given 120 mg compound B/kg/day,were apparent after 13 weeks' 
treatment. These effects were not apparent among dogs allowed 
to recover for 13 weeks after the last dose of compound B. The 
counts of pachytene primary spermatocytes, and of early and late 
spermatids, were significantly lower (p<0.05) among compound B- 
treated rats after 84 weeks' treatment than among control rats 
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Discussion
The results of these investigations suggest that there are 
differences in species-sensitivity to hyperprolactinaemia induced 
with compound B. Physiological serum prolactin concentrations•in 
young adult male Beagles vary from 1 to 3 ng/ml, whereas values of 
30-90 ng/ml are recorded for male rats weighing 300 g (Debeljuk et 
al., 1975). However, marked rises in peripheral prolactin 
concentrations are induced by ether anaesthesia in rats (Simonel 
et al., 1975) . Furthermore, comparisons of inter-species varia­
tions are restricted by the marked degree of species-specificity 
inherent in prolactin radioimmunoassays. The differences obtained 
between the control and treated animals used for the present 
investigations indicated that, although lower dose levels of 
compound B were given to dogs, the relative degree of prolactin 
stimulation was greater than that found in rats. The failure to 
detect significant effects on testicular weight and morphology in 
rats examined after 13 or 52 weeks' treatment' concurs with 
previous studies in rats showing a similar increase in serum 
prolactin concentrations (McNeilly et al., 1978). Administration 
of clomipramine to male rats at dosages of 50-100 mg/kg/day 
induced testicular atrophy after 26 weeks' treatment, but measure­
ments of prolactin concentrations were not reported (Groom and 
Evans, 1977). Administration of several benzamide derivatives to 
female rats, for up to 38 days, increased the number of pituitary 
cells, but pituitary weight was not affected (Lanza et al., 1975). 
Pituitary weights were similarly unaffected in the rats used for 
these experiments, after 13 weeks' dosing? however, marked increa­
ses were recorded after administering compoundB for 52 or 84 weeks. 
A high incidence of spontaneous testicular atrophy occurs in aged 
Sprague-Dawley rats, and prolactin-dependent pituitary chromophobe 
adenomata are common in several strains of laboratory rat (Ito et 
al., 1972; Thompson and Hunt, 1963? Wolfe et al., 1938).
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However, comparison of the incidence of pituitary chromophobe 
adenomata or hyperplasia and of the quantitative reductions in 
germinal cell counts found in rats after 84 weeks' compound B 
treatment, with the data from control rats, may indicate an earlier 
onset of these changes. Clarification of these phenomena requires 
evaluation of effects induced by administration of compound B at dose 
levels which do not decrease longevity in rats.
In contrast with the rodent data, compound B-induced-hyperprolactin- 
aemia in Beagle dogs was conclusively associated with modified 
testicular function. Effects on serum testosterone concentration, 
ejaculate volume, spermatid maturation and prostate morphology 
were apparent when control and treated dogs were compared. Although 
some changes were induced at both dosages tested, reversibility 
within 13 weeks of drug withdrawal was demonstrated. Although 
there do not appear to be any specific reports of the role of 
prolactin in canine testicular physiology, the responses obtained 
in this investigation seem to be explicable entirely on the basis 
of disruption of the synergistic role ascribed to prolactin in 
testicular spermiogenesis and steroidogenesis (Bartke and Dalterio, 
1976; Hafiez et al., 1972; Moger and Geschwind, 1972).
Although overdosage of experimental animals with various 
psychotropic drugs has induced effects explicable in terms of 
hyperprolactinaemia, there is a dearth of long-term follow-up 
studies in man (Groom and Evans, 1977). Francis et al., (1976) 
performed a cross-over study in patients treated with clomipramine 
and amitriptyline, which failed to establish conclusive correlat­
ions between side effects and hyperprolactinaemia. It is not easy 
to extrapolate risks on the basis of quantitatively differing 
species-responses to hyperprolactinaemia induced by drug overdosage.
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Further studies appear to be necessary to clarify the effects of 
long-term hyperprolactinaemia on the pituitary-testicular axis of 
different mammalian species.
2.4.4. Abstract
Hyperprolactinaemia was induced in male Sprague-Dawley rats and 
Beagle dogs by oral overdosage with compound B, a neuroleptic dopa­
mine antagonist.- Compound B was given to dogs for 13 weeks at 
dose levels of 30 or 120 mg/kg/day. Some dogs given 120 mg/kg/day 
were studied for a further 13 weeks after the last dose. Rats were 
given 300 mg compound B/kg/day until 20% survival was attained,with 
interim examinations after 13 and 52 weeks' treatment. Vehicle- 
dosed dogs and rats acted as control animals. Prolactin stimulation 
was more marked in dogs than in rats. Reversible changes in serum 
testosterone concentrations, ejaculate volume, spermatid maturation 
and prostate morphology induced in dogs were explicable in terms of 
disruption of the physiological synergism attributed to prolactin in 
testicular spermiogenesis and steroidogenesis. Failure to detect 
effects on the testicular weight and morphology of rats after 13 and 
52 weeks' treatment concurred with published data. Decreased long­
evity was recorded among rats given 300 mg compound B/kg/day and there 
was possibly an earlier onset of naturally occurring age-related 
changes in the testes and pituitary glands of these rats. The 
toxicological significance of these observations is discussed.
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P A R T T H R E E
3. Studies of chemical action on spermatogenic cells
In order to act directly on the cells of the seminiferous 
epithelium, chemicals must pass the 'blood-testis' barrier and 
subsequently modify cell structure or function (Fox and Fox, 1967) . 
The precise nature of this physiological barrier is incompletely 
understood (Dym and Cavicchia, 1977, 1978; Setchell and Waites,
1975) and it is not possible to define concisely the physicochemical 
properties inherent in molecules possessing th:s biological activity 
(Lee and Dixon, 1978; Setchell and Main, 1978; Tuck et al., 1970; 
Waites, 1976; Waites and Einer-Jensen, 1974). The currently 
available techniques for the study of this aspect of testicular 
pathophysiology call for considerable technical expertise and 
facilities and therefore are not available in the majority of 
toxicological laboratories. While detailed understanding of primary 
causal mechanisms is scientifically desirable, the most urgent 
toxicological priority is to recognise those changes in testicular 
function and histomorphometry which can provide a rational basis for 
investigators to assess the safety, in normal use, of chemicals 
exerting this activity. This information may be useful in the 
toxicological evaluation of potential antispermatogenic agents, and 
also in explaining effects observed following the administration of 
unusually high doses of drugs, food additives and agricultural, 
industrial or household chemicals to laboratory animals. For these 
reasons,a series of experiments was performed with antispermatogenic 
compounds and some widely used chemicals, using rats and Beagle dogs.
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3.1. Administration of lonidamine (AF 1890) to Beagle dogs for 9 
weeks
Coulston et al. (197 5) described the reversible inhibition of 
spermatogenesis, in rats and rhesus monkeys, induced by 
administration of 1-substituted indazole-3-carboxylic acids. 
Pharmacokinetic studies in rats (Catanese et al., 1977) suggested 
that selective action on spermatogenesis could be sustained by 
repeated gavage or dietary administration of doses corresponding to 
one-third of the effective single dose. The pharmacological and 
toxicological actions of l-p-chlorobenzyl-lH-indazole-3-carboxylic 
acid (AF 1312/TS) were investigated with Long-Evans rats, CFl mice, 
guinea-pigs. New Zealand White rabbits and cats (Silvestrini et al., 
1975). The acute oral to rats varied between 966 and 1790
mg/kg. The compound was devoid of analgesic, anti-inflammatory, 
sedative or pressor activity. The lowest single oral dose showing 
antispermatogenic activity in rats was 200 mg/kg. Derangement of 
the seminiferous epithelium was characterised by degenerative 
changes in spermatids and spermatocytes and vacuolation of Sertoli 
cells. Because of the narrow ratio between antispermatogenic and 
acute toxic actions, .further analogues were examined. Lonidamine,
1- ^ (2,4-dichlorophenyl)methylJ -lH-indazole-3-carboxylic acid (AF1890) 
was found to be effective in inhibiting spermatogenesis of rats at 
50 mg/kg (Coulston et al., 1975). Lobl and Mathews (1978) found 
that,at a dose of 50 mg/kg for five days, the antifertility effect 
could be confined to axoneme derangement and loss of fibre doublets 
in epididymal spermatozoa. The effect of lonidamine on circulating 
LH, FSH and testosterone concentrations of rhesus monkeys (Lobl et 
al., 1979) and rats (Lobl, 1979) has been investigated. Administra­
tion of antispermatogenic doses to rats increased FSH and decreased 
testosterone concentrations. With the rhesus monkey, antispermato­
genic effects were variable and no conclusive changes in hormonal 
parameters were apparent. Heywood et al. (1980a) studied the sub­
chronic toxicity of lonidamine in Sprague-Dawley rats and adolescent
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male rhesus monkeys. The only effect apparent in rats was on the 
hypothalamic-pituitary-gonadal axis: high doses in male rats 
induced testicular atrophy and increased pituitary weights; 
however, female rats developed suppression of ovarian activity 
and decreased pituitary weights. Variable effects were observed 
on spermatogenesis of rhesus monkeys, but the major manifestation 
of toxicity was renal tubular nephrosis at doses as low as 70 
mg/kg/day. The renal effects were attributed to the rapid 
accumulation of the compound in proximal convoluted tubules.
Since the pharmacokinetics in rhesus monkeys were possibly 
atypical, it seemed worth while to examine the effects of lonidamine 
in an alternative non-rodent species.
3.1.1. Experimental design
Four sexually mature male Beagles were obtained, the husbandry and 
management being as described in Appendices I (i) and (ii).
Body weight changes, food and water intake were recorded, see 
Appendix I (iii) .
Lonidamine, supplied by the Istituto di Ricerca F . Angelini, Rome, 
Italy, was administered orally in gelatine capsules at a dose rate 
of 25 mg/kg/day for nine consecutive weeks. Two dogs were then 
killed for histopathological studies; the remaining two dogs were 
kept undosed for a further 13 weeks before histopathological 
evaluation.
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Testes were measured, see Appendix I (vi) and semen examined, see 
Appendix I (vii) before treatment started, and during weeks 2, 4 
and 8 of the dosing period and weeks 4, 8 and 12 of the withdrawal 
period. Na"*” and K^(mEg/l), alanine aminotransferase (E.C.2.6.I.2.), 
aspartate aminotransferase (E.C.2.6.1.1.) and acid phosphatase 
concentrations (mU/ml) were measured in seminal plasma on each 
occasion. Serum LH and testosterone concentrations, see Appendix I 
(vi) were determined after 8, 15, 29 and 57 days' dosing and again 
during weeks 4, 8 and 12 of the recovery phase. At the terminal 
examinations the testes, prostates and pituitaries were weighed, 
preserved and prepared for histological evaluation, see Appendix I 
(viii). Counts of type B spermatogonia, pachytene spermatocytes, 
early (round) spermatids, late (elongated) spermatids, Sertoli cells 
and measurements of seminiferous tubule diameters were made as 
described in Appendix I (ix).
3.1.2. Results
Body weight change, food intake and water consumption were unaffected
by the experimental procedure. The mean changes in testicular area 
2
(mm ) are depicted in Fig. 3.1.2.1. During the nine weeks of 
treatment a progressive reduction in testicular area was apparent. 
Statistically significant decreases (p<0.05, paired 't'-test) in 
testicular area were recorded after two, four and eight weeks' dosing. 
Restoration of testicular size did not occur during the 13-week 
recovery period.
The-findings of the hormonal assays are presented in Table 3.1.2.1. 
There were no marked differences in the mean values obtained for 























Fig. 3.1.2.1. Mean changes in testicular area for dogs 
given lonidamine (25 mg/kg/day). Vertical lines represent 
- 1 standard deviation.
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It is possibly noteworthy that, after eight weeks' treatment, the 
range of LH values was slightly increased in comparison with those 
obtained before dosing started.
The principal changes observed in the ejaculates (Fig. 3.1.2.2., 
Table 3.1.2.2.) were consistently decreased motility of spermatozoa, 
reduced sperm concentration and increased numbers of morphologically 
abnormal spermatozoa. Sperm counts were reduced after two weeks' 
treatment and oligospermia (p<0.05, paired 't'-test) was apparent 
after four and eight weeks' treatment. The majority of spermatozoa 
were immotile after two, four and eight weeks' dosing and a high 
proportion of the spermatozoa present had coiled tails. These 
effects, although less marked, were still apparent after four weeks' 
withdrawal of lonidamine. After eight and 12 weeks' cessation of 
dosing, the semen characteristics examined were within the 
expected range of normal values. Seminal plasma biochemistry (Table
3.1.2.3.) was not affected by administration of lonidamine. It was 
not possible to establish correlations- between seminal plasma 
aspartate aminotransferase concentrations and the effects on sperm 
concentration and morphology.
There were no treatment-induced differences in the weights of the 
testes, pituitary glands or prostates. No histological changes were 
evident in the pituitary or prostate glands. Histological changes 
were evident in the seminiferous tubules and epididymides after nine 
weeks' treatment (Figs. 3.1.2.3., 3.1.2.4.). Elongated spermatids 
were rarely found in seminiferous tubules and the numbers of round 
spermatids also appeared to be decreased. Spermatozoa were only 
occasionally seen in the lumen of the ductus epididymis, but round 
and multinucleate giant cells were often present. After 13 weeks' 
withdrawal of treatment, all stages of spermatogenesis were apparent 

















































Fig. 3.1.2.2. Changes in semen motility, sperm concentration 
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Fig. 3.1.2.3. Seminiferous epithelium of a Beagle dog given 
lonidamine (25 mg/kg/day) for nine weeks. Marked absence of 
spermatids, especially elongated forms. PAS, x 200.
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Fig. 3.1.2.4. Ductus epididymis of a Beagle dog given lonidamine 
(25 mg/kg/day) for nine weeks. Reduced numbers of spermatozoa 
with round cells present in lumen. PAS, x 200.
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Quantitative assessment of spermatogenesis (Table 3.1.2.4.) 
confirmed the histological impressions. After nine weeks' treatment 
the decreased tubular diameter and reduced counts of pachytene 
spermatocytes, early and late spermatids differed significantly 
(p<0.05) from the values determined for dogs examined after 13 
weeks' withdrawal of lonidamine treatment.
3.1.3. Discussion
These data have provided useful information about the antispermato­
genic effects of lonidamine in Beagle dogs without recourse to 
serial mating procedures. Daily dosing for nine consecutive weeks 
at a dosage rate of 25 mg/kg/day induced obvious infertility 
within 14 days, and the effects persisted for up to eight weeks 
after cessation of dosing.
The results are compatible with the hypotheses of Coulston et al. 
(1975) and Silvestrini et al. (1975), that the primary anti­
spermatogenic effect of indazole-carboxylic acids is an action 
on the seminiferous epithelium and not the hormonal control of 
spermatogenesis. Depletion of maturing spermatids may be expected 
to provoke increased pituitary secretion of gonadotrophins 
(Steinberger, 1971) via the hypothalamic feedback mechanisms, it
was not possible to examine FSH activity; however, the results of 
the hormonal examinations which were undertaken provided no 
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The results of the semen examinations, together with the 
histological findings, suggest that, in the absence of reduced 
gonadotrophic output, oligospermia was caused by cytotoxic effects 
on spermatid development. These results confirm previous findings 
in rats (Coulston et al., 1975) and rhesus monkeys (Lobl et al., 
1979) following administration of substituted indazole-carboxylic 
acids.
Although the antispermatogenic effects of this compound in the dog 
appear to be essentially reversible, a number of points warrant 
further discussion. The area calculated from the gross dimensions 
of the testes, in the living animals^ was apparently irreversibly 
decreased, although the weight of the testes at post-mortem 
examination was within the range of normal values. Caution is 
necessary in reconciling these observations, because the observed 
30% decrease in testicular area followed mean decreases of less 
than 5 mm in testicular length and breadth. In view of the wide 
variations in weight of the Beagle testes, it is unlikely that 
reductions in testicular dimensions of this order would result in 
a detectable decrease in testicular weight.
At a dose of 25 mg/kg/day, obvious morphological changes in the 
seminiferous epithelium became apparent: in compounds not intended 
to act as contraceptives this is likely to be considered an 
undesirable toxic phenomenon. Although the observed histological 
changes were shown to be reversible, this was not so for changes in 
seminal plasma aspartate aminotransferase. The data do not permit 
assessment of mutagenic hazards during the induction of infertility 
or the restoration of normal spermatogenesis. The acceptability of 
using chemicals to act on dividing or differentiating spermatogenic 
cells remains, as yet, an unsolved toxicological question.
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3.1.4. Abstract
Four sexually mature Beagle dogs were given lonidamine at 25 mg/kg/ 
day, orally, for nine consecutive weeks. Two of the dogs were 
retained undosed for a further 13 weeks in order to assess recovery. 
Testicular dimensions, serum luteinising hormone (LH) and testos­
terone concentrations, together with semen characteristics, were 
assessed. The light-microscopic appearance of the testes was 
examined. Reduced testicular dimensions, oligospermia and coiled- 
tail immotile spermatozoa were evident after two weeks' dosing. 
There were no conclusive effects on serum LH or testosterone and 
testicular weights were within the normal range of variation. Light 
microscopy showed that spermatid development was arrested at the 
early round cell phases. Although testicular dimensions remained 
decreased, effects on the morphology of the seminiferous epithel­
ium were reversed following 13 weeks' withdrawal of treatment.
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3.2. Administration of l-amino-3-chloro-2-propanol hydrochloride 
(CL 88, 236) to rats for 12 weeks
A number of substituted chlorohydrin derivatives exert an 
antifertility action in male rodents (Ericsson and Youngdale, 1970) 
«^-Chlorohydrin(3-chloro-l,2 propanediol) was used to inhibit 
selectively the acquisition of fertilising capacity by rat 
epididymal spermatozoa without disrupting spermatogenesis or 
decreasing libido (Coppola, 1969). Development of this analogue 
as a human male contraceptive ceased after toxic changes were found 
in haemopoietic tissues of monkeys given comparatively low dosages 
(Kirton et al., 1970; Setty et al., 1970). The search has contin­
ued, to identify a chlorohydrin derivative which retains selective 
antifertility properties without concomitant toxicity in other 
organ systems. Tsunoda and Chang (197 6) reported that l-amino-3- 
chloro-2-propanol hydrochloride (CL 88, 236) effectively prevented 
the acquisition of fertilising capacity by epididymal spermatozoa 
of mature male Sprague-Dawley rats at an oral dose rate of 14.7 mg/ 
kg/day.
The chronic oral toxicity of CL 88, 236 has been studied in rhesus 
monkeys at doses of 0, 50, 150 or 300 mg/kg/day (Heywood et al., 
1978) and in rats at doses of 0, 50, 250 or 500 mg/kg/day (James et 
al., 1978). Acute neurotoxic lesions were induced in the medulla 
oblongata of rhesus monkeys at all doses tested. Apart from 
increases in kidney and liver weights without accompanying 
histological changes, no toxic effects occurred in the extragonadal 
tissues of rats given CL 88, 236. Although the possibility of 
human usage is excluded by the neurotoxic effects seen in rhesus 
monkeys, the effects of CL 88, 236 overdosage on the seminiferous
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epithelium of rats has been studied as the basis of a toxicological 
model for the safety evaluation of future potential extra-testicular 
male contraceptive agents.
3.2.1. Experimental design
60 specific pathogen-free male Sprague-Dawley rats of the CFY strain 
were obtained and allocated to groups of 15 rats. The housing, 
management and husbandry of the rats is described in Appendices I (i) 
and (ii). Body weight changes, food and water intake were 
recorded, see Appendix I (iii). CL 88, 236 was supplied by Lederle 
Laboratories. Solutions were prepared daily in distilled water at 
concentrations of 1%, 5% or 10% w/v; these solutions were administ­
ered by gastric intubation at a standard dose volume of 0.5 ml/100 g 
body weight so that daily doses of 50, 250 or 500 mg/kg were given. 
The fourth group of rats acted as controls and were given distilled 
water at 0.5 ml/100 g body weight. Dosing was continued for 12 
weeks, during which time any clinical abnormalities were recorded 
daily, and body weight and food intake were measured weekly. 
Premature deaths were fully investigated in order to establish 
factors contributing to death. All rats surviving the dosing period 
were killed by carbon dioxide asphyxiation and autopsied. The 
testes, epididymides and prostate of each rat were weighed and 
preserved. Histological sections of testes were stained with PAS; 
all the remaining tissues were stained with haematoxylin and eosin, 
see Appendix I (viii). A quantitative assessment of testicular 
spermatogenesis was undertaken, but rats which developed severe 
atrophy of seminiferous tubules and/or epididymal sperm granulomata 
were excluded from this examination. Counts of type B spermatogonia, 
pachytene spermatocytes, round (early) spermatids and elongated 
(late) spermatids, Sertoli cells and measurements of seminiferous 
tubule diameters were made as described in Appendix I (ix).
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3.2.2. Results
One male rat receiving 500 mg/kg/day died during week 11, but a 
conclusive cause of death could not be established. No adverse 
signs were seen in the remaining rats, and food consumption was 
unaffected by treatment with CL 88, 236. Rats given 500 mg/kg/day 
gained less weight than control rats. The selected organ weight 
data are presented in Table 3.2.2.1. Apart from a statistically 
significant ( p < 0.001) reduction in prostate weight for rats given 
500 mg/kg/day there were no other differences between control and 
treated rats. Oedema and/or yellow discoloration were apparent in 
the epididymides of one rat given 50 mg/kg/day, two given 250 mg/ 
kg/day and nine given 500 mg/kg/day. The testes were considered to 
be enlarged or flaccid in one control rat, six given 250 mg/kg/day 
and 11 given 500 mg/kg/day. The macroscopic post-mortem examinat­
ions and histological observations are summarised in Table 3.2.2.2.
Epididymal sperm granulomata (Fig. 3.2.2.1.) Were apparent at all
2
dosages and the ^ test for linear trend with increasing dosage was 
statistically significant (p<0.05). Varying degrees of atrophy 
of the seminiferous epithelium was found among all groups, including 
controls. Unilateral small foci of atrophic seminiferous tubules 
were evident in a single control rat and one given 50 mg/kg/day.
Bilateral foci of atrophic seminiferous tubules were seen in one 
rat given 250 mg/kg/day and one given 500 mg/kg/day. One control 
rat developed unilateral diffuse atrophy of seminiferous tubules.
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Dose CL 88, 236 Body weight Absolute organ weights (g)
(15 rats/group) change
(g) Testes Epididymides Prostate
Controls 394 3.4 1.4 1.0
50 mg/kg/day 401 3.5 1.5 1.0
250 mg/kg/day 392 3.5 1.5 1.0
500 mg/kg/day^ 359 + 3.7 1.5 0.7+++
Table 3.2.2.1. Body weight changes and testes, epididymal and
prostatic weights of rats given CL 88, 236 for 12 weeks. Stat-
istically significant differences from control data (ANOVAR), 
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Fig. 3.2.2.1. Sperm granuloma seen in the ductus epididymis 
of a rat given 250 mg/kg/day CL 88, 236 for 12 weeks. H & E, 
X 50.
:171:
Diffuse unilateral or bilateral atrophy of seminiferous tubules 
(Fig. 3.2.2.2.) was not induced at 50 mg/kg/day but was apparent in 
six out of 15 rats given 250 mg/kg/day and eight out of 14 rats 
surviving treatment at 500 mg/kg/day. The incidence among thè 
latter two groups differed significantly from the control incidence 
(Fishers' Exact test, two-tailed, p <0.05). The occurrence of severe, 
atrophy of the seminiferous epithelium was not strongly correlated 
with the presence of sperm granulomata. Although many rats given 
CL 88, 236 developed vacuolation of epididymal epithelium, severe 
atrophy of the seminiferous epithelium also occurred in the absence 
of this lesion. The findings of quantitative assessment of test­
icular spermatogenesis in rats with all stages of spermatogenesis 
recognisable in the majority of seminiferous tubules and absence of 
sperm granulomata are tabulated in Table 3.2.2.3. The diameter of 
seminiferous tubules was significantly decreased (p<0.05) for rats 
given 250 and 500 mg/kg/day. There were no statistically signifi­
cant differences (p >0.05) in respect of tubule diameter or counts 
of type B spermatogonia, pachytene spermatocytes, early or late 
spermatids for rats given 50 mg/kg/day. Statistically significant 
reductions in the counts of early (stage 1) and late (stage 8) 
spermatids were apparent at 250 and 500 mg/kg/day. The pachytene 
spermatocyte count of the single rat suitable for examination at 
500 mg/kg/day was also decreased.
3.2.3. Discussion
The results of giving CL 88, 23 6 at 250 and 500 mg/kg/day are 
similar to the epididymal lesions and atrophy of the germinal 
epithelium previously induced with high dosages of ^-chlorohydrin 
































Fig 3.2.2.2. Total atrophy of seminiferous epithelium 
observed in a rat given 250 mg/kg/day CL 88, 236 for 12 
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It is, however, important to distinguish between the primary 
mechanism of a selective antifertility action at low dosages and 
the pathological changes induced following administration of 
excessively large dosages. Studies of the influence of ^^chlorohy- 
drin on fluid reabsorption in the cauda epididymis (Wong and Yeung, 
1977), necrosis of the epididymis (Gunn et al., 1970), epididymal 
vasculature (Reijonen et al., 1975) and epididymal lipid and 
prostaglandin content (Voglmayr, 1974), show that functional infer­
tility may be induced without structural alteration unless excessive 
dosages are administered. Mohri et al. (1975) suggested that
-chlorohydrin is phosphorylated on entry into spermatozoa and so 
acts as a competitive inhibitor in the enzyme-mediated conversion of 
glyceraldehyde-3-phosphate to 3-phosphoglycerate. Ford et al.
(1977) studied the effects of «^-chlorohydrin enantiomers on triose 
phosphate metabolism in the glycolytic pathway of ram testicular 
spermatozoa and rat epididymal spermatozoa. Marked stereospecific 
effects were apparent, but epididymal and testicular spermatozoa 
showed qualitatively similar responses. However, a higher concen­
tration of enantiomer was needed to affect testicular than epididy­
mal spermatozoa. The results of this toxicological investigation . 
in the rat,using high dosages, do not conflict with these concepts. 
The testicular histomorphometry of rats given CL 88, 236 at 50 mg/ 
kg/day was comparable with that of control rats. The quantitative 
reduction in spermatogenic cells at the two higher dosages was 
predictable on the basis of other investigators' results. The lack 
of correlation between atrophy of the seminiferous epithelium and 
epididymal lesions confirms the view that disruption of epididymal 
physiology and testicular spermatogenesis in rats are independent 
but predictable hazards of overdosage.
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Although a dose of 50 mg/kg/day administered for 12 weeks did not 
induce deleterious changes in the seminiferous epithelium, 
epididymal changes were found. Even if the compound had not induced 
neurotoxic changes in primates (Heywood et al., 1978) the ratio 
between the minimal effective dose (14.7 mg/kg/day) and the lowest 
dose evoking signs of overdosage is unacceptably low.
3.2.4. Abstract
A quantitative histomorphometric assessment of testicular spermato­
genesis was undertaken on testes obtained from rats which received 
l-amino-3 chloro-2 propanol hydrochloride (CL 88, 236) at oral 
doses of O, 50, 250 or 500 mg/kg/day for 12 weeks. Rats which 
developed epididymal sperm granulomata or severe atrophy of the 
germinal epithelium were excluded from quantitative examinations. 
Pathological changes in the epididymis and seminiferous epithelium 
were not strongly correlated. CL 88, 236 administered at 50 mg/kg/ 
day was without effect on the histomorphometry of the seminiferous 
epithelium,although epididymal lesions occurred at this dose. At 
higher dosages a quantitative reduction in testicular spermatids 
was evident. It seems important to differentiate between the 
selective antifertility action of CL 88, 236 on the biochemistry of 
epididymal spermatozoa and the disruption of epididymal physiology 
and testicular spermatogenesis found at unusually high dosages.
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3.3. Administration of eyelohexylamine to Beagle dogs and rats for 
nine weeks
Effects on testicular weight and histology have been associated 
with prolonged dietary administration of cyclamates to rats (Oser 
et al., 1975; Taylor and Friedman, 1974). Testicular changes 
occur only after administration of dietary concentrations of
least 3% for 12 months-or longer. Such experimental treat­
ment also induces gastrointestinal disturbances, reduced food 
intake and impaired body weight gain. Coulston et al. (1977) found 
that the testes of rhesus monkeys given cyclamate at an oral dose 
rate of 200 mg/kg/day for eight years, were histologically normal. 
While testicular effects have not been observed in short-term 
rodent or canine studies (Richards et al., 1951; Taylor et al.,
1968) and testicular changes do not occur following chronic feeding 
at less than 3%, the safety in normal -usage of cyclamates as 
food additives is a continuing focus-'for debate.
The metabolic fate of cyclamate has been studied in both man and 
animals (Golberg et al., 1969; Parekh et al., 1970; Renwick and 
Williams, 1972). Following continuous ingestion of cyclamate, 
up to 70% conversion -to cyclohexylamine (CHA) occurs. The 
CHA formed is excreted in urine, mainly unchanged, with trace 
amounts of cyclohexanone, cyclohexanol and N-hydroxycyclohexylamine. 
The pharmacological characteristics of CHA include release of 
catecholamines, acetylcholine and histamine together with analgesic, 
sedative and tranquillising properties (Miyata et al., 1969). The 
compound is a strong base, irritant to skin and mucous membranes, 
with an oral LDg^ value of 710 mg/kg for rats (Smyth et al., 1969) .
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The potential testicular toxicity and antifertility effects of CHA 
have been examined in rats (Gaunt et al., 1974; Green et al., 197 2; 
Khera and Stoltz, 1970; Khera et al., 1971; Kroes et al., 1977; 
Mason and Thompson, 1977).
Testicular changes, reduced food intake and impaired weight gain 
are consistently reproducible at dosages of 288-528 mg/kg/day. At 
lower dosages of CHA, conflicting data exist: however, there is a 
definite 'no effect' dose at 30 mg/kg/day. The only effect obser­
ved in mating studies has been a slight increase in pre-implantation 
loss when high dosages are administered. Cattanach (1976) has 
reviewed the mutagenic studies undertaken with CHA and its 
metabolites. This author concluded that the effects observed in 
rodent breeding experiments could not be ascribed to dominant 
lethality. Furthermore, there was no evidence to implicate CHA as 
a mutagen in normal use. The mechanism underlying the testicular 
responses to overdosage with CHA remains a matter for speculation. 
Studies to examine the effects of massive dosages of CHA on 
pituitary-testicular hormones, semen characteristics and quantita­
tive assessment of spermatogenesis were therefore undertaken with 
Beagle dogs and rats.
3.3.1. Experimental design
Four sexually mature Beagle dogs and 30 specific pathogen-free 
male Sprague-Dawley rats (CD strain) aged 35 days were obtained. 
The animal management, housing and husbandry were as described in 
Appendices I (i) and (ii). Body weight changes, food and water 
intake were recorded, see Appendix I (iii). CHA conforming to the 
specification of the British Standards Institution (British Stand­
ards Institution, 1968) was obtained from Fisons Limited, 
Loughborough, Leics., UK.
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The 30 rats were allocated to an experimental or a control group, 
each of 15 rats, to comprise approximately equal initial group mean 
body weights. A 4.62% v/v suspension of CHA in corn oil was 
prepared once weekly and stored in airtight smoked glass containers, 
The CHA suspension was administered by oral gavage at a dosage 
volume of 0.5 ml/100 g so that each rat received 200 mg/kg CHA 
daily. Control rats were given corn oil at the same dosage volume. 
CHA was administered to all four dogs as a 3.47% v/v suspension in 
corn oil. Gastric irritation made it necessary to employ an 
incremental gavage regimen for the dogs. Initially the CHA 
suspension was administered to achieve oral doses of 75 mg/kg/day 
on days 1 and 2, of 75 mg/kg twice daily on days 3 and 4, of 150 
mg/kg on days 5 and 6, then 150 mg/kg twice daily on subsequent 
days. After day 9 the dose was reduced to 125 mg/kg twice daily 
to avoid marked appetite suppression. Five rats from each group 
were killed after four and nine weeks' administration and two dogs 
after nine weeks' dosing. The remaining five rats per group and 
two dogs were maintained undosed for 13 weeks before terminal 
examination.
All animals were examined several times daily for evidence of 
clinical malreaction to CHA treatment. Rats that died during the 
investigation were autopsied in order to establish a possible cause 
of death. Testicular measurements and semen examinations of the 
dogs, see Appendices I (vi) and (vii), were made before starting 
treatment and again during weeks 4, 8 and 12 of the withdrawal 
period. The concentrations in seminal plasma of Na+, K+ (mEq/1), 
acid phosphatase, alanine aminotransferase (E.C. 2.6.1.2.) and 
aspartate aminotransferase (E.C. 2.6.1.1.) were determined (mu/ml) 
as described in Appendix I (vii).
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Serum samples were obtained, see Appendix I (v), from five rats 
per group after one day and four and nine weeks' treatment and 
13 weeks' withdrawal for determination of follicle-stimulating 
hormone (FSH), luteinising hormone (LH) and testosterone, see 
Appendix I (vi). Canine sera were examined for LH and testosterone 
concentrations, see Appendix I (vi), after one, two, four and eight 
weeks' treatment and during weeks four, eight and 12 of the with­
drawal period.
Terminal procedures performed on up to five rats per group after 
four and nine weeks' dosing and 13 weeks withdrawal, and two dogs 
after nine weeks' dosing and 13 weeks' withdrawal, comprised full 
macroscopic post-mortem examination, together with weighing and 
preservation of pituitary, testes including epididymides, prostate 
and seminal vesicles (rats only). Histological preparations of the 
preserved organs were stained as described in Appendix I (viii).
Counts of type B spermatogonia, pachytene spermatocytes, round 
(early) and late (elongated) spermatids, Sertoli cells and 
measurements of seminiferous tubule diameters were made as descr­
ibed in Appendix I (ix).
3.3.2. Results
Two rats died during the investigation; one control rat during week 
11 of the recovery period and one rat eight weeks after cessation 
of CHA treatment. In both cases death was attributable to chronic 
respiratory disease.
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Clinical reactions to CHA administration were manifested in rats 
as reduced motor and grooming activity during the first week 
of treatment. Dogs given CHA vomited on up to 35% of the 
dosing occasions during the first four weeks; subsequently, ^
vomiting occurred after approximately 12% of the dosing occasions, 
Vomiting occurred between five and 120 minutes after dosing. The 
dogs were frequently observed to be unusually quiet and tended to 
pass loose faeces.
Over the nine-week dosing period dogs showed a 10 % loss of 
body weight (Fig. 3.3.2.1.) and treated rats showed a 25% 
suppression in the rate of weight gain in comparison with the 
control rats (Fig. 3.2.2.2.). The adverse effect on the body 
weight of dogs was completely reversed during the recovery 
period; however, rats which had received CHA still showed a 13% 
suppression in comparison with the corresponding control groups. 
Administration of CHA impaired appetite for both species; the
dogs showed a 25% reduction (Fig, 3.3.2,1.) and rats â 15% 
reduction in food intake over the nine weeks of treatment 
(Fig. 3.3.2.2.). During the recovery period the dogs regained 
normal appetite, but previously treated rats continued to exhibit 
a 10% reduction in food consumption. Both species tended 
to drink slightly increased quantities of water during the dosing 
period.
Treatment with CHA did not significantly affect the serum LH or 
testosterone concentrations of dogs. All values were as expected 
for sexually mature Beagle dogs. Increased FSH and decreased 
testosterone concentrations attained statistical significance 
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Fig 3.3.2.1. Effects of CHA on body weight and food residue when 
administered to Beagle dogs at 250 mg/kg/day for nine weeks 
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Fig. 3.3.2.2. Effect of CHA on body weight and food consumption 
when administered to rats at 200 mg/kg/day ( ■ ) for nine weeks 
followed by a 13-week recovery period in comparison with vehicle- 
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Although not statistically significant, similar trends were 
apparent for rats examined 13 weeks after cessation of CHA 
treatment.
Slight reductions in the testicular measurements of dogs given CHA 
attained statistical significance (p<0.05, paired 't'-test) after 
four and eight weeks' treatment. After eight weeks' CHA 
administration, decreased sperm counts and an increased percentage 
of abnormal (coiled-tail) spermatozoa were evident in canine 
ejaculates (Table 3.3.2.2.). Normal sperm counts were obtained at 
all examinations made during the recovery period. Increased numbers 
of abnormal spermatozoa were evident after four and eight weeks' 
withdrawal but not after 12 weeks. Administration of CHA did not 
modify the biochemical measurements made on seminal plasma samples. 
There were no correlations between seminal plasma enzyme concen­
trations and sperm morphology. The mean seminal plasma aspartate 
concentrations of each examination are depicted in Fig. 3.3.2.3. 
together with concurrent data for sperm concentration and morphology.
Organ weight data are summarised in Table 3.3.2.3. The pituitary, 
testicular and prostate weights of dogs examined after nine weeks' 
dosing were marginally lower than after 13 weeks' recovery.
However, dogs in the first group examined were of lower body 
weight and all values were within expected ranges. Testicular 
and seminal vesicle weights of rats given CHA were consistently 
lower than those of control rats at all examinations. Analysis of 
covariance with initial and final body weight as covariates was 
performed with the rat data. No statistically significant differen­
ces (p>0.05) were apparent.
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No histologically detectable lesions were found in any of the dogs' 
organs. One rat examined after 13 weeks' withdrawal of CHA showed 
diffuse bilateral testicular atrophy, the majority of seminiferous 
tubules being devoid of spermatogenic cells and containing syncytia 
of Sertoli cells. In this animal a few seminiferous tubules 
appeared morphologically normal (Fig. 3. 3.2.4.).
Quantitative assessment of testicular spermatogenesis revealed 
some statistically significant decreases (p<0.05) in the number of 
germ cells present in the seminiferous tubules of rats and dogs 
receiving CHA (Table 3.3.2.4.). After nine weeks' treatment, 
decreased counts of pachytene spermatocytes, early and late sperm­
atids were apparent in the dog testes. The rat which developed 
testicular atrophy was excluded from the rat examinations. Signif­
icant reductions in the numbers of late spermatids were apparent 
for all other CHA-treated rats, both during the dosing and the 
withdrawal periods. After 13 weeks' withdrawal, rats previously 
given CHA were also found to have reduced numbers of pachytene 
spermatocytes and early spermatids. No statistically significant 
effects (p >0.05) were obtained for counts of type B spermatogonia 
with either species.
3.3.3. Discussion
The findings of these investigations are in agreement with previously 
published accounts of the effects on testicular function of over­
dosage with CHA. The dosages used in rats (200 mg/kg/day) and dogs 
(250 mg/kg/day) quantitatively reduced testicular spermatogenesis 
in both species. The previously published 'no effect' level with 
regard to the rat testes is 30 mg/kg/day (Gaunt et al., 1974); the 
present dosages represent a six- to seven-fold increase and were 
chosen to attempt elucidation of mechanism of action rather than to 
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Fig. 3.3.2.4. Disruption of spermatogenesis in a rat examined 13 
weeks after receiving cyclohexylamine (200 mg/kg/day) for nine 
weeks. Note tubules showing severe atrophy of seminiferous 
epithelium although some tubules show evidence of active sperm­
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Although effects on testicular function were apparent they cannot 
be compared with the potent effects which may be produced with 
hormonal steroids, antispermatogenic or cytotoxic agents (Gomes, 
1970; Jackson, 1972; Patanelli, 1975). The observed effects of 
CHA on the semen quality of dogs, the serum FSH and testosterone 
concentrations of rats and the development of complete testicular 
atrophy, albeit in one rat 13 weeks after cessation of CHA 
administration, are circumstantial rather than conclusive evidence 
of a testicular effect. However, the findings of the quantitative 
assessments of testicular spermatogenesis indicate a subliminal 
loss of differentiating spermatogenic cells. There is thus suppor­
tive evidence that large doses of CHA may partly suppress spermato­
genesis in both rats and dogs. This is also in agreement with the 
finding (Gaunt et al., 1974) that rats remained fertile after CHA 
treatment and no evidence of embryo or foetotoxic effects was 
obtained. The single instance of testicular atrophy in this study 
is difficult to explain; however, no effects were seen in the dogs 
or remaining rats to suggest an effect on spermatogonial cells. 
Furthermore, spontaneous testicular atrophy does occur in the 
Sprague-Dawley rat. Either this was a spontaneous lesion or it 
represents increased sensitivity to the effects of CHA in a single 
rat.
Although obvious effects on body weight and food intake were 
apparent, the testicular effects are probably not explicable simply 
on this basis. The studies of Gaunt et al* (1974) and Mason and 
Thompson (1977) included observations on pair-fed and paired-weight 
rats. Both groups of investigators were of the opinion that
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inanition per se did not explain the testicular effects of CHA, 
although interaction between inanition and chemical action could 
not be excluded. CHA administration to rats was shown to increase 
their basal metabolic rate, possibly as a result of sympathomimetic 
effects.
The hormonal responses of rats given CHA were characteristic 
reactions to depletion of the germinal epithelium (Collins et al., 
1978; Debeljuket al., 1973), and are therefore secondary responses 
and not the primary cause of the testicular effects. The possibil­
ity of direct action of CHA on the seminiferous epithelium cannot 
be excluded. Further investigations should be designed to assess 
the pharmacokinetics of CHA within the seminiferous epithelium 
compartment of the blood-testis barrier (Setchell and Main, 1978). 
The ability of CHA to induce metabolising enzymes within the testes 
(Lee and Dixon, 1978) is also worthy of investigation.
The animal toxicity data available show no evidence of testicular 
effects at dosages corresponding to a dietary CHA intake of 30 mg/ 
kg/day, which is equivalent to 50 mg/kg/day of cyclamate. Human 
consumption of cyclamate is generally intermittent; CHA conversion 
does not always occur in man (Blumberg and Heaton, 1970; Glogner, 
1970) and the proportion of cyclamate converted to CHA decreases 
with increasing cyclamate consumption (Litchfield and Swan, 1971). 
The results of these investigations using high oral dosages should 
not shed doubts on the safety of cyclamates in normal dietary use.
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3.3.4. Abstract
Cyclohexylamine (CHA), the principal metabolite of cyclamate, was 
given by oral gavage to male rats (200 mg/kg/day) and male Beagles 
(250 mg/kg/day) for nine weeks. Some of these animals subsequently 
were maintained undosed for 13 weeks to assess recovery. CHA 
adversely affected body weight and food consumption in both species. 
Although a degree of tolerance developed, vomiting tended to occur 
after CHA administration to dogs. Serum FSH was increased and 
testosterone decreased in rats given CHA. No effects were found on 
the serum LH and testosterone levels in dogs, but reversible effects 
on sperm concentration and morphology were induced in this species. 
There were no statistically significant (p>0.05) effects on the 
weight of the pituitaries, testes or secondary sex organs of either 
species. The only lesion detectable by conventional histological 
examination was focal atrophy of seminiferous tubules in one rat 
examined 13 weeks after cessation of CHA treatment. Quantitative 
assessment of testicular spermatogenesis showed that CHA adminis­
tration reduced the counts of pachytene spermatocytes, and of early 
and late spermatids, in both species. These effects were apparently 
reversible in dogs but not in rats. The significance of these 
findings in relation to possible mechanisms of action and the 
assessment of safety in use of cyclamates is discussed.
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3.4. Administration of hexachlorophene to Beagle dogs and rats 
for nine weeks
2,2'-Methylene-bis (3,4,6-trichlorophenol)J, wasHexachlorophene
patented in 1941. Since then, this chemical has found a variety 
of uses as an antibacterial or fungicidal agent in soaps, cosmetics 
and toiletries. Veterinary and agrochemical uses include the 
treatment of fascioliasis, and crop-spraying. The first major 
review of hexachlorophene toxicity was published by Gump in 1969. 
Kimbrough (1971) collated the available data relating to the 
symptoms of hexachlorophene toxicity in man. Accidental oral 
overdosage precipitates marked gastrointestinal upset and central 
nervous system derangement. The severity of the encephalopathy 
is dose-dependent and may be reversible. Hexachlorophene is 
readily absorbed by the dermal route; symptoms of dermal intoxica­
tion include skin rashes and clinical signs of central and 
peripheral neuropathy. The extent and potential reversibility of 
hexachlorophene encephalopathy has been studied in rats (Kimbrough 
and Gaines, 1971), and new-born primates (Lockhart and Simons, 
1972). Weiss et al. (1978) demonstrated a long-lasting behavioural 
defect in rats allowed to recover from hexachlorophene intoxication. 
Hepatic damage has occurred in sheep dosed with hexachlorophene 
(Pugh and Crowley, 1966) . Enzyme histochemical studies indicated 
that hepatic lesions were a direct toxic effect of hexachlorophene 
in the portal blood supply (Thorpe, 1967) . Atrophy of the semini­
ferous epithelium has been described in rams and rats given single 
or short-duration repeated oral doses of hexachlorophene (Thorpe, 
1967; 1969). The effect of chronic administration of hexachloro­
phene on the seminiferous epithelium at dosages below those induc­
ing neurotoxic effects has not been described. A series of 
experiment's were conducted with rats and dogs to examine this 
aspect of hexachlorophene toxicity.
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3.4.1. Experimental design
Eight sexually mature Beagle dogs and 30 specific pathogen-free 
Sprague-Dawley rats CCD strain) aged 35 days were obtained. The 
animal management, housing and husbandry were as described in 
Appendices I (i) and (ii). Body weight changes, food and water 
consumption were monitored throughout the investigations, see 
Appendix I (iii). Hexachlorophene powder of analytical quality 
was obtained from the Sigma London, Chemical Company Ltd., Poole, 
Dorset, UK. . Administration of hexachlorophene to rats at 5 mg/kg/ 
day has previously been shown to be without neurotoxic effects 
(Kimbrough, 1971). Hexachlorophene suspensions (0.1% v/v) were 
prepared in corn oil and administered to 15 rats by oral gavage at a 
dosage volume of 0.5 ml/100 g body weight for up to nine weeks so 
that each rat received 5 mg/kg/day. Fifteen rats acted as controls 
and were given corn oil at the same dosage volume. A suitable dose 
for dogs was not apparent from the available literature; preliminary 
studies were therefore necessary. Hexachlorophene powder was given 
orally in gelatine capsules to dogs. A pair of dogs was given 15 
mg/kg/day; a second pair received 3 mg/kg/day for 28 days, then the 
dose was increased to 6 mg/kg/day for a further 14 days. On the 
basis of these studies, four dogs were given 3 mg/kg/day for nine 
weeks in order to assess effects on the seminiferous epithelium.
Testicular function was assessed in rats and dogs (3 mg/kg/day) which 
received hexachlorophene for nine weeks,and in five rats per group 
and two dogs which were retained undosed for 13 weeks after the last 
dose of hexachlorophene. The dogs' testes were measured with 
vernier calipers and semen was collected see Appendices I (vi) and
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(vil), before dosing started, after two, four and eight weeks' 
treatment and during weeks four, eight and 12 of the withdrawal 
period. The semen characteristics and seminal plasma Na"*", k "*", acid 
phosphatase, aspartate aminotransferase (É.C.2.6.I.I.) and alanine 
aminotransferase (E.C.2.6.1.2.) concentrations were monitored, see 
Appendix I (vii). Serum was obtained, see Appendix I (v), from dogs 
after one, two, four and eight weeks' treatment and during weeks 
four, eight and 12 of the withdrawal phase. Rat sera were obtained 
from five rats per group after one days' dosing, four and nine weeks' 
treatment and also after 13 weeks' withdrawal of hexachlorophene.
The concentration of LH and testosterone was determined in dog and 
rat sera; FSH was also measured in rat sera, see Appendix I (vi).
Terminal investigation of dogs used in the preliminary studies was 
restricted to macroscopic post-mortem examinations. Five rats per 
group were killed after four and nine weeks' treatment and 13 weeks' 
withdrawal. Two dogs given 3 mg/kg/day were examined after nine 
weeks' dosing and the remaining two after 13 weeks' withdrawal.
In addition to macroscopic post-mortem examinations,the pituitaries, 
testes and secondary sex organs of these animals were weighed and 
preserved. Histological sections of the preserved organs were 
prepared, see Appendix I (vii). Counts of type B spermatogonia, 
pachytene spermatocytes, early (round) spermatids, late (elongated) 
spermatids and Sertoli cells, together with measurements of 
seminiferous tubule diameter were noted, see Appendix I (ix).
3.4.2. Results
Administration of hexachlorophene to dogs at 15 mg/kg/day produced 
clinical encephalopathy and mucoid diarrhoea on the third day of 
treatment. The dogs became prostrate and exhibited nystagmus.
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opisthotonus and extensor rigidity. No macroscopic abnormalities 
were recognisable at post-mortem examination. No evidence of 
clinical malreaction was seen in dogs given 3 mg/kg/day for 28 days, 
but increasing the dose to 6 mg/kg/day induced posterior paresis and 
incoordination after a further 10 days. Again, no gross abnormal­
ities were recognisable at post-mortem examination. Three rats 
died during the 13-week withdrawal period; of these, two rats 
previously had received hexachlorophene and one was a control. In 
all cases the death of rats was attributable to chronic respiratory 
disease.
No adverse effects on weight, food consumption or water intake 
occurred for dogs given 3 mg/kg/day, or among rats^ There were 
no statistically significant differences (p>0.05, A NO VAR) between 
the serum hormone concentrations of control and hexachlorophene- 
treated rats. The serum LH and testosterone concentrations of the 
dogs remained within the expected ranges for young adult Beagle 
dogs. The testicular measurements of the dogs remained essentially 
unaltered throughout the experimental period. Administration of 
hexachlorophene did not have any appreciable effects on the physical 
and biochemical parameters measured in the canine semen samples.
No macroscopic post-mortem abnormalities, organ weight changes or 
lesions detectable by conventional light microscopy were found in 
the testes, pituitaries or secondary sex organs of either species.
Some statistically significant differences (p<0.05) were found as 
a result of counting germinal cells in the seminiferous tubules of 
rats and dogs given hexachlorophene (Table 3.4.2.1.). Reduced 
numbers of type B spermatogonia were recorded for dogs after nine 
weeks' treatment although the counts of later cell types were as 
expected for normal dogs. Reduction of all cell types counted was 
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A slightly increased count of type B spermatogonia was recorded in 
rats after nine weeks' treatment. After 13 weeks' withdrawal of 
hexachlorophene no effects were apparent on the cell counts 
obtained from dog or rat testes.
3.4.3. Discussion
The object of these experiments was to determine whether hexa­
chlorophene can exert selective testicular toxicity at dosages 
below those previously associated with neurotoxicity or hepato- 
toxicity. The absence of clinical evidence of malreaction to 
hexachlorophene dosing and the lack of adverse effects on body 
weight or food and water intake suggests that the selected dosages 
were appropriate for this purpose. Thorpe (1967, 1969) inferred 
from his studies of the testicular toxicity of large doses of 
hexachlorophene in sheep and rats that the lesions resulted from 
cytotoxic effects on the seminiferous epithelium and, unless wide­
spread degeneration of spermatogonia occurred, then the lesions 
should be reversible. In order to act directly on the seminiferous 
epithelium, chemicals must penetrate the blood-testis barrier 
(Waites, 1976). It is notable that several neurotoxic chemicals 
which must be permeable to the blood-brain barrier can also affect 
the seminiferous epithelium (Heywood et al., 1980b). The analogy 
is not straightforward, because the principal barrier to the entry 
of large molecules into brain tissue is at the level of the endo­
thelial junctions in the capillary wall, whereas similar junctions 
have not been found in the testes (Fawcett et al., 1970). The 
anatomical basis for the blood-testis barrier is found at the level 
of the peritubular myoid cells and the tight junctions between 
Sertoli cells (Dym and Fawcett, 1970). The blood-testis barrier is
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resistant to temperature damage (Main and Waites, 1977) and remains 
intact following hypophysectomy (Hagenas et al., 1978). The 
processes by which chemicals may penetrate the blood-testis barrier 
have been discussed by Setchell and Main (1978). The blood-testis 
barrier is most efficient in restricting chemical action on the 
meiotic stages of spermatogenesis. Spermatogonia are enclosed by 
the peritubular myoid cell system but not by the tight junctions 
between Sertoli cells (Dym and Fawcett, 1970). Although the 
susceptibility of spermatogenic cells to direct chemical action 
will depend on dosage, tissue distribution and duration of treatment, 
in purely anatomical terms the spermatogonia are most vulnerable.
The reduced number of type B spermatogonia observed in these 
experiments may be explicable on this basis. As the maximum detec­
table change was observed after four and not nine weeks' treatment 
of rats, the effects do not appear to be progressive and the 
development of tolerance is a definite possibility. Calculation of 
the ratio between successive spermatogenic cell generations for the 
rats examined after four weeks indicates that the number of later 
cell types was as would be expected from the reduced spermatogonial 
count (Clermont, 1962) . This is further evidence that the effects 
of hexachlorophene administered at these dosages are probably 
confined to spermatogonial cells. The discrimination between sperm­
atogonial cell populations of the dog is equivocal (Foote et al.,
197 2) and inadvertent inclusion of Type A or intermediate spermato­
gonia may occur when quantifying canine type B spermatogonia. The 
data obtained suggest that sufficient canine type B spermatogonia 
were unaffected to allow spermatogenesis to proceed satisfactorily.
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In conclusion, it appears that chronic exposure to subneurotoxic 
doses of hexachlorophene did not induce permanent or serious 
impairment of spermatogenesis. No clinical changes were detectable 
in pituitary-testicular relationships and the semen production of 
dogs was unaffected. The slight quantitative changes detected in 
the seminiferous epithelium were not progressive in nature and 
delayed effects were not apparent. While disruption of spermato­
genesis may be one of the hazards of hexachlorophene overdosage, 
there is no evidence to suggest that this occurs at the concentra­
tions normally used.
3.4.4. Abstract
Hexachlorophene was administered orally, at subneurotoxic dosages, 
to rats (5 mg/kg/day) and Beagle dogs (3 mg/kg/day) for nine weeks.
A proportion of rats and dogs was observed for a further 13 weeks 
following cessation of dosing. The serum concentrations of 
pituitary gonadotrophins and testosterone were unaffected. No 
changes were induced in the testicular dimensions or semen charac­
teristics of dogs. No macroscopic post-mortem abnormalities, organ 
weight differences or lesions detectable by conventional light 
microscopy were found in the testes, pituitaries or secondary sex 
organs. A transient reduction in the number of germ cells countable 
in cross-sections of seminiferous tubules was seen in rats after 
four weeks' treatment only. After nine weeks' treatment, reduced 
spermatogonial counts were recorded in canine seminiferous tubules; 
in other respects, spermatogenesis was proceeding normally. No 
delayed effects were apparent in either species. The possible 
mechanism of action and the role of the blood-testis barrier is 
discussed. It is concluded that repeated administration of hexachlo­
rophene at subneurotoxic levels did not induce significant impairment 
of spermatogenesis in rats or dogs.
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The primary objective in undertaking the work presented in this 
thesis was to provide a practical basis for the study of possible 
chemical testicular hazards using laboratory animal models. The 
current legislation for extensive toxicity testing of a large 
number of chemicals intended for human exposure must be considered, 
not only on the basis of scientific relevance, but also in terms of 
economic and logistic capability. The selection of appropriate 
animal models should be based on the similarity of their pharmaco­
kinetic and metabolic characteristics to those of man, and on the 
ability to study breeding performance and the development of 
progeny following exposure to chemicals. In practice, safety 
evaluation studies are normally undertaken with laboratory rats. 
Beagle dogs or subhuman primates. Fertility and general reproduc­
tive performance can be investigated in rats with comparative 
simplicity, but satisfactory data are unlikely to be obtained using 
subhuman primates or dogs, except in the most specialised labora­
tories. The ready availability, simple restraint and handling, and 
lack of obvious seasonal breeding rhythms of the male Beagle, .make 
this species a possible alternative to the subhuman primates for 
the study of chemically induced changes in testicular size, semen 
characteristics and circulating pituitary-testicular hormone 
concentrations. The value of Beagle dogs for this type of 
experimental study would be enhanced by the development of a 
radioimmunoassay for canine FSH. It is possible to use clinical 
testicular function data as a guide to explaining the changes in 
testicular weight and morphology which are revealed by routine 
post-mortem studies.
Hormonal studies are useful for studies using rats, not only for 
clarification of mechanisms of testicular toxicity but also to 
reconcile apparent differences in species sensitivity with the
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testicular effects of the same chemical entity. Whichever species 
is studied, the sampling times for-hormonal examinations are 
crucial: unless the interaction between the pharmacokinetics of the 
test substances and the temporal effects on hormone concentrations 
are considered, misleading data may be obtained. Iatrogenic lesions 
may be caused by testicular biopsy and this technique is not 
recommended for routine toxicological studies with experimental 
animals. Quantitative histometric analyses of testicular sperm­
atogenesis are useful to define the responses of the seminiferous 
epithelium but,in most instances, this technique merely reinforces 
the data provided by other less laborious techniques. Unless there 
is a specific need to study prepubertal or adolescent animals it is 
more appropriate to use sexually mature animals, in order to ensure 
that testicular function is adequate before administering the test 
substances. Awareness of the incidence and nature of spontaneous 
variations in testicular-pituitary physiology and pathology is 
necessary for a variety of reasons. Lifespan studies with rats are 
complicated by the high incidence of spontaneous testicular atrophy 
found in aged rats. The wide range of testicular weights found for 
Beagle dogs restricts the value of statistical comparisons when 
small numbers of dogs are studied. Although dogs are rarely used 
for lifespan studies, testicular tumours occur commonly among ageing 
Beagles.
The testicular effects of overdosage with several compounds able to 
modify centrally active neurotransmitter substances or prostaglan­
dins have been examined. Although the rat and dog appeared to 
respond in a qualitatively similar manner to the chemical modulation 
of pituitary-testicular hormone relationships, differences between 
the two species were apparent in the observable effects on test­
icular and secondary sex-organ morphology and function. Depletion 
of LH and disruption of the physiological synergism between prolac­
tin and LH induced reversible effects of spermatid maturation or
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prostate secretion of the Beagle dog. In the absence of breeding 
performance data,the effects on the testes of rats, induced by 
overdosage with similar compounds, were more equivocal. Evidence 
from the literature indicated that, although overdosage of rats 
with indomethacin, an inhibitor of prostaglandin synthesis, 
decreased LH and testosterone concentrations, the ability to 
fertilise ova was unaffected. Repeated overdosage of Beagle dogs 
with a prostaglandin inhibitor induced comparable hormonal effects, 
which were correlated with suppression of spermatid maturation, but 
prostate function remained adequate. In addition to hormonally 
dependent retardation of spermiogenesis, changes in the counts of 
earlier spermatogenic cells were considered to be a consequence of 
inhibition of prostaglandin synthesis at the level of the semini­
ferous epithelium. No precise reasons have been determined for 
these apparent quantitative differences in species response. The 
physiology of canine spermatogenesis has not been studied exten­
sively and there may be, as yet, undiscovered differences between 
the hormonal control of spermatogenesis in the rat and the dog.
The laboratory rat has an extraordinary ability to adapt to 
sustained chemical overdosage and the observed differences may 
simply reflect greater tolerance by rats, rather than intrinsic 
differences in the physiology of the two species. In all cases, 
the testicular effects of modified pituitary hormone secretion or 
release were shown to be reversible. The time allotted for the 
demonstration of reversibility was critical, because it seemed 
unreasonable to expect restoration of normal spermatogenesis before 
a complete spermatogenic cycle had elapsed after withdrawal of the 
test compounds. However, as the deficits were considered to 
represent disruption of physiological interactions, complete 
reversibility within two spermatogenic cycles was an essential 
criterion.
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The nature of the pharmacological properties of the compounds 
studied for this aspect of testicular toxicity raises the question 
of whether the induced changes were truly toxic effects or simply 
manifestations of pharmacological overdosage. The assessment of 
safety in normal use depends on comparisons of the hormonal 
changes induced by small and large multiples of the recommended 
exposures, demonstration of 'no effect' levels and evidence of 
reversible effects following overdosage.
The assessment of toxicity arising from chemical actions on the 
seminiferous epithelium is less well defined. The antispermato­
genic effects of potential male contraceptives can be studied in 
the rat and Beagle dog. The concepts of'no effect' levels and 
safety margins change their toxicological definitions when this 
type of chemical activity is being considered. Safety assessment, 
in these cases, has to be assessed on the dual criteria of absence 
of toxic effects in extragonadal tissues, and. careful character­
isation of the pharmacological effects following prolonged over­
dosage. The choice of dosage levels is paradoxical because 
selective action on the testes may not be possible with large 
multiples of the minimally effective dosages. Testicular function 
tests, such as those advocated in this work, could be usefully 
included in toxicological studies of potential male contraceptives 
with rats and Beagle dogs. The possibility of genetically 
damaged spermatozoa being able to fertilise ova, either during the 
induction of infertility or the restoration of fertility, is an 
important toxicological question. Currently, animal models are 
needed which could be used to predict such a hazard.
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The most inconclusive aspect of this work relates to the studies of 
those testicular hazards which may arise from the largely un­
controlled exposure of populations to industrial, agricultural or 
domestic chemicals which affect the seminiferous epithelium of 
experimental animals when given in excessively large amounts. It 
becomes difficult to differentiate selective testicular effects 
from secondary responses to systemic toxicity, disturbed metabolic 
functions or dietary imbalance. Important features of the 
investigations with hexachlorophene and cyclohexylamine were the 
differences in systemic tolerance to these agents, shown by rats 
and Beagle dogs. The experimental methods used here appear to 
have limited application when studying this type of chemical 
toxicity. The data obtained allows conjecture that the seminiferous 
epithelium was accessible to these chemicals at the concentrations 
used, but that the responses were incompletely characterised. When 
slow progressive actions on the seminiferous epithelium are suspec­
ted, study of the roles of the physiological compartmentation of 
the seminiferous epithelium, induction of metabolising enzymes and 
covalent binding may be more rewarding. Estimates of the 
distribution and clearance of chemicals within the seminiferous 
tubules could be used to identify those threshold concentrations of 
the test substances which are necessary for the onset of toxic 
changes.
; 207 :
R E F E R E N C E S
Journal titles are abbreviated according to "Bibliographic guide 
for Editors and Authors", American Chemical Society, Washington, 
D.C., (1974).
Abbatiello, E.R., Kaminsky, M. and Weisbroth, S.
The effects of prostaglandins and prostaglandin inhibitors on 
spermatogenesis.
Int. J. Fertil., 11975) 20, 177-182.
Abercrombie, M.
Estimation of nuclear population from microtome sections.
Anat. Rec., (1946) 94, 239-247.
Adamopoulos, D.A., Lawrence, D.M., Vassilopoulos, P. and 
Contoyiannis, P.A.
Pituitary-testicular interrelationships in mumps orchitis and other 
viral infections.
Br. Med. J . , (1978) 1, 1177-1180.
Aiman, J . , Griffin, J.E., Gazak, J.M., Wilson, J.D. and MacDonald, 
P.C.
Androgen insensitivity as a cause of infertility in otherwise 
normal men.
New Engl. J. Med., (1979) 300, 223-227.
Averback, P. and Wight, D.G.
Seminiferous tubule hypercurvature: a newly recognised common 
syndrome of human male infertility.
Lancet, (1979) I, 181-183.
Badr, F.M., Barcikowski, B. and Bartke, A.
Effect of castration, testosterone treatment and hereditary 
sterility on prostaglandin concentration in the male reproductive 
system of mice.
Prostaglandins, (1975) 9, 289-297.
: 208
Bang, S. and Gautvik, K.M.
Inhibition of prolactin secretion and synthesis by dopamine, 
noradrenaline and pilocarpine in cultured rat pituitary tumour cells 
Acta Pharmacol, et Toxicol., (1977) 41, 317-327.
Banhawy, M.A., Rashed, R.M.A., Bowler, K. and Stacey, M.J.
The effect of a single injection of mepivacaine hydrochloride on 
spermatogenesis in the rat.
J. Reprod. Fertil., (1977) 51, 477-479.
Bartke, A.
Pituitary-testis relationships, role of prolactin in the regulation 
of testicular function.
Sperm Action Prog. Reprod. Biol., (1976) 1, 136-152.
Bartke, A. and Dalterio, S.
Effects of prolactin on the sensitivity of the testis to LH.
Biol. Reprod., (1976) 15, 90-93.
Bartke, A., Kupfer, D. and Dalterio, S.
Prostaglandins inhibit testosterone secretion by mouse testes in 
vitro.
Steroids, (1976) 28, 81-88.
Bartke, A., Steele, R.E., Musto, N. and Caldwell, B.V.
Fluctuations in plasma testosterone levels in adult male rats and 
mice.
Endocrinology, (1973) 92, 1223-1228.
: 209
Bartlett, D.J.
Studies on dog semen. I. Morphological characteristics.
J. Reprod. Fertil., (1962a) 3, 173-189.
Bartlett, D.J.
Studies on dog semen. II. Biochemical characteristics.
J. Reprod. Fertil., (1962b) 3, 190-205.
Bateman, A.J. and Jackson, H.
Screening for mutagenic hazards of potential chemical contraceptives 
in the male.
Acta Endocrinol., (Copenhagen), Suppl., (1974) 184, 224-239.
Batta, S.K., Zanisi, M. and Martini, L.
Prostaglandins and gonadotrophin secretion.
Neuroendocrinology, (1974) 14, 224-232.
Beck, W. and Wuttke, W.
Annual rhythms of luteinizing hormone, follicle-stimulating hormone, 
prolactin and testosterone in the serum of male rhesus monkeys.
J. Endocrinol., (1979) 83, 131-139.
Bhattacharyya, A.K., Zaneveld, L.D.J., Dragoje, B.M., Schumacher, 
G.F.B. and Travis, J.
Inhibition of human sperm acrosin by synthetic agents.
J. Reprod. Fertil., (1976) 47, 97-100.
Biava, C.G., Smuckler, E.A. and Whorton, D .
The testicular morphology of individuals exposed to 
dibromochloropropane.
Exp. Mol. Pathol., (1978) 29, 448-458.
: 210:
Birnbaum, D. and Hall, T.
An electroejaculation technique for rats.
Anat. Rec., (1961) 140, 49-50.
Blackshaw, A.W. and Elkington, J.S.H.
The effect of age and hypophysectomy on growth and the isoenzymes 
of lactate dehydrogenase in the mouse testis.
Biol. Reprod., (1970) 2, 268-274.
Blandau, R.J. and Jordan, E.S.
A technique for the artificial insemination of the White rat.
J. Lab. Clin. Med., (1941) 26, 1361-1363.
Bloom, F.
Testis and epididymis.
In "Pathology of the dog and cat", pp 213-312. American Veterinary 
Publications Inc., Evanston, Illinois, (1954). .
Blumberg, A.G. and Heaton, A.M.
The occurrence of cyclohexylamine in urines studied for drug use 
by thin layer chromatography.
J. Chromatogr., (1970) 48, 565-566.
Bohnet, H.G., Aragona, C. and Friesen, H.G.
Age and sex differences in prolactin response to phenothiazines in 
rats.
Biol. Reprod., (1976) 15, 168-172.
Bonser, G.M. and Robson, J.M.
The effects of prolonged oestrogen administration upon male mice 
of various strains; development of testicular tumours in the strong 
A strain.
J. Pathol. Bacteriol., (1940) 51, 9-22.
:211:
Boria, T., Mason, M.M. and Rosenkrantz, H.
A volumetric and biochemical study of canine prostatic fluid 
using mechanical and pharmacologic stimuli.
Am. J. Vet. Res., (1963) 24, 343-347.
Boucher, J.H., Foote, R.H. and Kirk, R.W.
The evaluation of semen quality in the dog and the effects of 
frequency of ejaculation upon semen quality, libido and depletion 
of sperm reserves.
Cornell Vet., (1958) 48, 67-86.
Boyd, E . M .
Testicular atrophy from analgesic drugs.
J. Clin. Pharmacol., (1970) 10, 222-227.
Bradley, P.B., Gayton, R.J. and Lambert, L.A.
Electrophysiological effects of opiates and opioid peptides.
In "Centrally acting peptides", ed. Hughes, J., pp 215-229, 
Baltimore, University Park, (1978) .
Briggs, M. and Briggs, H.
Oral contraceptive for men.
Nature (London), (1974) 252, 585-586.
British Standards Institution.
Specification for cyclohexylamine.
British Standards Institution, (1968), 2534.
Brittinger, D.
Die mutagene Wirkung von Endoxan bei der M a u s .
Humangenetik, (1966) 3, 156-165.
:212:
Bullock, F.D. and Curtis, M.R.
Spontaneous tumours of the rat.
J. Cancer Res., (1930) 14, 1-115.
Burns, J.J.
Variation of drug metabolism in animals and the prediction of 
drug action in man.
Ann. N.Y. Acad. Sci., (1968) 151, 959-967.
Bustos-Obregon, E. and Feito, R.
The effect of vinblastine sulphate on rat spermatogenesis.
Arch. Biol. (Bruxelles), (1974) 85, 353-364.
Call, J.W. and Barker, C.A.V.
Observations on the effects of ICI compound 33828 (methallibure) 
on semen production in dogs.
Can. Vet. J . , (1967) 4, 91-92.
Capel-Edwards, K . , Hall, D.E., Fellowes, K.P., Vallance, D.K., 
Davies, M.J., Lamb, D. and Robertson, W.B.
Long-term administration of progesterone to the female Beagle dog 
Toxicol. Appl. Pharmacol., (1973) 24, 474-488.
Carlson, J.C., Barcikowski, B. and McCracken, J.A.
Prostaglandin F^^^ and the release of LH in sheep.
J. Reprod. Fertil., (1973) 34, 357-361.
Carlson, H.E., Briggs, J.E. and McCallum, R.W.
Stimulation of prolactin secretion by metaclopramide in the rat. 
Proc. Soc. Exp. Biol. Med., (1977) 154, 475-478.
:213;
Carmichael, L.E. and Kenney, R.M.
Canine abortion caused by Brucella canis.
J. Am. Vet. Med. Assoc., (1968) 152, 605-616.
Catanese, B . , Baldini, A., Burberi, S., Silvestrini, B. and 
Coulston, F.
Study of rat serum concentrations of 1 - j^(4-chlorophenyl) methylj-IH- 
indazole-3-carboxylic acid, new antispermatogenic agent.
Toxicol. Appl. Pharmacol., (1977) 42, 11-18.
Cater, B.R., Cook, M.W., Gangolli, S.D. and Grasso, P.
Studies on dibutyl phthalate-induced testicular atrophy in the rat: 
effect on zinc metabolism.
Toxicol. Appl. Pharmacol., (1977) 41, 609-618.
Cattanach, B.M.
The mutagenicity of cyclamates and their metabolites.
Mutat. Res., (1976) 39, 1-28.
Chapman, R.W., Sutcliffe, S.B., Rees, L.H., Edwards, C.R.W. and 
Malpas, J.S.
Cyclical combination chemotherapy and gonadal function; 
retrospective study in males.
Lancet, (1979) I, 287-289.
Chen, K.K.
Pharmacology of methadone and related compounds.
Ann. N.Y. Acad. Sci., (1948) 51, 83-97.
Chiquoine, A.D.
Observations on the early events of cadmium necrosis of the testis 
Anat. Rec., (1964) 149, 23-36.
:214:
Chowdhury, A.K.
Dependence of testicular germ cells on hormones: a quantitative 
study in hypophysectomized testosterone-treated rats.
J. Endocrinol., (1979) 82, 331-340.
Cicero, T.J.
An ^  vivo assay for the analysis of the biological potency and 
structure-activity relationships of narcotics: serum testosterone 
depletion in the male rat.
J. Pharmacol. Exp. Ther., (1977) 202, 670-675.
Cicero, T.J., Badger, T.M., Wilcox, C.E., Bell, R.D. and Meyer, E.R. 
Morphine decreases luteinizing hormone by an action on the 
hypothalamic-pituitary axis.
J. Pharmacol. Exp. Ther., (1977a) 203, 548-555.
Cicero, T.J., Bell, R.D., Meyer, E.R. and Schweitzer, J.
Narcotics and the hypothalamic-pituitary-gonadal axis: acute 
effects on luteinizing hormone, testosterone and androgen- 
dependent systems,
J. Pharmacol. Exp. Ther., (1977b) 201, 76-83.
Cicero, T.J., Bell, R.D., Wiest, W.G., Allison, J.H., Polakoski,
K. and Robins, E.
Function of the male sex organs in heroin and methadone users.
New Engl. J. Med., (1975a) 296, 882-887.
Cicero, T.J., Meyer, E.R., Bell, R.D. and Koch, G.A.
Effects of morphine and methadone on serum testosterone and 
luteinizing hormone levels and on the secondary sex organs of the 
male rat.
Endocrinology, (1976a) 98, 367-372.
:215:
Cicero, T.J., Meyer, E.R., Bell, R.D. and Wiest, W.G.
Effects of morphine on the secondary sex organs and plasma 
testosterone levels of rats.
Res. Commum. Chem. Pathol. Pharmacol., (1974) 7, 17-24.
Cicero, T.J., Meyer, E.R., Wiest, W.G., Olney, J.W. and Bell, R.D. 
Effects of chronic morphine administration on the reproductive 
system of the male rat.
J. Pharmacol. Exp. Ther., (1975b) 192, 542-548.
Cicero, T.J., Wilcox, C.E., Bell, R.D. and Meyer, E.R.
Acute reductions in serum testosterone levels by narcotics in the 
male rat: stereospecificity, blockade by naloxone and tolerance.
J. Pharmacol. Exp. Ther., (1976b) 198, 340-346.
Clarke, E.G.C.
Species difference in toxicology.
Vet. Rec., (1976) 98, 215-218.
Clermont, Y.
Quantitative analysis of spermatogenesis of the rat: a revised 
model for the renewal of spermatogonia.
Am. J. Anat., (1962) 111, 111-129.
Clermont, Y. and Morgentaler, H.
Quantitative study of spermatogenesis in the hypophysectomized rat, 
Endocrinology, (1955) 57, 369-382.
:216:
Clermont, Y. and Perey, B.
The stages of the cycle of the seminiferous epithelium of the rat; 
practical definitions in PA-Schiff-haematoxylin and haematoxylin- 
eosin stained sections.
Rev. Can. Biol., (1957a) 16, 241-267.
Clermont, Y. and Perey, B.
Quantitative study of the cell population of the seminiferous 
tubules in immature rats.
Am. J. Anat., (1957b) 100, 241-267.
Cohen, J.P., Hoffer, A.P. and Rosen, S.
Carbonic anhydrase localization in the epididymis and testis of 
the rat; histochemical and biochemical analysis.
Biol. Reprod., (1976) 14, 339-346.
Collins, P.M., Collins, W.P., McNeilly, A.S. and Tsang, W.N. 
Plasma FSH, LH and testosterone levels in the male rat during 
degeneration of the germinal epithelium caused by severe heat
treatment or ligation of the vasa efferentia.
J. Reprod. Fertil., (1978) 54, 285-291.
Cooke, R.A., Nikles, A. and Roeser, H.P.
A comparison of the antifertility effects of alkylating agents 
and vinca alkaloids in male rats.
Br. J. Pharmacol., (1978) 63, 677-681.
Cooper, T,G& and Waites, G.M.H.
Testosterone in rete testis fluid and blood of rams and rats.
J. Endocrinol., (1974) 62, 619-629.
;217:
Cooper, E.R.A., Jones, A.R. and Jackson, H.
Effects of d-chlorohydrin and. related compounds on the reproductive 
organs and fertility of the rat.
J.' Reprod. Fertil., (1974) 38, 379-386.
Coppola, J.A.
An extragonadal male antifertility agent.
Life Sci., (1969) 8, 43-48.
Coppola, J.A. and Saldarini, R.J.
A new orally active male antifertility agent (l-amino-3-chloro- 
2-propanol hydrochloride).
Contraception, (1974) 9, 459-470.
Cotchin, E.
Testicular neoplasms in dogs.
J. Comp. Pathol. Ther., (1960) 70, 232-252.
Coulston, F ., Beyler, A.L. and Drobeck, H.P.
The biologic actions of a new series of bis (dichloroacetyl) 
diamines.
Toxicol. Appl. Pharmacol., (1960) 2, 715-731.
Coulston, F . , Dougherty, W.J., LeFevre, R . , Abraham, R. and 
Silvestrini, B.
Reversible inhibition of spermatogenesis in rats and monkeys with 
a new class of indazole-carboxylic acids.
Exp. Mol. Pathol., (1975) 23, 357-366.
Coulston, F . , McChesney, E.W., and Benitz, K.-F.
Eight year study of cyclamate in rhesus monkeys.
Toxicol. Appl. Pharmacol., (1977) 41, Abstr. 164-165.
218
Coutinho, E.M. and Melo, J.F.
Successful inhibition of spermatogenesis in man without loss of 
libido; A potential new approach to male contraception. 
Contraception, (1973) 8, 207-217.
Coy, D.H., Coy, E.J., Schally, A.V., Vilchez-Martinez, J.A., 
Debeljuk, L . , Carter, W.H. and Arimura, A.




The development of a qualitative assay for male infertility from a 
study of enzymes in human semen.
J. Reprod. Fertil., (1977) 51, 73-76.
Crain, R.C.
Spontaneous tumours in the Rochester strain of the Wistar rat.
Am. J. Pathol., (1958) 34, 311-335.
Crighton, D.B.
Review of releasing hormones in domestic animals.
Vet. Rec., (1973) 94, 254.
Cronqvist, S.
Spermatic invasion of the epididymis.
Acta. Pathol. Microbiol. Scand., (1949) 24, 786-794.
;219
Cummins, J.M. and Orgebin-Crist, M.-C.
Effects of the anti-androgen SK&F 7690 on the fertility of 
epididymal spermatozoa in the rabbit.
Biol. Reprod., (1974) 11, 56-63.
Davidson, J.M. and Bloch, G.J.
Neuroendocrine aspects of male reproduction.
Biol. Reprod., (1969) 1, 67-92.
Davidson, J.M. and Ganong, W.F.
The effect of hypothalamic lesions on the testes and prostate of 
male dogs.
Endocrinology, (1960) 66, 480-488.
Debeljuk, L . , Arimura, A. and Schally, A.V.
Pituitary and serum FSH and LH levels after massive and selective 
depletion of the germinal epithelium in the rat testis. 
Endocrinology, (1973) 92, 48-54.
Debeljuk, L . , Daskal, R.H., Villegas-Velez, C. and Mancini, A.M. 
Acute and chronic effects of sulpiride on serum prolactin and 
gonadotrophin levels in castrated male rats.
Proc. Soc. Exp. Biol. Med., (1975) 148, 550-552.
DePalatis, L . , Moore, J. and Falvo, R.E.
Plasma concentrations of testosterone and LH in the male dog.
J. Reprod. Fertil., (1978) 52, 201-207.
Dixit, V.P., Gupta, C.L. and Agrawal, M.
Testicular degeneration and necrosis induced by chronic 
administration of cannabis extract in dogs.
Endokrinologie, (1977) 69, 299-305.
220:
Dow, C .
Testicular tumours in the dog.
J. Comp. Pathol. Ther., (1962) 72, 247-265.
Duggan, D.E., Hooke, K.F., Noll, R.M. and Kwan, K.C. 
Enterohepatic circulation of indomethacin and its role in 
intestinal irritation.
Biochem. Pharmacol., (1975) 25, 1749-1754.
Dym, M. and Cavicchia, J.C.
Further observations on the blood-testis barrier in monkeys 
Biol. Reprod., (1977) 17, 390-403.
Dym, M. and Cavicchia, J.C.
Functional morphology of the testis.
Biol. Reprod., (1978) 18, 1-15.
Dym, M. and Fawcett, D.W.
The blood-testis barrier in the rat and the physiological 
compartmentation of the seminiferous epithelium.
Biol. Reprod., (1970) 3, 308-326.
Editorial.
B.I.B.R.A. Bulletin, (1977) 16, 173-174.
Eliasson, R.
Pharmacological actions on the production and physiology of 
mammalian spermatozoa.




Environ. Health Persp., (1978) 24, 81-85.
Ellis, L.C., Sorenson, D.K. and Buhrley, L.E.
Mechanisms and interactions in testicular steroidogenesis and 
prostaglandin synthesis.
J. Steroid. Biochem., (1975) 6, 1081-1090.
Ericsson, R.J.
Male antifertility compounds: U-5897 as a rat chemasterilant.
J. Reprod. Fertil., (1970) 22, 213-222.
Ericsson, R.J. and Youngdale, G.A.
Male antifertility compounds: structure and activity relationships 
of U-5897, U-15,64 6 and related substances.
J. Reprod. Fertil., (1970) 21, 263-266.
Euker, J.S., Meites, J. and Riegle, G.D.
Effects of acute stress on serum LH and prolactin in intact, 
castrate and dexamethasone-treated male rats.
Endocrinology, (1975) 96, 85-92.
Evans, J. and Renton, J.P.
A case of azoospermia in a previously fertile dog with subsequent
recovery.
Vet. Rec., (1973) 92, 198-199.
Eyden, B.P., Maisin, J.R. and Mattelin, G.
Long-term effects of dietary lead acetate on survival, body weight
and seminal cytology in mice.
Bull. Environ. Contam. Toxicol., (1978) 19, 266-272.
: 222:
Falaschi, P., Frajese, G., Sciarra, F . , Rocco, A. and Conti, C. 
Influence of hyperprolactinaemia due to metoelopramide 
on gonadal function in men.
Clin. Endocrinol., (1978) 8, 427-433.
Fang, V.S., Refetoff, S. and Rosenfield, R.L.
Hypogonadism induced by a transplantable, prolactin-producing 
tumour in male rats: Hormonal and morphological studies. 
Endocrinology, (1974) 95, 991-998.
Fang, V.S., Zimo, D.A. and Byyny, R.
Pituitary response to metoclopramide in the rat.
J. Endocrinol., (1977) 74, 155-156.
Fawcett, D.W., Leak, L.V. and Heid^ger, P.M.
Electron microscopic observations on the structural components 
of the blood-testis barrier.
J. Reprod. Fertil., Suppl., (1970) 10, 105-122.
Finco, D.R.
Biopsy of the testicle.
Vet. Clin. N. A m . , (1974) 4, 377-381.
Fjalland, B. and Boeck, V.
Neuroleptic blockade of the effect of various neurotransmitter 
substances.
Acta Pharmacol. Toxicol., (1978) 42. 206-211.
Fletcher, A.P.
Drug safety tests and subsequent clinical experience.
J.R. Soc. Med., (1978) 71, 693-696.
:223
Foote, R.H., Swierstra, E.E. and Hunt, W.L.
Spermatogenesis in the dog.
Anat. Rec., (1972) 173, 341-352.
Ford, W.C.L. and Waites, G.M.H,
A reversible contraceptive action^of some 6—chloro-6-deoxy sugars 
in the male rat.
J. Reprod. Fertil., (1978) 52, 153-157.
Ford, W.C.L.,, Harrison, A. aijd Waites, G.M.H.
Effects of the optical isomers of »-chlorohydrin on glycolysis 
by ram testicular spermatozoa and the fertility of male rats.
J. Reprod. Fertil., (1977) 51, 105-109.
Fordney Settlage, D.S. and Hendrickx, A.G.
Observations on coagulum characteristics of the rhesus monkey 
electroejaculate.
Biol. Reprod., (1974) 11, 619-623.
Fox, B.W. and Fox, M.
Biochemical aspects of the actions of drugs on spermatogenesis. 
Pharmacol. Rev., (1967) 19, 21-57.
Francis, A.F., Williams, R . , Cole, E.W., Williams, P., Link, J. and 
Hughes, D.
The effect of clomipramine on prolactin levels - pilot studies. 
Postgrad. Med. J. , Suppl., (1976) 52, 87-91.
Frankel, A.I., Mock, E.J., Wright, W.W. and Kamel, F . 
Characterization and physiological validation of a radioimmunoassay 
for plasma testosterone in the male rat.




New Engl. J. Med., (1978) 298, 201-207.
Frick, J . , Bartsch, G. and Marberger, H.
Steroidal compounds (injectable and implants) affecting 
spermatogenesis in men.
J. Reprod. Fertil., Suppl., (1976) 24, 35-47.
Friedman, N.B. and Garske, G.L.
Inflammatory reactions involving sperm and the seminiferous 
tubules: Extravasation, spermatic granulomas and granulomatous 
orchitis.
J. Urol., (1949) 62, 363-374.
Friedman, L . , Weinberger, M.A., Farber, T.M., Moreland, F.M., 
Peters, E.L., Gilmore, C.E. and Khan, M.A.
Testicular atrophy and impaired spermatogenesis in rats fed high 
levels of the methylxanthines caffeine, theobromine, or 
theophylline.
J. Environ. Pathol. Toxicol., (1979) 2, 687-706.
Fritz, H . , Forg-Brey, B . , Fink, E . , Meier, M . , Schiepier, H. and 
Schirren, C.
Humanakrosin: Gewinnung und Eigenschaften.
Hoppe-Seyler's Z. Physiol. Chem., (1972) 351, 1943-1949.
Galina, C.S.
An evaluation of testicular biopsy in farm animals.
Vet. Rec., (1971) 88, 628-631.
225:
Gaunt, I.F., Sharratt, M . , Grasso, P., Lansdown, A.B.G. and 
Gangolli, S.D.
Short-term toxicity of cyclohexylamine hydrochloride in the rat. 
Food Cosmet. Toxicol., (1974) 12, 609-624.
Gero, A.
Steric considerations on the chemical structure and physiological 
activity of methadone and related compounds.
Science, (1954) 119, 112-114.
Gilboa, E . , Elkana, Y. and Rigbi, M.
Purification and properties of human acrosin.
Eur. J. Biochem., (1973) 39, 85-92.
Gillman, J., Gilbert, C. and Spence, I.
Phaeochromocytoma in the rat.
Cancer, (1953) 6, 494-511.
Glass, A.R. and Swerdloff, R.S.
Serum gonadotrophins in rats fed a low-valine diet.
Endocrinology, (1977) 101, 702-707.
Glassy, F.J. and Mostofi, F.K.
Spermatic granulomas of the epididymis.
Am. J. Clin. Pathol., (1956) 26, 1303-1313.
Glogner, P.
The metabolism of tolbutamide and cyclamate.
Humangenetik, (1970) 9, 230-232.
Golberg, L., Parekh, C . , Patti, A. and Soike, K.
Cyclamate degradation in mammals and vitro.
Toxicol. Appl. Pharmacol., (1969) 14, Abstr., 654.
; 226:
Goldberg, G.M., Goldberg, S. and Gold, J.J.
An endocrine mechanism involved in testicular changes produced 
by a DL-ethionine supplemented diet; A study of morphologic 
changes and endocrine dysfunction.
Endocrinology, (1961) 69, 430-437.
Gomes, W.R.
Chemical agents affecting testicular function and male fertility. 
In "The Testes", eds. Johnson, A.D., Gomes, W.R. and Vandemark, 
N.L., Vol III, pp 483-554, Academic Press, New York, (1970).
Graf, K.-J., Friedrich, E . , Matthes, S. and Hasan, S.H.
Homologous radioimmunoassay for canine proLaptin and its 
application in various physiological states.
J. Endocrinol., (1977) 75, 93-103.
Gray, G.D.
Changes in the levels of luteinizing hormone and testosterone 
in the circulation of ageing male rats.
J. Endocrinol., (1978) 76, 551-552.
Green, S., Palmer, K.A. and Legator, M.S.
Effects of cyclohexylamine on the fertility of male rats.
Food Cosmet. Toxicol., (1972) 10, 29-34.
Creep, R.O.
The male reproductive system.
In "Reproduction and human welfare; A challenge to research", 
eds.. Creep, R.O., Koblinsky, M.A. and Jaffe, F.S., pp 165-280, 
MTI press, London, (1976).
:227 :
Groom, G.V. and Evans, G.
The effect of long-term administration of toxic doses of 
clomipramine on plasma prolactin, luteinizing hormone, follicle 
stimulating hormone and testosterone in the male rat.
Postgrad. Med. J . / Suppl., (1977) 53, 190-197.
Gump, W.S.
Toxicological properties of hexachlorophene.
J. Soc. Cosmet. Chem., (1969) 20, 173-184.
Gunn, S.A., Gould, T.C. and Anderson, W.A.D.
The selective injurious response of testicular and epididymal 
blood vessels to cadmium and its prevention by zinc.
Am. J. Pathol., (1963) 42, 685-702.
Gunn, S.A., Gould, T.C. and Anderson, W.A.D.
Comparative mechanisms of action of monochlor.ohydrin and cadmium- 
induced necrosis of the caput epididymis of the rat.
Biol. Reprod., (1970) 3, 35-42.
Gupta, D . , Zarzycki, J. and Rager, K.
Plasma testosterone and dihydrotestosterone in male rats during 
sexual maturation and following orchidectomy and experimental 
bilateral cryptorchidism.
Steroids, (1975) 25, 33-42.
Hadley, J.C.
Spermatogenic arrest with azoospermia in two Welsh Springer 
Spaniels.
J. Small Anim. Pract., (1972) 13, 135-138.
:228
14
1- C acetate into testosterone and cholesterol
Hafiez, A.A., Bartke, A. and Lloyd, C.W.
The role of prolactin in the regulation of testis function: The 
synergistic effects of prolactin and luteinizing hormone and the 
incorporation of 
by testes from hypophysectomized rats vitro.
J. Endocrinol., (1972) 53, 223-230.
Hagenas, L . , Ploen, L. and Ekwall, H.
Blood-testis barrier: Evidence for intact inter-Sertoli cell 
junctions after hypophysectomy in the adult rat.
J. Endocrinol., (1978) 76, 87-91.
Harcourt, R.A.
Polyarteritis in a colony of beagles.
Vet. Rec., (1978) 102, 519-522.
Harrop, A.E.
A new type of canine artificial vagina.
Br. Vet. J., (1954) 110, 194-196.
Harrop, A.E.
Some observations on canine semen.
Vet. Rec., (1955) 66, 494-498.
Harrop, A.E.
The infertile male dog.
J. Small Anim. Pract., (1966) 7, 723-725.
Heller, C.G., Moore, D.J., Paulsen, C.J., Nelson, W.O. and Laidlaw, 
W.M.
Effects of progesterone and synthetic progestins on the 
reproductive physiology of normal men.
Fed. Proc., Fed. Am. Soc. Exp. Biol., (1959) 18, 1057, 1064.
: 229:
Heller, C.G., Nelson, W.O., Hill, I.E., Henderson, E . , Maddock, 
W.O., Jungck, E.G., Paulsen, G.A. and Mortimore, G.E.
Improvement in spermatogenesis following depression of the human 
testis with testosterone.
Fertil. Steril., (1950) 1, 415-422.
Hemsworth, B.N., Jackson, H. and Walpole, A.L.
Effect of the pituitary inhibitor IGI 33,828 (methallibure) on 
the reproductive system of male rats.
J. Endocrinol., (1968) 40, 275-284.
Hendricks, F.B., Lambird, P.A. and Murphy, G.P.
Percutaneous needle biopsy of the testis.
Fertil. Steril., (1969) 20, 478-481.
Hendry, J.A., Homer, R.F., Rose, F.L. and Walpole, A.L.
Gytotoxic agents: III, derivatives of ethyleneimine.
Br. J. Pharmacol., (1951) 6, 357-410.
Heywood, R .
Animal studies in drug safety evaluation.
J.R. Soc. Med., (1978) 71, 686-689.
Heywood, R. and James, R.W.
Assessment of testicular toxicity in laboratory animals.
Environ. Health Persp., (1978) 24, 73-80
Heywood, R. and James, R.W.
Toxicological models for testing chemical fertility regulating 
agents.
In "Recent Advances in Primatology (Medicine Section)", ed. Anand 
Kumar, T.G., Vol. 5, in press. Academic Press, London. (1980).
:230;
Heywood, R. and Sortwell, R.J.
Semen evaluation in the beagle dog.
J. Small Anim. Pract., (1971) 12, 343-346.
Heywood, R . , James, R.W. and Prentice, D.E.
Chemical toxicity in the CNS of laboratory animals.
Symposium proceedings "Animal models of neurological disease", 
ed., Rose, E.G., in press, (1980a).
Heywood, R . , Sortwell, R.J. and Prentice, D.E.
The toxicity of l-amino-3-chloro-2-propanol hydrochloride 
(GL 88,236) in the rhesus monkey.
Toxicology, (1978) 9, 219-225.
Heywood, R . , Ghesterman, H . , Ball, S.A. and Wadsworth, P.P. 
Toxicity of methyl testosterone in the beagle dog.
Toxicology, (1977a) 7, 357-365.
Heywood, R . , Hunter, B . , Green, O.P. and Kennedy, S.J.
The toxicity of methyl testosterone in the rat.
Toxicol. Lett., (1977b) 1, 27-31.
Heywood, R . , James, R.W., Scorza-Barcellona, P. and Gampana, A. 
Toxicological studies on l-substituted-indazole-3-carboxylic acids 
Proceedings of international workshop, L'Aquila, Italy, Sept. 
18-19th, ed., Silvestrini, B . , in press, (1980b).
:231:
Heywood, R . , Sortwell, R.J., Noel, P.R.B., Street, A.E., Prentice, 
D.E., Roe'i-F. J.C. , Wadsworth, P.F. and Worden, A.N.
Safety evaluation of toothpaste containing chloroform. III. Long­
term study in beagle dogs.
J. Environ. Pathol. Toxicol., (1979) 2, 835-831.
Hoey, M.J. ^
The effects of metaj^c salts on the histology and functioning of 
the rat testis.
J. Reprod. Fertil., (1966) 12, 461-471.
Hoffer, A.P., Hamilton, D.W. and Fawcett, D.W.
The ultrastructural pathology of the rat epididymis after 
administration of a-chlorohydrin (U-5897).1. Effects of a single 
dose.
Anat. Rec., (1973) 175, 203-230.
Holdsworth, S., Atkins, R.C. and de Kretser, D.M.
The pituitary-testicular axis in men with chronic renal failure. 
New Engl. J. Med., (1977) 296, 1245-1249.
Hooker, C.W., Gardner, W.U. and Pfeiffer, C.A.
Testicular tumours in mice receiving oestrogens.
J. Am. Med. Assoc., (1940) 115, 443-445.
Hooker, C.W., Pfeiffer, C.A. and de Vita, J.
The significance of the character of the interstitial cells of the 
testis in the aged dog.
Anat. Rec., (1946) 94, Abstr., 471-472.
Horrobin, D.F.
Male reproduction.
In "Prolactin (Annual Research Reviews)", vol. 5, pp 68-73,
Eden Press Inc., Montreal, (1977).
:232:
Hottendorf, G.H. and Hirth, R.S.
Lesions of spontaneous subclinical disease in beagle dogs.
Vat. Pathol., (1974) 11, 240-258.
Huggins, C.
The physiology of the prostate gland.
Physiol. Rev., (1945) 25, 281-295,
Hunt, W.L., Paufler, S.K. and Foote, R.H.
Testicular biopsies and spermatogenesis in dogs.
J. Anim. Sci., (1965) 29, Abstr., 921.
Ito. A., Moy, P., Kaunitz, H . , Kortwright, K . , Clarke, S., Furth, 
J. and Meites, J.
Incidence and character of the spontaneous pituitary tumours in 
strain CR and W/Fu male rats.
J. Natl. Cancer Inst., (1972) 49, 701-711.
Jackson, H.
Antifertility substances.
Pharmacol. Rev., (1959) 11, 135-172.
Jackson, H.
Chemical interference with spermatogenesis and fertility.
In "Advances in Reproductive Physiology", ed. McLaren, A., Vol. 4, 
pp 65-98, Logos Press Ltd., (1969).
Jackson, H.
Chemical methods of male contraception.
In "Artificial Control of Reproduction", Book 5, eds. Austin, C.%. 
and Short, R.V., pp 67-86, University Press, Cambridge, (1972).
:233:
Jackson, B. and Cappiello.
Ranges of normal organ weights of dogs.
Toxicol. Appl. Pharmacol., (1964) 6, 664-668.
Jackson, H. and Craig, A.W.
Antifertility action and metabolism of hexamethylphosphoramide. 
Nature (London), (1966) 212, 86-87.
Jackson, H . , Fox, B.W. and Craig, A.W.
Antifertility substances and their assessment in the male rodent.
J. Reprod. Fertil., (1961) 2, 447-465.
Jacobs, B.B. and Huseby, R.H.
Neoplasms occurring in aged Fischer rats, with special reference to 
testicular, uterine and thyroid tumours.
J. Natl. Cancer Inst., (1967) 39, 303-309.
James, R.W., Heywood, R . , Colley, J.C. and Hunter, B.
The oral toxicity of l-amino-3-chloro-2-propanol hydrochloride 
(CL 88,236) in rats.
Toxicology, (1978) 11, 235-243.
Johnson, J.M. and Ellis, L.C.
The histochemical localization of prostaglandin synthetase activity 
in reproductive tract of the male rat.
J. Reprod. Fertil., (1977) 51, 17-22.
Johnson, M.I. and Newman, L.
Radiation-induced fetal testicular damage in the monkey (Macaca 
radiata).
J. Med. Primatol., (1976) 5, 195-199.
234 :
Jones, P w  Jackson, H, and Whiting, M.S.
Comparative' effects of niridazole on spermatogenesis and 
reproductive capacity in the mouse, rat and Japanese quail.
J. Reprod. Fertil., (1976) 46, 217-224.
Jones, T.C. and Friedman, N.B.
Pathologic" and Clinical features of canine testicular tumours. 
Bull. Int. Assoc. Med. Mus., (1950) 31, 36-53.
de Jong, F.H. and Sharpe, R.M.
The onset and establishment of spermatogenesis in rats in relation 
to gonadotrophin and testosterone levels.
J. Endocrinol., (1977) 75, 197-207.
Joseph, M.M. and Siwela, A.A.
Effects of prostaglandin F-2p^ and indomethacin on the response of 
the accessory sex glands of male rats to testosterone.
J. Reprod. Fertil., (1976) 47, 93-94.
Jubb, K.V.F. and Kennedy, P.O.
The male genital system.
In "Pathology of Domestic Animals", Vol. I, pp 444-483, Academic 
Press, New York, (1970).
Kalra, S.P. and Prasad, M.R.N.
Effect of clomiphene on fertility in male rats.
J. Reprod. Fertil., (1967) 14, 39-48.
Karras, P.J. and North, R.A.
Inhibition of neuronal firing by opiates: Evidence against the 
involvement of cyclic nucleotides.
Br. J. Pharmacol., (1979) 65, 647-652.
:235
Keogh, E.J., Lee, V.W.K., Rennie, G.C., Burger, H.G., Hudson,
B.B. and de Kretser, D.M.
Selective suppression of FSH by testicular extracts.
Endocrinology, (1976) 98, 997-1004.
Khera, K.S* and Stoltz, D.R.
Effects of cyclohexylamine on rat fertility.
Experientia, (1970) 26, 761-762.
Khera, K.S., Stoltz, D.R., Gunner, S.W., Lyon, D.A. and Grice,
H.C.
Reproduction study in rats orally treated with cyclohexylamine 
sulfate.
Toxicol. Appl. Pharmacol., (1971) 18, 263-268.
Kimbrough, R.D.
Review of the toxicity of hexachlorophene.
Arch. Environ. Health., (1971) 23, 119-122.
Kimbrough, R.D. and Gaines, T.B.
Hexachlorophene effects on the rat brain. Study of high doses by 
light and electron microscopy.
Arch. Environ. Health, (1971) 23, 114-118.
King, N.W.
The reproductive tract.
In "Pathology of Laboratory Animals" eds. Benirschke, K . , Garner, 
F.M. and Jones, T.C., Vol I, pp 554-580, Springer Verlag, New York, 
(1978).
236:
King, T.O., Berliner, V.R. and Blye, P.R.
Pharmacology of 2,4-Dinitropyrroles - a new class of anti­
spermatogenic compounds.
Bioch. Pharmacol., Suppl., (1963) 12, Abstr., 69.
Kirton, K.T., Ericsson, R.J., Ray, J.A. and Forbes, A.D.
Male antifertility compounds efficacy of U-5897 in primates 
(Macaca mulatta) .
J. Reprod. Fertil., (1970) 21, 275-278.
Knight, P.J., Hamilton, J.M. and Soanes, C.G.
Homologous radioimmunoassay for canine prolactin.
Acta Endocrinol. (Copenhagen), (1977) 85, 736-743.
Kosterlitz, H.W. and Waterfield, A.A.
In vitro models in the study of structure-activity relationships 
of narcotic analgesics.
Annu. Rev. Pharmacol., (197 5) 15, 29-57.
Kovacic, N.M.I.
Endocrinology of reproduction.
In "Reproduction and Breeding Techniques for Laboratory Animals", 
ed. Hafez, E.S.E., pp 5-27, Lea and Febiger, Philadelphia, (1970)
Krause, W . , Hamm, K. and Weissmuller,
The effect of DDT on spermatogenesis of the juvenile rat.
Bull. Environ. Contam. Toxicol., (1975) 14, 171-178.
de Kretser, D.M.
Towards a pill for men.
Proc. R. Socw Lond. B .  ,(1976) 195, 161-174.
:237:
de Kretser, D.M., Burger, H.G. and Hudson, B.
The relationship between germinal cells and serum FSH levels in 
males with infertility.
J. Clin. Endocrinol. Metab., (1974) 38, 787-793.
de Kretser, D.M., Burger, H.G., Hudson, B. and Keogh, E.J.
The pituitary-testicular response to luteinising hormone releasing 
hormone administration to normal men.
Aust. N.Z. J. Med., (1975) 5, 227-230.
Kroes, R . , Peters, P.W.J., Berkvens, J.M., Verschuuren, H.G., de 
Vries, Th. and Van Esch, G.J.
Long-term toxicity and reproduction study (including a teratogen­
icity study) with cyclamate, saccharin and cyclohexylamine. 
Toxicology, (1977) 8, 285-300.
Krulich, L.
Central neurotransmitters and the secretion of prolactin, GH, LH 
and TSH.
Annu. Rev. Physiol., (1979) 41, 603-615.
Lanza, M . , Picard, D. and Carlon, N.
Comparative endocrinological effects of four substituted 
benzamides on the genital tract, mammary gland and anterior 
pituitary of female rats.
Therapie, (1975) 30, 231-245.
Larsen, R.E.
Testicular biopsy in the dog.
Vet. Clin. N. A m . , (1977) 7, 747-755.
:238
Leathern, J.H.,
Nutritional influences on testicular composition and function in 
mammals.
In "Handbook of Physiology, Section 7", e d s . Creep, R.O. and 
Astwood, E.B., Vol 5, pp 225-232, American Physiological Society, 
Washington, D.C., (1975).
Leblond, C.P. and Clermont, Y.
Definition of the stages of the cycle of the seminiferous 
epithelium in the rat.
Ann. N.Y. Acad. Sci., (1952a) 55, 548-573.
Leblond, C.P. and Clermont, Y.
Spermiogenesis of rat, mouse, hamster and guinea pig as revealed 
by the "periodic acid-fuschin sulfurous acid" technique.
Am. J. Anat., (1952b) 90, 167-215.
Lee, I.P. and Dixon, R.L.
Factors influencing reproduction and genetic toxic effects on male 
gonads.
Environ. Health Persp., (1978) 24, 117-127.
Lee, V.W.K., de Kretser, D.M., Hudson, B. and Wang, C.
Variations in serum FSH, LH and testosterone levels in male rats 
from birth to sexual maturity.
J. Reprod. Fertil., (1975) 42, 121-126.
Levin, J.I. and Voogt, J.L.
Effects of dopaminq, norepinephrine, and serotonin on plasma 
prolactin levels in ovariectomized, pituitary-grafted rats.
Proc. Soc. Exp. Biol. Med., (1978) 157, 576-579.
239:
Litchfield, M.H. and Swan, A.A.B.
Cyclohexylamine production and physiological measurements in 
subjects ingesting sodium cyclamate.
Toxicol. Appl. Pharmacol., (1971) 18, 535-541.
Lobl, T.J.
Characterization of the exfoliative antispermatogenic agent 
1-(2,4-dichlorobenzyl)-lH-indazole-3-carboxylic acid in the rat. 
Arch. Androl., C1979) 2, 351-361.
Lobl, T.J. and Porteus, S.E.
Antispermatogenic effects of 5-aminoindazole in rats.
J. Reprod. Fertil., (1977) 50, 371-372.
Lobl, T.J., Forbes, A.D., Kirton, K.T. and Wilks, J.W. 
Characterization of the exfoliative antispermatogenic agent l-(2,4- 
dichlorobenzyl)-lK-lndazole-3-carboxÿlic acid in the rhesus monkey 
Arch. Androl., (1979) 3, 67-77.
Lobl, T.J. and Matthews, J.
Effect of 1-(2,4-dichlorobenzyl)-lHlindazole-3-carboxylic acid on 
sperm tails in rhesus monkeys.
J. Reprod. Fertil., (1978) 52, 275-278.
Lockhart, J.D. and Simons, H.E.
Hexachlorophene decisions at the FDA.
Paediatrics, (1972) 51, 430-434.
Liltzen, L. , Trieb, G. and Pappritz, P.
Allometric analysis of organ weights: II. Beagle dogs.
Toxicol. Appl. Pharmacol., (1976) 35, 543-551.
:240:
McGinty, D.A. and Djerassi, C.
Some chemical and biological properties of 19-nor-17#- 
ethynyltestosterone.
Ann. N.Y. Acad. Sci., (1958) 71, 500-514.
McKeever, S.
Male reproductive organs.
In "Reproduction and Breeding Techniques for Laboratory Animals", 
ed. Hafez, E.S.E., pp 28-55, Lea and Febiger, Philadelphia, (1970).
MacLeod, R.M. and Lehmeyer, J.E.
Studies on the mechanism on the dopamine-mediated inhibition of 
prolactin secretion.
Endocrinology, (1974) 94, 1077-1085.
McNeilly, A.S., Sharpe, R.M., Davidson, D.W. and Fraser, H.M. 
Inhibition of gonadotrophin secretion by induced hyerprolactinaemia 
in the male rat.
J. Endocrinol., (1978) 79, 59-68.
Madwha Raj, H.G. and Dym, M.
The effects of selective withdrawal of FSH and LH on spermatogenesis 
in the immature rat.
Biol. Reprod., (1976) 14, 489-494.
Mahone, J.P. and Dukelow, W.R.
Seasonal variation of reproductive parameters in the laboratory- 
housed male cynomologus macaque (Macaca fasicularis) .
J. Med. Primatol., (1979) 8, 179-183.
:241:
Main, S.J. and Waites, G.M.H.
The blood-testis barrier and temperature damage to the testis of 
the rat.
J. Reprod. Fertil., (1977) 51, 439-450.
Mann, T h .
Spermiostatic, spermicidal and antispermatogenic substances.
In "The Biochemistry of Semen and of the Male Reproductive Tract", 
pp 379-396, Methuen and Co. Ltd., London (1964).
Mannisto, P.T., Kortilla, K. and Seppalla, T.
Serum prolactin levels after a single and subchronic oral 
administration of chlorpromazine and sulpiride.
Arzneim.-Forsch., (1978) 28, 76-78.
Marks, B.H.
/\' -Tetrahydrocannabinol and luteinizing hormone secretion.
Prog. Brain Res., (1973) 39, 331-338.
Martin, K.H. and Richmond, M.E.
A method for repeated sampling of testis tissue from small 
mammals.
Lab. Anim. Sci., (1972) 22, 541-545.
Mason, P.L. and Thompson, G.R.
Testicular effects of cyclohexylamine hydrochloride in the rat. 
Toxicology, (1977) 13, 143-156.
Mattheij, J.A.M. and Swarts, J.J.M.
Circadian variations in the plasma concentration of prolactin in 
the adult male rat.
J. Endocrinol., (1978) 79, 85-89.
: 242:
Mawdesley-Thomas, L.E. and Urwin, C.
Epithelial hyperplasia of the epididymis in the beagle dog.
Vet. Rec., (1967) 81, 356-357.
Meltzer, H.Y., Daniels, S. and Fang, V.S.
Clozapine increases serum prolactin levels.
Life. Sci., (1975) 17, 339-342.
Mendelson, J.H., Mendelson, J.E. and Patch, V.D.
Plasma testosterone levels in heroin addiction and during 
methadone maintenance.
J. Pharmacol. Exp. Ther., (1975) 192, 211-217.
Michael, R.P. and Bonsall, R.W.
A 3-year study of an annual rhythm in plasma androgen levels in male 
rhesus monkeys (Macaca mulatta) in a constant laboratory 
environment.
J. Reprod. Fertil., (1977) 48, 129-131.
Miyata, T., Kas^, Y ., Kamikawa, Y ., Kataoka, M . , Kikuchi, K. and 
Touchi, T.
Pharmacological characteristics of cyclohexylamine, one of the 
metabolites of cyclamate.
Life Sci., (1969) 8, 834-853.
Mock, E.J., Kamel, F . , Wright, W.W. and Frankel, A.I.
Seasonal rhythm in plasma testosterone and luteinising hormone of 
the male laboratory rat.




Serum 5#-Andr^stane-3#,l%)-diol, androsterone, and testosterone 
concentrations in the male rat, influence of age and 
gonadotrophin stimulation.
Endocrinology, (1977) 100, 1027-1032.
Moger, W.H. and Geschwind, I.I.
The action of prolactin on the sex accessory glands of the male 
rat.
Proc. Soc. Exp. Biol. Med., (1972) 141, 1017-1021.
Moger, W.H. and Murphy, P.R.
Serum 5«-andro.stane-3«, 17jS-diol, androsterone and testosterone 
concentrations in the immature male rat: Influence of time of day 
J. Endocrinol., (1977) 75, 177-178.
Mohri, H . , Suter, D.A.I., Brown-Woodman, P.D.C., White, I.G. and 
Ridley, D.D.
Identification of the biochemical lesion produced by «-chloro- 
hydrin in spermatozoa.
Nature (London), (1975) 255, 75-77.
Moore, C.R. and Gallagher, T.F.
Seminal-vesicle and prostate function as a testis-hormone 
indicator; the electric ejaculation test.
Am. J. Anat., (1934) 45, 39-69.
Morse, H.C., Leach, D.R., Rowley, M.J. and Heller, C.G.
Effect of cyproterone acetate on sperm concentration, seminal 
fluid volume, testicular cytology and levels of plasma and 
urinary ICSH, FSH and testosterone in normal men.
J. Reprod. Fertil., (1973) 32, 365-378.
:244
Mulinos, M.G. and Pomerantz, L.
The reproductive organs in malnutrition, effects of chorionic 
gonadotrophin upon atrophic genitalia of underfed male rats. 
Endocrinology, (1941) 29, 267-275.
Muraki, T., Tokunaga, Y . , Matsumoto, S. and Makino, T.
Time course of effects of morphine on hypothalamic content of 
LHRH and serum testosterone and LH levels of morphine-tolerant 
and nontolerant male rats.
Arch. Int. Pharmacodyn. Ther., (1978) 233, 290-295.
Ne^gro-Vilar, A., Krulich, L. and McCann, S.M.
Changes in serum prolactin and gonadotrophins during sexual 
development of the male rat.
Endocrinology, (1973) 93, 660-664.
Neumann, F. and Eiger, W.
Permanent changes in gonadal function and sexual behaviour as a 
result of early feminization of male rats by treatment with an 
antiandrogenic steroid.
Endokrinologie, (.1966) 50, 209-225.
Neumann, F. and Schenck, B.
Preclinical evaluation of drug effects on testicular functions. 
Pharmacol. Ther., (1979) 5, 345-359.
Newburgh, R.W.
Toxicology of the reproductive system.
In "Toxicology, The Basic Science of Poisons", eds. Cassarett, L.J. 
and Doull, J . , pp 261-274, Macmillan Publishing Co. Inc., New 
York, (1975).
: 245:
Nielsen, S.W. and Lein, D.H.
VI. Tumours of the testis.
Bull. W.H.O., (1974) 50, 71-78.
Nieschlag, E.
Clinical evaluation of drug effects on testicular function. 
Pharmacol. Ther., (1979) 5, 361-364.
Nigam, S.K., Lakkad, B.C., Karnik, A.B., Thakore, K.N., Bhatt,
D.K., Aravinda Babu, K. and Kashyap, S.K.
Effect of hexachlorocyclohexane feeding on testicular tissue of 
pure inbred Swiss mice.
Bull. Environ. Contam. Toxicol., (1979) 23, 431-437,
Noble, R.L.
Effect of synthetic oestrogenic substances on the body-growth and 
endocrine organs of the rat.
Lancet, (1938) 2, 192-195.
Noel, P J?..B.
The challenge of selecting the suitable animal species in 
toxicology. Non-rodents (particularly the dog).
Excerpta Medica International Congress Series, (1970) 198, 57-69, 
Noel, P.R.B.
Traditional animal screening tests.
Acta Endocrinol. (Copenhagen), Suppl., (1974) 75, 17-33.
North, R.A. and Williams, J.T.
Extracellular recording from the guinea-pig myenteric plexus and 
the action of morphine.
Eur. J. Pharmacol., (1977) 45, 23-33.
246:
Oishi, S., Oishi, H. and Hiraga, K.
The effect of food restriction for 4 weeks on common toxicity 
parameters in male rats.
Toxicol. Appl. Pharmacol., (1979) 47, 15-22.
Ojeda, S.R., Harris, P.O. and McCann, S.M.
Central effect of prostaglandin E, (PGE^) on prolactin release. 
Endocrinology, (1974) 95, 613-618.
Orbach, J.
Spontaneous ejaculation in the rat.
Science, (1961) 134, 1072-1073.
Oser, B.L., Carson, S., Cox, G.E., Vogin, E.E. and Sternberg, S.S. 
Chronic toxicity study of cyclamate : saccharin (10:1) in rats. 
Toxicology, (1975) 4, 315-330.
Ott, F . , Hoffet, H. and Hodel, H.
Uber die Erholung der Spermiogenese nach Behandlung Cyproteron 
azetat.
Schweiz. Med. Wochenschr., (1972) 102, 1124-1126.
Parekh,C., Goldberg, E.K. and Goldberg, L.
14Fate of sodium cyclamate- c in the rhesus monkey (M. mulatta) . 
Toxicol. Appl. Pharmacol., (1970) 17, Abstr., 17.
Patanelli, D.J.
Suppression of fertility in the male.
In "Handbook of Physiology, Section 7", eds. Greep, R.O. and Astwood,
E.B., vol. 5, pp 245-258, American Physiological Society,
Washington, D.C.,(1975).
:247:
van Pelt, L.F. and Keyser, P.E.
Observations on semen collection and quality in macaques.
Lab. Anim. Care, (1970) 20, 726-733.
Pepperell, R.J., de Kretser, D.M. and Burger, H.G.
Studies on the metabolic clearance rate and production rate of 
human luteinizing hormone and on the initial half-time of its 
subunits in man.
J. Clin. Invest., (1975) 56, 118-126.
Piacsek, B.E. and Goodspeed, M.P.
Maturation of the pituitary-gonadal system in the male rat.
J. Reprod. Fertil., (1978) 52, 29-35.
Plaa, G.L.
Animal models in the safety evaluation process.
Aust. J. Pharm. Sci., (1976) 5, 57-63.
Pliny,
Historia Naturalis, (77) Lib. 11, cap. 93.
Poulos, A., Brown-Woodman, P.D.C., White, I.G. and Cox, R.I. 
Changes in phospholipids or ram spermatozoa during migration 
through the epididymis and possible origin of prostaglandin F^^ 
in testicular and epididymal fluid.
Biochem. Biophys. Acta., (1975) 388, 12-18.
Prasad, M.R.N., Singh, S.P. and Rajalakshmi, M.
Fertility control in male rats by continuous release of micro­
quantities of cyproterone acetate from subcutaneous silastic 
capsules.
Contraception, (1970) 2, 165-177.
: 248 :
Prior, J.T. and Ferguson, J.H.-
Cytotoxic effects of a nitrofuran on the rat testis.
Cancer, (1950) 3, 1062-1072.
Pugh, D.M. and Crowley, J.
Some observations on the toxicity of hexachlorophene for sheep. 
Vet. Rec., (1966) 78, 86-91.
Quadri, S.K., Pierson, C. and Spies, H.G.
Effects of centrally acting drugs on serum prolactin levels in 
rhesus monkeys.
Neuroendocrinology, (1978) 27, 136-147.
Reichert, L.E. and Abou-Issa, H.
Studies on a low molecular weight testicular factor which inhibits 
binding of FSH to receptor.
Biol. Reprod., (1977) 17, 614-621.
Reid, J.T.
Relationship of nutrition to fertility in animals.
J. Am. Vet. Med. Assoc., (1949) 114, 158-164.
Reif, J.S., Maguire, T.G., Kenney, R.M. and Bradley, R.S.
A cohort study of canine testicular neoplasia.
J. Am. Vet. Med. Assoc., (1979) 175, 719-723.
Reijonen, K . , Kormano, M. and Ericsson, R.J.
Studies on the rat epididymal blood vessels following alpha- 
chlorohydrin administration.
Biol. Reprod., (1975) 12, 483-490.
; 249;
Renton, J.P. and Aughey, E.
Certain interesting aspects of infertility in two Shetland Collies. 
Vet. Rec., (1971) 88, 408-410.
Renwick, A.G. and Williams, R.T.
The fate of cyclamate in man and other species.
Biochem. J . , (1972) 129, 869-879.
Ribelin, W.E.
Atrophy of rat testis as index of chemical toxicity.
Arch. Pathol., (1963) 75, 229-235.
Richards, R.K., Taylor, J.D., O'Brien, J.L. and Duescher, H.O. 
Studies on cyclamate sodium (sucaryl sodium), a new noncaloric 
sweetening agent.
J. Am. Pharm. Assoc., (1951) 40, 1-6.
Richter, K.D., Korte, R. and Senge, Th.
Morpho-functional studies of the testes of healthy rhesus monkeys.
In "Physiology and Pathophysiology of Testicular Function", eds. 
Senge, Th., Neumann, F. and Schenk, B . , pp 41-47, George Thieme 
Verlag, Stuttgart, (1978) .
Riegle, G.D. and Meites, J.
Effects of ageing on LH and prolactin after LHRH L-dopa, methyl- 
dopa, and stress in male rats.
Proc. Soc. Exp. Biol Med., (1976) 151, 507-511.
Rivett, K.F., Heywood, R . , Saxena, S.C. and Offringa, O.R.
Toxicity of DU 41274, an experimental gestagen, in the beagle dog 
after oral administration for 50 weeks.
In "Proceedings of the European Society of Toxicology", eds. Duncan, 




The process of spermatogenesis in mammals.
Biol. Rev., (1962) 37, 343-377.
Rosenkrantz, H. and Kirdani, E.S.
The proteolytic enzymes of canine prostatic fluid.
Cancer Chemother. Rep., (1961) 15, 9-16.
Roussel, J.D, and Austin, C.R.
Improved electro-ejaculation of primates.
J. Inst. Anim. Tech., (1968) 19, 22-32.
Roussel, J.D. and Stallcup, O.T.
Parallelism between semen characteristics and glutamic-oxaloacetic 
transaminase, glutamic-pyruvic transaminase activities.
J. Dairy Sci., (1961) 48, 1684-1687.
Roussel, J.D. and Stallcup, O.T.
Relationships between phosphatase activity and other characteris­
tics in bull semen.
J. Reprod. Fertil., (1966) 12, 423-429.
Rowley, M.J. and Heller, C.G.
The testicular biopsy: Surgical procedure, fixation and staining 
techniques.
Fertil. Steril., (1966) 17, 177-186.
Rubin, R.T., Poland, R.E. and Tower, B.B.
Prolactin-related testosterone secretion in normal adult men.
J. Clin. Endocrinol. Metab., (1976) 42, 112-116.
:251
Russfield, A.B.
Pathology of the endocrine glands, ovary and testis of rats and 
mice.
In "Pathology of Laboratory Rats and Mice", eds. Cotchin, E. and 
Roe, F.J.C., pp 391-4 65, Blackwell Scientific Publications, Oxford, 
(1967).
Saksena, S.K., Lau, I.F., Bartke, A. and Chang, M.C.
Effect of indomethacin on blood plasma levels of LH and 
testosterone in male rats.
J. Reprod. Fertil., (1975) 42, 311-317.
Sandifer, S.H., Wilkins, R.T., Loadholt, C.B., Lane, L.G. and 
Eldridge, J.C.
Spermatogenesis in agricultural workers exposed to dibromochloro- 
propane (DBCP).
Bull. Environ. Contam. Toxicol., (1979) 23, 703-710.
Sato, T., Hirono, M . , Jyujo, T., lesaka. T., Taya, K. and 
Igarishi, M.
Direct action of prostaglandins on the rat pituitary.
Endocrinology, (1975) 96, 45-49.
Scharer, K.
The effect of chronic underfeeding on organ weights of rats. How 
to interpret organ weight changes in cases of marked growth 
retardation in toxicity tests.
Toxicology, (1977) 7, 45-46.
252:
Scott, J.V. and Dzuick, P.J.
Evaluation of the electroejaculation technique and the 
spermatozoa thus obtained from rats, mice and guinea pigs.
Anat. Rec., (1959) 133, 655-664.
Scully, R.E. and Coffin, D.L.
Canine testicular tumours. With special reference to their 
histogenesis, comparative morphology, and endocrinology.
Cancer, (1952) 5, 592-605.
Setchell, B.P. and Waites, G.M.H.
The blood-testis barrier.
In "Handbook of Physiology, Section 7", eds. Greep, R.O. and 
Astwood, E.B., vol. 5, pp. 143-172, American Physiological Society, 
Washington D.C., (1975).
Setchell, B.P., Davies, R.V. and Main, S.J.
Inhibin.
In "The Testes", eds. Johnson, A.D. and Gomes, W.R., vol. 4, pp 
189-238, Academic Press, New York, (1977).
Setchell, B.P. and Main, S.J.
Drugs and the blood-testis barrier.
Environ. Health Persp», (1978) 24, 61-64.
Setty, B.S., Kar, A.B., Roy, R.K. and Chowdhury, S.R.
Studies with sub-toxic doses of a-chlorohydrin in the male monkey 
(Macaca mulatta).
Contraception, (1970) 1, 279-289.
Sherrins, R.J., Gandy, H.M., Thorslund, T.W. and Paulsen, C.A. 
Pituitary and testicular function studies. I. Experience with a new 
gonadal inhibitor, 17a-pregn-4-en-20-yno-(2,3-d) isoxayol-17-ol 
(Danazol).
J. Clin. Endocrinol. Metab., (1971) 32, 522-531.
Sieber, S.M., Correa, P., Dalgard, D.W. and Adamson, R.H. 
Carcinogenic and other adverse effects of procarbazine in non­
human primates.
Cancer Res., (1978) 38, 2125-2134.
Silvestrini, B . , Burberi, S., Catanese, B . , Cioli, V., Coulston,
F . , Lisciani, R. and Scorza-Barcellona, P.
Antispermatogenic activity of l-p-chlorobenzyl-lH-indazole-3- 
carboxylic acid (AF 1312/TS) in rats.
Exp. Mol. Pathol., (1975) 23, 288-307.
Simonel, C.C., Brooks, C.L. and Welsch, C.W.
Effects of ether anaesthesia on plasma prolactin sampling. 
Experientia, (1975) 31, 688-689.
Singh, G.B. and Khanna, S.K.
Testicular lesions induced by metanil yellow .in mice.
Exp. Pathol., (1974) 9, 251-255.
Slob, A.K., Ooms. M.P. and Vreeburg, J.T.M.
Annual changes in serum testosterone in laboratory housed male
stumptail macaques (M. arctoides) .
Biol. Reprod., (1979) 20, 981-984.
Smith, M.S. and McDonald, L.E.
Serum levels of luteinizing hormone and progesterone during the 
estrous cycle, pseudopregnancy and pregnancy in the dog. 
Endocrinology, (1974) 94, 404-412.
:254:
Smyth, H.F., Carpenter, C.P., Weil, C.S., Pozzani, V.C., Striegel, 
J.A. and Nycum, J.S.
Range-finding toxicity data: List VII.
Am. Ind. Hyg. Assoc. J . , (1969) 30, 470-476.
Sorgen, C.D. and'Glass, R.H.
Lack of effect of prostaglandin F^^ on the fertilising capacity of 
rabbit sperm.
Prostaglandins, (1972) 1, 229-233.
Sorrentino, L . , Capasso, F. and di Rosa, M.
Indomethacin and prostaglandins.
Eur. J. Pharmacol., (1972) 17, 306-308.
Spitz, S.
The histological effects of nitrogen mustards on human tumours and 
tissues.
Cancer, (1948) 1, 383-398.
Steinberger, E.
A quantitative study of the effect of pn alkylating agent 
(triethylenemelamine) on the seminiferous epithelium of rats.
J. Reprod. Fertil., (1962) 3, 250-259.
Steinberger, E.
Hormonal control of mammalian spermatogenesis.
Physiol. Rev., (1971) 51, 1-22.
Steinberger, E. and Sud, B.N.
Specific effect of fluoroacetamide on spermiogenesis.
Biol. Reprod., (1970) 2, 369-375.
:255:
steinberger, E., Boccabella, A. and Nelson, W.O.
Cytotoxic effects of 5-chlor-2-acetyl thiophen (Ba 11044, Ciba) on 
the testes of the rat.
Anat. Rec., (1956) 125, Abstr,, 312-313.
Stevens, M.T.
The value of relative organ weights.
Toxicology, (1975) 5, 311-318.
Svare, B . , Bartke, A., Doherty, P., Mason, I., Michael, S.D. and 
Smith, M.S.
Hyperprolactinaemia suppresses copulatory behaviour in male rats 
and mice.
Biol. Reprod., (1979) 21, 529-535.
Swanson, E.W. and Boyd, L.J.
Factors affecting coiled-tail spermatozoa in the bull.
Am. J. Vet. Res., (1962) 3, 300-309.
Swierstra, E.E. and Foote, R.H.
Cytology and kinetics of spermatogenesis in the rabbit.
J. Reprod. Fertil., (1963) 5, 309-322.
Swierstra, E.E., Whitefield, J.W. and Foote, R.H.
Action of amphotericin B (Fungizone) on spermatogenesis in the 
rabbit.
J. Reprod. Fertil., (1964) 7, 13-19.
Takatori, T. and Yamaoka, A.
Effects of phenylmethylsulphonylfluoride on activities of 
cholesterol ester synthesis and hydrolysis in testes of rats, and 
on serum testosterone and LH levels.
J. Reprod. Fertil., (1979) 55, 69-74.
:256:
Takemori, A.E.
Biochemistry of drug dependence.
Annu. Rev. Biochem., (1974) 43, 15-33.
Taylor, J.M. and Friedman, L.
Combined ùhronic feeding and three-generation reproduction study of 
sodium saccharin in the rat.
Toxicol. Appl. Pharmacol., (1974) 29, Abstr., 154.
Taylor, J.D,, Richards, R.K. and Wiegand, R.G.
Toxicological studies with sodium cyclamate and saccharin.
Food Cosmet. Toxicol., (1968) 6, 313-327.
Tenniswood, M.P., Abrahams, P.P., Bird, C.E. and Clark, A.F.
Effects of castration and androgen replacement on acid 
phosphatase activity in the adult rat prostate gland.
J. Endocrinol., (1978) 77, 301-308.
Texter, J.H. and Coffey, D.S.
The effects of Amphotericin B on prostatic and testicular function 
in the dog.
Invest. Urol., (1969) 7, 90-106.
van Thiel, D.H., Gavaler, J.S., Smith, W.I. and Paul, G. 
Hypothalamic-pituitary-gonadal dysfunction in men using 
cimetidine.
New Engl. J. Med., (1979) 300, 1012-1015.
Thomas, J.A. and Dombrosky, J.T.
Effect of methadone on the male reproductive system.
Arch. Int. Pharmacodyn. Ther., (1975) 215, 215-221.
;257
Thomas, J.A., Donovan, M.P. and Schein, L.G.
A biochemical basis for insecticide-induced changes in the male 
reproductive system.
Toxicol. Appl. Pharmacol., (1978) 42, Abstr., 145
Thomas, J.A., Shahid-Salles, K.S. and Donovan, M.P.
Effects of narcotics on the reproductive system.
Adv. Sex. Horm. Res., (1977) 3, 169-195.
Thompson, S.W. and Hunt, R.D.
Spontaneous tumours in the Sprague-Dawley rat: incidence rates of 
some types of neoplasms as determined by serial section versus 
single section technics.
Ann N.Y. Acad. Sci., (1963) 108, 832-845.
Thompson, S.W., Huseby, R.A., Fox, M.A., Davis, C.L. and Hunt, R.D 
Spontaneous tumours in the Sprague-Dawley rat.
J. Natl. Cancer Inst., (1961) 27, 1037-1057.
Thorner, M.O., Besser, G.M., Hagen, C. and McNeilly, A.S.
The relationship between prolactin and gonadotrophins: effect of 
clomiphene administration in normal men.
J. Endocrinol., (1974) 638, 43-44.
Thorpe, E.
Some pathological effects of hexachlorophene in the rat.
J. Comp. Pathol. Ther., (1967) 77, 137-142.
Thorpe, E .
Some toxic effects of hexachlorophene in sheep.
J. Comp. Pathol. Ther., (1969) 79, 167-171.
:258:
de Toranzo, E.G.D., Villarruel, M.C. and Castro, J.A.
Early destruction of cytochrome P-450 in testes of carbon 
tetrachloride poisoned rats.
Toxicology, (1978) 10, 39-44.
Torkelson, T.R., Sadek, S.E., Rowe, V.K., Kodama, J.K., Anderson,
H.H., Loquvam, G.S. and Hine, C.H.
Toxicologic investigations of 1,2-dibromo-3-chloropropane.
Toxicol. Appl. Pharmacol., (1961) 3, 545-559.
Tremblay, R.R., Forest, M.G., Shalf, J . , Martel, J.G., Kowarski, A. 
and Migeon, C.J.
Studies on the dynamics of plasma androgens and on the origin of 
dihydrotestosterone in dogs.
Endocrinology, (1972) 92, 556-581.
Trentini, G.P., Batticelli, A. and Barbalini, G.
Testicular lesions in rats treated for one year with ethambutol 
in low doses.
Virchows Arch. Pathol. Anat. Physiol., (1974) 362, 311-314.
Trieb, G . , Pappritz, G. and Lutzen, L.
Allometric analysis of organ weights. I. Rats.
Toxicol. Appl. Pharmacol., (1976) 35, 531-542.
Tsunoda, Y. and Chang, M.C.
The fertilizing capacity of spermatozoa from rats and mice treated 
with CL-88,236 and AY-22,352 as examined both vivo and ^  vitro, 
Biol. Reprod., (1976) 14, 202-211.
:259 ;
Tuck, R.P., Setchell, B.P., Waites, G.M.H. and Young, J.A.
The composition of fluid collected by micropuncture- and
catheterization from- the— seminiferous tubules and rete testes of 
rats.
Pflügers Arch. Gesamte Meuschen Tiere., (1970) 318, 225-243. 
Vandenbergh, J.A.
The penile smear: An index of sexual maturity in male golden 
hamsters.
Biol. Reprod., (1971) 4, 234-237.
Vane, J.R.
Inhibition of prostaglandin synthesis as a mechanism of action for 
aspirin-like drugs.
Nature (London), (1971) 231, 232-235.
Vessey, M.P. and Doll, R . ,
Investigation of relation between use of oral contraceptives and 
thromboembolic disease. A further report.
Br. Med. J . , (1969) 2, 651-657.
Voglmayr, J.K.
Prostaglandin F 2^ concentration in genital tract secretion of dairy 
bulls.
Prostaglandins, (197 3) 4, 673-678.
Voglmayr, J.K.
Alpha-chlorohydrin-induced changes in the distribution of free 
myo-inositol and prostaglandin F^ ,^  , and synthesis of phospha- 
tidylinositol in the rat epididymis.
Biol. Reprod., (1974) 11, 593-600.
:260i
Wadsworth, P.F.
Some aspects of oestrogen toxicity in the beagle dog and subhuman 
primates.
Ph.D. Thesis, (1979), University of Bath.
Waites, G.M.H.
Permeability of the seminiferous tubules and the rete testis to 
natural and synthetic compounds.
J. Reprod. Fertil., Suppl., (1976) 24, 49-69.
Waites, G.M.H. and Einer-Jensen, W.
Collection and analysis of rete testis fluid from macaque monkeys. 
J. Reprod. Fertil., (1974) 41, 505-508.
Walsh, P.O.
A new cause of male infertility.
New Engl. J. Med., (1979) 300, 253-254.
Weiss, L.R., Williams, J.T. and Krop, S.
Effects of hexachlorophene intoxication on learning in rats. 
Toxicology, (1978) 9, 331-340.
Whorton, D ., Krauss, R.M., Marshall, S. and Milby, T.H.
Infertility in male pesticide workers.
Lancet, (1977) II, 1259-1261.
Wolfe, J.M., Bryan, W.R. and Wright, A.W.
Histologic observations on the anterior pituitaries of old rats 
with particular reference to the spontaneous appearance of 
pituitary adenomata.
Am. J. Cancer, (1938) 34, 352-372.
:261:
Wong, P.Y.D. and Yeung, C.H.
Inhibition by “ -chlorohydrin of fluid reabsorption in the rat 
cauda epididymis.
J. Reprod. Fertil., (1977) 51, 469-471.
Wong, T.-W., Hruban, Z. and Slesers, A.
Chlorcyclizine-induced changes in the epididymides and the 
prostatic complex of rats.
Biol. Reprod., (1972) 7, 398-413.
Wong, T.-W., Straus, F.J. and Warner, N.E.
Testicular biopsy in the study of male infertility. 1. Testicular 
causes of infertility.
Arch. Pathol., (1973a) 95, 151-159.
Wong, T.-W., Straus, F.H. and Warner, N.E.
Testicular biopsy in the study of male infertility. II. Post- 
testicular causes of infertility.
Arch. Pathol., (1973b) 95, 160-164.
Wright, P.L.
Test procedures to evaluate effects of chemical exposure on 
fertility and reproduction.
Environ. Health Persp., (1978) 24, 39-43.
Yang, Y.H.
Polyarteritis nodosa in laboratory rats.
Lab. Invest., (1965) 14, 81-88.
Yeates, W.K.
Male infertility.
J. R. Soc. Med., (1978) 71, 395-396.
;262
Zaneveld, L.J.D., Dragoje, B.M. and Schumacher, G.F.B. 
Acrosomal proteinase and proteinase inhibitor of human 
spermatozoa.
Science, (1972) 177, 702-703.
d o U . Spcrwt«itoj9nîfi tUc rcpaur s c W n ifc iv ^
W /iTaJûfttûw oÇ- tk t  ffct ,
N w v.T . Arviot.) V29?, Z V S -Z K  .
^K. UvkA T>foiy, V.
Pro^o^lowMiUw» VV» Uruk i^ otfiJQUL bcMÂcwlUr CAif#>ul«. op 
ovmH tuSa .
frosto^Uu^Uûv» , \'h,
M o w , S.T.,T)<fcVCU>, R .V.; h.Gr.kf.L. Ouful SoktkiM,
B . e .
WmjJL ^jovwoiofcrophmfr c^(4^\
dl^brvkfiXMV\ oÇ ^«4r*w\na2 odUA W  k )
X -  uraÂik.afÂrnA onr .
y ^JVulUcvWtt.j C\SrH») ^ 1
:263:
A C K N O W L E D G M E N T S
Grateful thanks and appreciation are due to the following
Professor A.N. Worden, Wolfson College, Cambridge and Founder of 
the Huntingdon Research Centre, Dr. R. Heywood and Dr. D. Mansel- 
Jones for constant encouragement to undertake research and 
helpful advice and criticism in presenting the results obtained.
The animal technicians who have ensured the health and welfare of 
the animals used for experimental studies.
Dr. D. Crook, Huntingdon Research Centre, for technical 
collaboration and assistance with radioimmunoassay procedures
Mr. H. Chesterman, Mr. B. Hunter, Mr. D.E. Prentice and Mr. A.E, 
Street, Huntingdon Research Centre, for permitting the use of 
facilities and materials in their departments.
The library staff, Huntingdon Research Centre, for obtaining and 
verifying the references cited in the text.
Miss J. Mejer, Huntingdon Research Centre, for excellent 
secretarial assistance and for typesetting the manuscript.
Finally to all my relatives, friends and colleagues for their 
consideration and support during the period of my endeavours.
: 264 ;
A P P E N D I X  I
Materials and Methods
(i) Animal Sources
Beagle dogs obtained from commercial suppliers (Beaulong Ltd., 
Harewood Park, Harewood End, Herefordshire; Balbeggie Kennels, 
Thornton Road, Kirkcaldy, Fife), or the colony maintained at 
Huntingdon Research Centre and Sprague-Dawley rats of the CD 
(Charles River Ltd., Manston, Kent, U.K. or Wilmington, Mass., 
U.S.A.) and CFY (Anglia Laboratory Animals, Alconbury, Huntingdon, 
Cambridgeshire) strains were used for the experiments. All 
animals were allowed at least 10 days acclimatisation to our 
laboratory environment before experimental treatment commenced.
(ii) Animal Management
Beagle dogs were housed individually in galvanised metal kennels. 
Apart from vaccination against distemper, hepatitis and lepto­
spirosis and regular anthelmintic therapy (.'Cobpane', Wellcome 
Veterinary Products), no medication was permitted. Each dog was 
offered 400 g Spratt's Dog Diet No. 2 (Spratt's Laboratory Services, 
Barking, Essex) daily and tap water was freely available.
Rats were housed in barrier-maintained rooms and caged in fives in 
suspended metal cages with wire mesh flooring. Room temperature 
and relative humidity were maintained at 21 - 2°C and 50 - 5% 
respectively. Lighting was controlled to give alternate 12 h 
periods (8 a.m. to 8 p.m. BST) of light and dark. Spratt's 
Laboratory Rodent Diet No. 1 (Spratt's Laboratory Services, Barking, 
Essex) and tap water were freely available.
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(iii) Body Weight Change, Food and Water Intake
The body weight of all animals was determined at least once before 
the start of experimental treatment. Throughout the experiments 
body weight recordings were made at 7-day intervals. Food 
consumption was measured daily for individual dogs but water intake 
was measured on weekdays only. The cage mean water and food intake 
of rats was measured once weekly.
(iv) Testicular measurements
Testicular measurements were recorded for the canine studies only
The length (/) and breadth (b) of each testis was measured in the
2
scrotum using vernier calipers. The area (mm ) given by the 
formula T^b/4 was used as an index of testicular size.
(v) Withdrawal of Blood
Blood samples were obtained from dogs by hypodermic puncture of 
the jugular vein. Rats were bled by puncture of the orbital sinus  ^
under deep ether anaesthesia. The blood was collected into lithium 
heparin bottles (for plasma) or plain plastic vials (for serum) and 
allowed to stand at room temperature for at least 20 minutes. 
Following centrifugation at 5000 g for 10 minutes, the supernatant 




Prolactin, luteinising hormone (LH), follicle-stimulating hormone 
(FSH) and testosterone concentrations were measured in serum or 
plasma by radioimmunoassay.
Canine samples were assayed for prolactin concentration using the 
homologous double antibody method of Graf, Friederich, Matthes and 
Hasan (J. Endocr. , (1977) 93-103). Purified canine prolactin
CPA3/F4, supplied by Drs. El Etreby and Hasan, Endocrine Laborator­
ies, Sobering AG, Berlin, was radio-iodinated using the lacto- 
peroxidase procedure (Knight, Hamilton and Scanes, Acta Endocr.,
(1977) 736-743). CPA3/F4 was also used as a standard, being
assayed in triplicate over the range 0.625 - 160 ng/ml. Test 
samples were assayed in duplicate at a level of 200 jal. The 
prolactin radioimmunoassays on samples from rats during median life­
span administration of Compound B were performed by Dr. C. Robyn, 
Hospital Universitaire St. Pierre, Brussels.
Canine LH was assayed using the double antibody radioimmunoassay 
devised by Niswender, Riechert, Midgley and Nalbondov (Endocrinology, 
(1969) 1166-1173) using Niswender's ovine LH antibody No. 15,
radio-iodinated ovine LH (LER-1056-C2) and a canine pituitary 
reference standard (LER-1685-1; 0.025 NIH-LH-SI units/mg). The use 
of anti-ovine LH antisera has been validated for canine LH assays 
by Smith and McDonald (Endocrinology, (1974) 94.f 404-412). The 
buffer used for the dilution of unknown and standard samples was
0.1% gelatin in O.OIM phosphate-buffered saline, pH 7.6. Unknown 
samples were assayed in duplicate at a volume of 100 p i ; standards 
were assayed in triplicate over the range 0.025 - 12.8 ng/tube 
and contained 100 pi of pooled rhesus monkey serum per tube. The
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second antibody (goat anti-rabbit gamma globulin) was used at 1:80 
dilution in O.OIM phosphate-buffered saline, pH 7.6. The lowest 
limit of detectability of the assay was 0.5 ng/ml LH.
Rat LH and FSH were assayed by the method of Daane and Par low,- (End­
ocrinology (1971) 88,. 653-663), using reagents and techniques obtained 
from the National Institute of Arthritis, Metabolism and Digestive 
Diseases,pituitary hormone distribution programme by courtesy of Dr. 
A.F. Parlow. Department of Obstetrics and Gynecology, Harbor General 
Hospital, University of California, 1000 West Carson Street, 
Torrance, California 90509. Testosterone concentrations were 
determined in rat and dog material essentially following the pro­
cedure of Frankel, Mock, Wright and Kamel (Steroids, (1975) 25, 
73-98), but modified as follows. Testosterone was extracted using 
diethyl ether and petroleum ether (1:4 mixture); testosterone-ll^- 
hemisuccinate was radio-iodinated by the 'chloramine T ' procedure; 
separation of free and bound fractions was achieved using 50% 
saturated ammonium sulphate. The lowest level of detectability of 
the assay was 0.2 ng/ml testosterone.
(vii) Semen examination
Semen was collected from dogs using the artificial vagina method 
described by Harrop (Br. Vet. J. (1954) 110, 194-196). The quality 
of the semen obtained was evaluated as described by Heywood and 
Sortwell (J. small Anim. Pract., (1971) ]^, 343-346). The follow­
ing characteristics were assessed:
Volume (ml) - ejaculates were collected in graduated tubes;
Density (0-5) - visual grading on a O - 5 scale;
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Motility (0-5) - examination of one drop of fresh semen at 100
X magnification;
0 = no motile spermatozoa
1 = approximately 20% of spermatozoa motile
2 = approximately 40% of spermatozoa motile
3 = approximately 60% of spermatozoa motile
4 = approximately 80% of spermatozoa motile
5 = virtually 100% of spermatozoa motile.
Sperm concentration (10^/ml or 10^/ejaculate). 0.1 ml of
ejaculate was diluted in 2 ml 0.5% formol saline containing a trace 
of eosin. 0.1 ml of the resulting diluent was placed in the well 
of a modified Neubauer haemocytometer and the spermatozoa were 
counted at x 250 magnification. Sperm concentration was expressed 
both as millions per ml of ejaculate and as millions per total
ejaculate.
Sperm morphology A drop of fresh semen was placed on a
microscope slide and mixed with a drop of 10% nigrosin followed by
mixing and spreading. The resultant smear was air-dried and 
examined by oil immersion microscopy. Live spermatozoa are 
unstained and dead spermatozoa stain pink. The percentage of live 
or dead normal and live or dead abnormal spermatozoa was classified 
by examination of five fields per smear. Air-dried nigrosin smears 
do not constitute a permanent record,and when abnormalities were 
apparent,air-dried unstained smears were fixed in 70% methanol and 
stained with Giemsa stain (Watson, Vet. Rec. , (1975) 97^ , 12-15), or
aniline blue and eosin (L. Cooke, personal communication) before 
mounting in Canada balsam.
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Limited biochemical examinations were performed on some semen 
samples. Ejaculates were kept at room temperature for approximately 
30 minutes and were then centrifuged at 2000 g for 10 minutes. 
Supernatant seminal plasma was decanted off and the remaining sperm 
fractions were resuspended in Fisons ' phosphate buffer (pH 7.0, Na'*’ 
53 itiEq/1 and k"*” 20.1 mEq/1) . The samples were stored at - 20°C 
pending biochemical examination. Enzyme and electrolyte concentra­
tions in either fraction were examined as follows. Na^ and k"*" ion 
concentration was determined using an IL/34 3 flame photometer. 
Alanine aminotransferase (AIT 2.6.1.2.) and aspartate aminotransfer­
ase (AsT 2.6.1.1.) activities were estimated using a Union Carbide 
Centrifichem and Roche Diagnostics Test Kits (mU/ml). Acid and 
alkaline phosphatase concentrations were determined also using a 
Union Carbide Centrifichem and Smith Kline Instruments Test Kits 
(mU/ml).
(viii) Histological Preparation
Representative pieces of selected tissues were preserved for 
histopathological examination as follows: testes in formol saline 
solution for 24 h followed by post-fixation in buffered neutral 
formalin solution; pituitaries in mercuric chloride for 12 h foll­
owed by post-fixation in formol saline solution; prostate in 
buffered neutral formalin solution. The preparation and properties 
of these fixatives is described in 'Manual of Histologic Staining 
Methods of the Armed Forces Institute of Pathology', Ed. L.G. Luna, 
3rd Edition, McGraw-Hill Book Company, New York, (1960) pp 2-3. 
Samples of tissue obtained by percutaneous testicular biopsy were 
preserved in Helly's solution (Rowley and Heller, Fert. and Steril., 
(1966) 17, 177-186).
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Following preservation and adequate fixation, the tissues were 
passed through graded ethanol solutions before being embedded in 
melted paraffin wax (56°C). Microtome sections cut at 5 |im were 
stained as follows. Testes were stained with the periodic acid 
schiff technique (PAS) for demonstration of glycogen in 
spermatids (McManus, Stain Techn., (1948) 7^, 99-108). Differen­
tial staining of the anterior pituitary cells was achieved using 
the PAS-Alcian blue-Orange G procedure described by El Etreby 
and Tüshaus (Histochemie, (1973) 3^, 121-127), Prostate sections 
were stained routinely with Harris' haematoxylin and eosin 
(Histopathology Laboratories, Armed Forces Institute of Pathology, 
Washington D.C., 20305).
(ix) Quantitative Testicular Histomorphometry
Quantitative histomorphometric analysis of spermatogenesis was 
performed using the histological sections prepared (Appendix I
(vi) ) from dog and rat testes. The cyclical activity of the 
seminiferous epithelium (Roosen-Runge, Ann. N.Y. Acad. Sci.,
(1952) 574-584 and Biol. Rev., (1962) 37, 343-377) fa\^cili-
tates recognition of stages of spermatogenesis based on the 
position and morphology of spermatids associated with specific 
earlier cell types. The cycle of the seminiferous epithelium 
has been documented for a number of species including the dog 
(Foote, Swierstra and Hunt, Anat. Rec. , (1972) 173, 341-351) and 
rat (Clermont and Perey, Rev. Canad. Bio., (1957) 451-462) .
Although Clermont and Perey recognised 19 morphological phases of 
spermatid development for the rat, it is sufficient to define 
eight characteristic cellular associations in the rat and dog 
testis. The results presented in this thesis are based on adoption 
of the eight stage classification to facilitate species comparisons.
: 271:
In the following description of the cells present in successive 
■'stages of spermatogenesis, the roman numerals in parenthesis 
indicate the corresponding stages in Clermont and Perey's more 
elaborate classification.
Stage 1 (VIII-IX)
Type A spermatogonia, leptotene young primary spermatocytes, 
pachytene old primary spermatocytes and round spermatids.
Stage 2 (X-XI)
Type A spermatogonia, leptotene young primary spermatocytes, 
pachytene old primary spermatocytes and elongating spermatids.
Stage 3 (XII-XIII)_
Type A spermatogonia, zygotene young primary spermatocytes, 
diplotene old primary spermatocytes and elongating spermatids.
Stage 4 (XIV)
Type A spermatogonia, pachytene old primary spermatocytes, 
secondary spermatocytes and elongated spermatids attaching in 
groups to Sertoli cells.
Stage 5 (I-III)
Type A spermatogonia, pachytene old primary spermatocytes, round 
spermatids and elongated spermatids attached to Sertoli cells.
Stage 6 (IV-V)
Type A and B spermatogonia, pachytene old primary spermatocytes, 




Type A and B spermatogonia, pachytene old primary spermatocytes, 
round spermatids, elongated spermatids detaching from Sertoli 
cells and migrating towards tubule lumen.
Stage 8 (VII)
Type A spermatogonia, preleptotene young primary spermatocytes, 
pachytene old primary spermatocytes, round spermatids and tailed 
spermatids (spermatozoa) detached in lumen of tubule.
Tubules at stage 7, 5, 1 and 8 were selected for counting 
type B spermatogonia, old pachytene primary spermatocytes, early 
(round) spermatids and late (elongated) spermatids respectively. 
Only tubules in circular cross-section were examined; a minimum of 
three tubules at each stage was counted in each section (i.e. 24 
tubules per animal). The diameter of each tubule (^) was 
measured twice at right angles using an optical graticule 
(Graticules Ltd., Tonbridge, Kent, UK) and the mean value calcu­
lated. Sertoli cell counts were also recorded. The crude cell 
counts were corrected for differing nuclear (Abercrombie, Anat. 
Rec., (1946) £4, 239-247) and tubular (Swierstra and Foote, J. 
Reprod. Fert., (1963) 309-322) diameters using the following
formula:
M A 
T = C X ______ X _ ,.where
N+M D
T = true count, C = crude count,
M = thickness of section (pm), N = average nuclear diameter
(pm) of 10 nuclei of given cell type, D = observed diameter
(pm) of tubule, A = average diameter (jam) of seminiferous
tubules for that species.
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Summary tables of the quantitative testicular histomorphometric 
data obtained from the control rats and Beagle dogs used for these 
studies follow overleaf.
1 (x) Statistical procedures
Measures of the distribution of the data were expressed as
arithmetic means, standard deviations and absolute or 95% ranges.
The experimental design and small number of animals used for some
of the investigations restricted the value of statistical
comparisons; however the results of statistical calculations were
included for completeness and to confirm biological trends. Tests
of statistical probability included analysis of variance (ANOVAR),
paired 't'-tests, linear regression analysis, Fisher's Exact test 
2
and X test for trends in linear proportions (Snedecor, G.W. 
and Cochran, G.W., Statistical Methods, Iowa State Press, 1968). 
The use of ANOVAR was justified by testing for homogeneity of 
variance (Bartlett's test) and calculating the variance (F) ratio. 
When significant heterogeneity of variance occurred (p<0.01), 
data transformation did not stabilise variances and there were too 
few observations to justify the use of non-parametric tests.
When experimental treatment affected body weight, organ weights 
were analysed using analysis of covariance (Angervall, L. and 
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